0001641172-25-010230.txt : 20250514 0001641172-25-010230.hdr.sgml : 20250514 20250514153032 ACCESSION NUMBER: 0001641172-25-010230 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 88 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250514 DATE AS OF CHANGE: 20250514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Investview, Inc. CENTRAL INDEX KEY: 0000862651 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] ORGANIZATION NAME: 07 Trade & Services EIN: 870369205 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-27019 FILM NUMBER: 25944888 BUSINESS ADDRESS: STREET 1: 521 W. LANCASTER AVE STREET 2: FLOOR 2 CITY: HAVERFORD STATE: PA ZIP: 19041 BUSINESS PHONE: 732-889-4300 MAIL ADDRESS: STREET 1: 521 W. LANCASTER AVE STREET 2: FLOOR 2 CITY: HAVERFORD STATE: PA ZIP: 19041 FORMER COMPANY: FORMER CONFORMED NAME: Global Investor Services, Inc. DATE OF NAME CHANGE: 20081001 FORMER COMPANY: FORMER CONFORMED NAME: TheRetirementSolution.com, Inc. DATE OF NAME CHANGE: 20060918 FORMER COMPANY: FORMER CONFORMED NAME: Voxpath Holdings, Inc. DATE OF NAME CHANGE: 20060619 10-Q 1 form10-q.htm 10-Q
false --12-31 Q1 0000862651 0000862651 2025-01-01 2025-03-31 0000862651 2025-05-09 0000862651 2025-03-31 0000862651 2024-12-31 0000862651 us-gaap:RelatedPartyMember 2025-03-31 0000862651 us-gaap:RelatedPartyMember 2024-12-31 0000862651 us-gaap:NonrelatedPartyMember 2025-03-31 0000862651 us-gaap:NonrelatedPartyMember 2024-12-31 0000862651 2024-01-01 2024-03-31 0000862651 INVU:MembershipRevenueMember 2025-01-01 2025-03-31 0000862651 INVU:MembershipRevenueMember 2024-01-01 2024-03-31 0000862651 INVU:MiningRevenueMember 2025-01-01 2025-03-31 0000862651 INVU:MiningRevenueMember 2024-01-01 2024-03-31 0000862651 INVU:HealthAndWellnessRevenueMember 2025-01-01 2025-03-31 0000862651 INVU:HealthAndWellnessRevenueMember 2024-01-01 2024-03-31 0000862651 INVU:OtherMember 2025-01-01 2025-03-31 0000862651 INVU:OtherMember 2024-01-01 2024-03-31 0000862651 us-gaap:NonrelatedPartyMember 2025-01-01 2025-03-31 0000862651 us-gaap:NonrelatedPartyMember 2024-01-01 2024-03-31 0000862651 us-gaap:RelatedPartyMember 2025-01-01 2025-03-31 0000862651 us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0000862651 us-gaap:PreferredStockMember 2023-12-31 0000862651 us-gaap:CommonStockMember 2023-12-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000862651 us-gaap:TreasuryStockCommonMember 2023-12-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000862651 us-gaap:RetainedEarningsMember 2023-12-31 0000862651 us-gaap:NoncontrollingInterestMember 2023-12-31 0000862651 2023-12-31 0000862651 us-gaap:PreferredStockMember 2024-12-31 0000862651 us-gaap:CommonStockMember 2024-12-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000862651 us-gaap:TreasuryStockCommonMember 2024-12-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000862651 us-gaap:RetainedEarningsMember 2024-12-31 0000862651 us-gaap:NoncontrollingInterestMember 2024-12-31 0000862651 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0000862651 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000862651 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000862651 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000862651 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0000862651 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0000862651 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000862651 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0000862651 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000862651 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0000862651 us-gaap:PreferredStockMember 2024-03-31 0000862651 us-gaap:CommonStockMember 2024-03-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000862651 us-gaap:TreasuryStockCommonMember 2024-03-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000862651 us-gaap:RetainedEarningsMember 2024-03-31 0000862651 us-gaap:NoncontrollingInterestMember 2024-03-31 0000862651 2024-03-31 0000862651 us-gaap:PreferredStockMember 2025-03-31 0000862651 us-gaap:CommonStockMember 2025-03-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000862651 us-gaap:TreasuryStockCommonMember 2025-03-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000862651 us-gaap:RetainedEarningsMember 2025-03-31 0000862651 us-gaap:NoncontrollingInterestMember 2025-03-31 0000862651 INVU:ContributionAgreementMember INVU:WealthGeneratorsLLCMember 2017-04-01 0000862651 INVU:ContributionAgreementMember INVU:WealthGeneratorsLLCMember 2017-04-01 2017-04-01 0000862651 INVU:AcquisitionAgreementMember INVU:MarketTrendStrategiesLLCMember 2017-06-06 2017-06-06 0000862651 INVU:MembershipRevenueMember 2025-03-31 0000862651 INVU:MembershipRevenueMember 2024-12-31 0000862651 INVU:ForeignRevenueMember 2025-01-01 2025-03-31 0000862651 INVU:DomesticRevenueMember 2025-01-01 2025-03-31 0000862651 INVU:ForeignRevenueMember 2024-01-01 2024-03-31 0000862651 INVU:DomesticRevenueMember 2024-01-01 2024-03-31 0000862651 INVU:FurnitureFixturesAndEquipmentMember 2025-03-31 0000862651 INVU:FurnitureFixturesAndEquipmentMember 2024-12-31 0000862651 us-gaap:ComputerEquipmentMember 2025-03-31 0000862651 us-gaap:ComputerEquipmentMember 2024-12-31 0000862651 INVU:DataProcessingEquipmentMember 2025-03-31 0000862651 INVU:DataProcessingEquipmentMember 2024-12-31 0000862651 INVU:ManufacturingEquipmentMember srt:MinimumMember 2025-03-31 0000862651 INVU:ManufacturingEquipmentMember srt:MaximumMember 2025-03-31 0000862651 INVU:ManufacturingEquipmentMember 2025-03-31 0000862651 INVU:ManufacturingEquipmentMember 2024-12-31 0000862651 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000862651 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000862651 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000862651 us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000862651 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000862651 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000862651 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000862651 us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000862651 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0000862651 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0000862651 us-gaap:WarrantMember 2025-01-01 2025-03-31 0000862651 us-gaap:WarrantMember 2024-01-01 2024-03-31 0000862651 us-gaap:ConvertibleDebtSecuritiesMember 2025-01-01 2025-03-31 0000862651 INVU:ConversionOfNonVotingMembershipInterestMember 2025-01-01 2025-03-31 0000862651 2025-01-01 2025-01-01 0000862651 us-gaap:RetainedEarningsMember 2025-01-01 2025-01-01 0000862651 INVU:BitcoinMember 2025-03-31 0000862651 INVU:USDCMember 2025-03-31 0000862651 INVU:ConvertiblePromissoryNoteOneMember 2025-03-31 0000862651 INVU:ConvertiblePromissoryNoteOneMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember 2025-03-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteThreeMember 2025-03-31 0000862651 INVU:ConvertiblePromissoryNoteThreeMember 2024-12-31 0000862651 INVU:WorkingCapitalPromissoryNoteMember 2025-03-31 0000862651 INVU:WorkingCapitalPromissoryNoteMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteOneMember 2025-03-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember 2025-03-31 0000862651 INVU:ConvertiblePromissoryNoteThreeMember 2025-03-31 0000862651 INVU:ConvertiblePromissoryNoteOneMember INVU:DBRCapitalLLCMember 2020-04-27 2020-04-27 0000862651 INVU:ConvertiblePromissoryNoteOneMember INVU:DBRCapitalLLCMember 2020-04-27 0000862651 INVU:ConvertiblePromissoryNoteOneMember INVU:DBRCapitalLLCMember 2020-11-09 0000862651 INVU:ConvertiblePromissoryNoteOneMember INVU:DBRCapitalLLCMember 2025-01-01 2025-03-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember INVU:DBRCapitalLLCMember 2020-05-27 2020-05-27 0000862651 INVU:ConvertiblePromissoryNoteTwoMember INVU:DBRCapitalLLCMember 2020-05-27 0000862651 INVU:ConvertiblePromissoryNoteTwoMember INVU:DBRCapitalLLCMember 2020-11-09 0000862651 INVU:ConvertiblePromissoryNoteTwoMember INVU:DBRCapitalLLCMember 2025-01-01 2025-03-31 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:DBRCapitalLLCMember 2020-11-09 2020-11-09 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:DBRCapitalLLCMember 2020-11-09 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:DBRCapitalLLCMember 2025-01-01 2025-03-31 0000862651 INVU:SecuritiesPurchaseAgreementsMember INVU:SSATechnologiesLLCMember 2021-03-22 0000862651 INVU:WorkingCapitalPromissoryNoteMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember srt:MaximumMember 2021-03-22 0000862651 INVU:WorkingCapitalPromissoryNoteMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2025-03-31 0000862651 INVU:WorkingCapitalPromissoryNoteMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2021-03-22 0000862651 INVU:WorkingCapitalPromissoryNoteMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2025-01-01 2025-03-31 0000862651 INVU:WorkingCapitalPromissoryNoteMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2021-03-22 2021-03-22 0000862651 INVU:WorkingCapitalPromissoryNoteMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2024-01-01 2024-09-30 0000862651 INVU:DBRCapitalLLCMember INVU:SecuritiesPurchaseAgreementsMember 2020-04-27 2020-04-27 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:MarioRomanoAndAnnetteRaynorMember 2023-09-29 2023-09-29 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:MarioRomanoAndAnnetteRaynorMember 2023-09-29 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:MarioRomanoAndAnnetteRaynorMember 2025-03-31 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:MarioRomanoAndAnnetteRaynorMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2025-03-31 0000862651 us-gaap:CommonStockMember INVU:StockPurchaseAndReleaseAgreementMember INVU:RyanSmithAndChandMillerMember 2024-02-07 2024-02-07 0000862651 us-gaap:CommonStockMember INVU:StockPurchaseAndReleaseAgreementMember INVU:RyanSmithAndChandMillerMember 2024-02-07 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:RyanSmithAndChandMillerMember 2025-03-31 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:RyanSmithAndChandMillerMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2025-03-31 0000862651 INVU:USSmallBusinessAdministrationMember 2025-03-31 0000862651 INVU:USSmallBusinessAdministrationMember 2024-12-31 0000862651 INVU:USSmallBusinessAdministrationMember 2020-04-01 2020-04-30 0000862651 INVU:USSmallBusinessAdministrationMember 2020-04-30 0000862651 INVU:USSmallBusinessAdministrationMember 2025-01-01 2025-03-31 0000862651 INVU:APEXTexLLCMember 2020-11-30 0000862651 INVU:APEXTexLLCMember us-gaap:CommonStockMember 2020-04-01 2021-03-31 0000862651 INVU:APEXTexLLCMember us-gaap:PreferredStockMember 2020-04-01 2021-03-31 0000862651 INVU:APEXTexLLCMember 2020-04-01 2021-03-31 0000862651 INVU:APEXTexLLCMember 2024-01-01 2024-03-31 0000862651 INVU:APEXTexLLCMember 2024-03-31 0000862651 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember us-gaap:WarrantMember 2025-03-31 0000862651 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember us-gaap:WarrantMember 2025-03-31 0000862651 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember us-gaap:WarrantMember 2025-03-31 0000862651 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember us-gaap:WarrantMember 2025-03-31 0000862651 us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember us-gaap:WarrantMember 2025-03-31 0000862651 us-gaap:MeasurementInputPriceVolatilityMember srt:MaximumMember us-gaap:WarrantMember 2025-03-31 0000862651 INVU:WyckoffLeaseMember 2021-07-01 2021-07-31 0000862651 INVU:WyckoffLeaseMember 2021-07-31 0000862651 INVU:WyckoffLeaseMember 2025-01-01 2025-03-31 0000862651 INVU:HaverfordLeaseMember 2021-09-30 0000862651 INVU:HaverfordLeaseMember 2025-01-01 2025-03-31 0000862651 INVU:WarminsterLeaseMember 2024-11-01 2024-11-30 0000862651 INVU:WarminsterLeaseMember 2024-11-30 0000862651 INVU:IvylandLeaseMember 2024-12-01 2024-12-31 0000862651 INVU:IvylandLeaseMember 2024-12-31 0000862651 us-gaap:SeriesBPreferredStockMember 2025-03-31 0000862651 us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-03-31 0000862651 INVU:UnitOfferingMember 2020-04-01 2021-03-31 0000862651 INVU:UnitOfferingMember 2021-03-31 0000862651 INVU:UnitOfferingMember 2021-08-17 2021-08-17 0000862651 us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-03-31 0000862651 INVU:StockRepurchaseProgramMember us-gaap:CommonStockMember 2025-03-06 0000862651 INVU:StockRepurchaseProgramMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000862651 INVU:StockRepurchaseProgramMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000862651 INVU:StockRepurchaseProgramMember 2025-01-01 2025-03-31 0000862651 INVU:StockRepurchaseProgramMember 2024-01-01 2024-03-31 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember INVU:ClassBUnitsMember 2025-03-31 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember INVU:ClassBUnitsMember 2024-12-31 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember INVU:ClassBUnitsMember 2025-01-01 2025-03-31 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember 2021-09-02 2021-09-03 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember 2021-09-03 0000862651 2025-01-17 2025-01-17 0000862651 INVU:PromissoryNoteMember 2020-06-01 2020-06-30 0000862651 INVU:PromissoryNoteMember 2020-06-01 2020-06-20 0000862651 INVU:PromissoryNoteMember 2024-12-01 2024-12-31 0000862651 2023-08-01 2023-08-31 0000862651 INVU:IGeniusLLCMember us-gaap:CreditCardMember 2025-03-31 0000862651 INVU:JosephCammarataMember 2021-03-30 0000862651 INVU:JosephCammarataMember 2021-09-21 0000862651 INVU:JosephCammarataMember 2025-01-01 2025-03-31 0000862651 us-gaap:ReportableSubsegmentsMember INVU:FinancialEducationAndTechnologyMember 2025-01-01 2025-03-31 0000862651 us-gaap:ReportableSubsegmentsMember INVU:BlockchainTechnologyAndCryptoMiningProductsAndServicesMember 2025-01-01 2025-03-31 0000862651 us-gaap:ReportableSubsegmentsMember INVU:ManufacturingAndDevelopmentOfHealthBeautyAndWellnessProductsMember 2025-01-01 2025-03-31 0000862651 us-gaap:ReportableSubsegmentsMember 2025-01-01 2025-03-31 0000862651 us-gaap:ReportableSubsegmentsMember INVU:FinancialEducationAndTechnologyMember 2024-01-01 2024-03-31 0000862651 us-gaap:ReportableSubsegmentsMember INVU:BlockchainTechnologyAndCryptoMiningProductsAndServicesMember 2024-01-01 2024-03-31 0000862651 us-gaap:ReportableSubsegmentsMember 2024-01-01 2024-03-31 0000862651 INVU:GoldmansPharmaceuticalsLLCMember 2024-10-11 0000862651 INVU:ElRTTechnologiesLLCMember 2024-10-11 0000862651 INVU:RenuLaboratoriesIncMember 2024-10-11 2024-10-11 0000862651 2024-10-11 0000862651 INVU:RenuLaboratoriesIncMember 2024-10-11 0000862651 us-gaap:SubsequentEventMember INVU:StockRepurchaseProgramMember us-gaap:TreasuryStockCommonMember 2025-04-01 2025-05-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares utr:sqft xbrli:pure INVU:Integer INVU:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED

 

March 31, 2025

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from__________________ to _______________________.

 

Commission File Number 000-27019

 

Investview, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   87-0369205

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

521 West Lancaster Avenue, Second Floor, Haverford, Pennsylvania  

 

19041

(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 732-889-4300

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

 

Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes No

 

As of May 9, 2025, there were 1,857,910,500 shares of common stock, $0.001 par value, outstanding.

 

 

 

 

 

 

INVESTVIEW, INC.

 

Form 10-Q for the Three Months Ended March 31, 2025

 

Table of Contents

 

PART I – FINANCIAL INFORMATION 3
ITEM 1 – FINANCIAL STATEMENTS 3
Condensed Consolidated Balance Sheets as of March 31, 2025 (Unaudited) and December 31, 2024 3
Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) for the Three Months Ended March 31, 2025 and 2024 (Unaudited) 4
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) for the Three Months Ended March 31, 2025 and 2024 (Unaudited) 5
Condensed Consolidated Statements of Cash Flows for the three Months Ended March 31, 2025 and 2024 (Unaudited) 6
Notes to Condensed Consolidated Financial Statements as of March 31, 2025 (Unaudited) 7
ITEM 2 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 30
ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 34
ITEM 4 – CONTROLS AND PROCEDURES 34
PART II – OTHER INFORMATION 35
ITEM 1 – LEGAL PROCEEDINGS 35
ITEM 1.A – RISK FACTORS 35
ITEM 2 – UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 36
ITEM 3 – DEFAULTS UPON SENIOR SECURITIES 36
ITEM 4 – MINE SAFETY DISCLOSURES 36
ITEM 5 – OTHER INFORMATION 36
ITEM 6 – EXHIBITS 37
SIGNATURE PAGE 38

 

2

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1 – FINANCIAL STATEMENTS

 

INVESTVIEW, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   March 31   December 31, 
   2025   2024 
   (unaudited)     
ASSETS          
Current assets:          
Cash and cash equivalents  $17,506,288   $22,467,710 
Prepaid assets   1,294,048    497,620 
Deposits, current   2,807,780    936,434 
Receivables   2,231,577    2,534,727 
Inventory   856,126    495,865 
Income tax paid in advance   459,872    459,872 
Total current assets   25,155,691    27,392,228 
           
Fixed assets, net   1,968,049    1,868,441 
           
Other assets:          
Digital assets   1,676,351    1,127,891 
Goodwill   873,701    873,701 
Intangible assets, net   40,310    40,310 
Operating lease right-of-use asset   173,412    211,996 
Deposits   57,028    57,028 
Total other assets   2,820,802    2,310,926 
           
Total assets  $29,944,542   $31,571,595 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
Current liabilities:          
Accounts payable and accrued liabilities  $6,152,883   $7,139,684 
Payroll liabilities   149,742    271,606 
Income tax payable   209,646    202,573 
Deferred revenue   2,834,758    3,029,145 
Derivative liability   2,853    758 
Dividend liability   247,437    245,101 
Operating lease liability, current   140,112    165,707 
Related party debt, net of discounts, current   1,204,897    1,204,567 
Debt, net of discounts, current   29,244    29,244 
Total current liabilities   10,971,572    12,288,385 
           
Operating lease liability, long term   33,381    46,433 
Accrued liabilities, long term   48,459    45,532 
Related party debt, net of discounts, long term   1,584,327    1,501,041 
Debt, net of discounts, long term   487,932    490,619 
Total long-term liabilities   2,154,099    2,083,625 
           
Total liabilities   13,125,671    14,372,010 
           
Commitments and contingencies   -    - 
           
Stockholders’ equity (deficit):          
Preferred stock, par value: $0.001; 50,000,000 shares authorized, 252,192 and 252,192 issued and outstanding as of March 31, 2025 and December 31, 2024, respectively   252    252 
Common stock, par value $0.001; 10,000,000,000 shares authorized; 1,859,231,786 and 1,859,231,786 shares issued and 1,858,142,500 and 1,859,231,786 outstanding as of March 31, 2025 and December 31, 2024, respectively   1,859,231    1,859,231 
Additional paid in capital   102,947,954    102,560,320 
Treasury stock, at cost, 1,089,286 and 0 shares as of March 31, 2025 and December 31, 2024, respectively   (24,006)   - 
Accumulated other comprehensive income (loss)   (23,218)   (23,218)
Accumulated deficit   (87,947,425)   (87,205,070)
Accumulated noncontrolling interest   6,083    8,070 
Total stockholders’ equity (deficit)   16,818,871    17,199,585 
           
Total liabilities and stockholders’ equity (deficit)  $29,944,542   $31,571,595 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3

 

 

INVESTVIEW, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

AND OTHER COMPREHENSIVE INCOME (LOSS)

(Unaudited)

 

   2025   2024 
   Three Months Ended March 31, 
   2025   2024 
         
Revenue:          
Membership revenue, net of refunds, incentives, credits, and chargebacks  $8,791,443   $13,029,318 
Mining revenue   862,944    2,642,599 
Health and wellness product sales   368,321    - 
Other revenue   7,344    - 
Total revenue, net   10,030,052    15,671,917 
           
Operating costs and expenses:          
Cost of sales and service   1,544,116    2,142,334 
Commissions   5,076,503    7,275,210 
Advertising, selling, and marketing   95,103    11,795 
Salary and related   1,701,092    1,628,970 
Professional fees   610,150    406,529 
General and administrative   1,416,168    2,336,655 
Total operating costs and expenses   10,443,132    13,801,493 
           
Net income (loss) from operations   (413,080)   1,870,424 
           
Other income (expense):          
Gain (loss) on fair value of derivative liability   (2,095)   74 
Realized gain (loss) on digital assets   (13,252)   276,227 
Unrealized gain (loss) on digital assets   (220,184)   - 
Interest expense   (4,623)   (4,675)
Interest expense, related parties   (308,744)   (309,670)
Other income (expense)   284,125    337,635 
Total other income (expense)   (264,773)   299,591 
           
Income (loss) before income taxes   (677,853)   2,170,015 
Income tax expense   (10,000)   (500,075)
           
Net income (loss)   (687,853)   1,669,940 
Net income (loss) attributable to noncontrolling interest   (1,987)   - 
Net income (loss) attributable to Investview, Inc.   (685,866)   1,669,940 
           
Dividends on Preferred Stock   (204,835)   (204,835)
           
Net income (loss) applicable to common shareholders  $(890,701)  $1,465,105 
           
Basic income (loss) per common share  $(0.00)  $0.00 
Diluted income (loss) per common share  $(0.00)  $0.00 
           
Basic weighted average number of common shares outstanding   1,859,076,249    2,053,046,229 
Diluted weighted average number of common shares outstanding   1,859,076,249    3,089,474,800 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4

 

 

INVESTVIEW, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

THREE MONTHS ENDED MARCH 31, 2025 AND 2024

(Unaudited)

 

   Shares   Amount   Shares   Amount   Capital   Shares   Amount   Income (Loss)   Deficit   Interest   Total 
                               Accumulated             
                   Additional           Other             
   Preferred stock   Common stock   Paid in   Treasury stock   Comprehensive   Accumulated   Noncontrolling     
   Shares   Amount   Shares   Amount   Capital   Shares   Amount   Income (Loss)   Deficit   Interest   Total 
                                             
Balance, December 31, 2023   252,192   $252    2,333,356,496   $2,333,356   $104,056,807    -   $-   $(23,218)  $(87,576,899)  $-   $18,790,298 
Common stock issued for services and other stock-based compensation   -    -    -    -    430,760    -    -    -    -    -    430,760 
Common stock repurchased from former related parties and canceled   -    -    (472,374,710)   (472,374)   (3,098,772)   -    -    -    -    -   $(3,571,146)
Dividends   -    -    -    -    -    -    -    -    (204,835)   -    (204,835)
Net income (loss)   -    -    -    -    -    -    -    -    1,669,940    -    1,669,940 
Balance, March 31, 2024   252,192   $252    1,860,981,786   $1,860,982   $101,388,795    -   $-   $(23,218)  $(86,111,794)  $-   $17,115,017 
                                                        
Balance, December 31, 2024   252,192   $252    1,859,231,786   $1,859,231   $102,560,320    -   $-   $(23,218)  $(87,205,070)  $8,070   $17,199,585 
Cumulative effect adjustment upon adoption of ASU 2023-08   -    -    -    -    -    -    -    -    148,346    -    148,346 
Common stock issued for services and other stock-based compensation   -    -    -    -    387,634    -    -    -    -    -    387,634 
Common stock repurchased and held as treasury stock   -    -    -    -    -    1,089,286    (24,006)   -    -    -    (24,006)
Dividends   -    -    -    -    -    -    -    -    (204,835)   -    (204,835)
Net income (loss)   -    -    -    -    -    -    -    -    (685,866)   (1,987)   (687,853)
Balance, March 31, 2025   252,192   $252    1,859,231,786   $1,859,231   $102,947,954    1,089,286   $(24,006)  $(23,218)  $(87,947,425)  $6,083   $16,818,871 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5

 

 

INVESTVIEW INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   2025   2024 
   Three Months Ended March 31, 
   2025   2024 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income (loss)  $(687,853)  $1,669,940 
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:          
Depreciation   224,302    1,178,430 
Amortization of debt discount   83,286    84,210 
Stock issued for services and other stock-based compensation   387,634    430,760 
Lease cost, net of repayment   (63)   14,215 
(Gain) loss on fair value of derivative liability   2,095    (74)
Change in fair value of digital assets   220,184    - 
Realized (gain) loss on digital assets   13,252    (276,227)
Digital assets collected for membership revenue   (336,614)   (407,138)
Revenue recognized from bitcoin mined   (862,944)   (2,642,599)
Operating expenses paid with digital assets   527,058    3,599,825 
Changes in operating assets and liabilities:          
Receivables   303,150    (108,312)
Inventory   (360,261)   - 
Prepaid assets   (796,428)   (151,192)
Deposits   (1,871,346)   (935)
Accounts payable and accrued liabilities   (262,798)   676,274 
Income tax payable   7,073    498,280 
Deferred revenue   (194,387)   4,020 
Accrued interest   4,623    4,675 
Accrued interest, related parties   225,459    225,459 
Net cash provided by (used in) operating activities   (3,374,578)   4,799,611 
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of digital currencies   (1,695)   - 
Purchase of Treasury Stock   (24,006)   - 
Cash paid for fixed assets   (323,910)   (2,903)
Net cash provided by (used in) investing activities   (349,611)   (2,903)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Repayments for related party debt   (225,129)   (225,129)
Repayments for debt   (7,310)   (114,261)
Payments for shares repurchased from former related parties   (842,940)   (842,940)
Dividends paid   (161,854)   (174,760)
Net cash provided by (used in) financing activities   (1,237,233)   (1,357,090)
           
Net increase (decrease) in cash and cash equivalents   (4,961,422)   3,439,618 
Cash and cash equivalents - beginning of period   22,467,710    21,142,630 
Cash and cash equivalents - end of period  $17,506,288   $24,582,248 
           
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:          
Cash paid during the period for:          
Interest  $232,440   $232,440 
Income taxes  $2,927   $1,795 
Non-cash investing and financing activities:          
Common stock repurchased for payables  $-   $3,571,146 
Dividends declared  $204,835   $204,835 
Dividends paid with digital assets  $40,645   $40,170 
Debt extinguished in exchange for digital assets  $-   $38,767 
Cumulative effect adjustment upon adoption of ASU 2023-08  $148,346   $- 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

6

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

 

Organization

 

Investview, Inc. was incorporated on January 30, 1946, under the laws of the state of Utah as the Uintah Mountain Copper Mining Company. In January 2005, we changed domicile to Nevada and changed our name to Voxpath Holding, Inc. In September of 2006, we merged with The Retirement Solution Inc. and then changed our name to TheRetirementSolution.Com, Inc. Subsequently, in October 2008 we changed our name to Global Investor Services, Inc., before changing our name to Investview, Inc., on March 27, 2012.

 

Effective April 1, 2017, we closed on a Contribution Agreement with the members of Wealth Generators, LLC, a limited liability company (“Wealth Generators”), pursuant to which the Wealth Generators members contributed 100% of the outstanding securities of Wealth Generators in exchange for an aggregate of 1,358,670,942 shares of our common stock. Following this transaction, Wealth Generators became our wholly owned subsidiary, and the former members of Wealth Generators became our stockholders and controlled the majority of our outstanding common stock.

 

On June 6, 2017, we entered into an Acquisition Agreement with Market Trend Strategies, LLC, a company whose members are also former members of our management. Under the Acquisition Agreement, we spun-off our operations that existed prior to the merger with Wealth Generators and sold the intangible assets used in those pre-merger operations in exchange for Market Trend Strategies’ assumption of $419,139 in pre-merger liabilities.

 

On February 28, 2018, we filed a name change for Wealth Generators, LLC to Kuvera, LLC (“Kuvera”).

 

On January 17, 2019, we renamed our non-operating wholly owned subsidiary WealthGen Global, LLC to SAFETek, LLC, a Utah limited liability company.

 

On January 11, 2021, we filed a name change for Kuvera, LLC to iGenius, LLC (“iGenius”) and on February 2, 2021, we filed a name change for Kuvera (N.I.) Limited to iGenius Global LTD.

 

On September 20, 2021, the Board of Directors approved a change in our fiscal year from March 31 to December 31.

 

Nature of Business

 

We operate a diversified financial technology services company offering multiple business units across key sectors, including a financial education division offering tools, products and content through a global network of independent distributors; a manufacturing division focused on proprietary over-the-counter aesthetics, health, nutrition and cognitive wellness products for wholesale and retail markets, with strategic plans for global expansion: an early-stage online trading platform that intends to offer self-directed retail brokerage services; and a business unit that owns and operates a sustainable blockchain business focused on bitcoin mining.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Accounting

 

Our policy is to prepare our financial statements on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations (Regulation S-X) of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the three months ended March 31, 2025, are not necessarily indicative of the operating results that may be expected for our year ending December 31, 2025, as will be included in the filing of our Annual Report on Form 10-K for the year ending December 31, 2025. These unaudited condensed consolidated financial statements should be read in conjunction with the December 31, 2024 consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2024.

 

7

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of Investview, Inc., and our wholly owned subsidiaries: iGenius, LLC, SAFETek, LLC, Investview Financial Group Holdings, LLC, Opencash Finance, Inc., Opencash Securities, LLC, Investview MTS, LLC, myLife Wellness Company, Renu Laboratories LLC, and Goldman’s Pharmaceuticals LLC. The Company also owns 50% of ELRT Technologies, LLC, which has been included in the consolidated financial statements and the Company has recorded a noncontrolling interest for the 50% interest that it does not own. All intercompany transactions and balances have been eliminated in consolidation.

 

Operating Segments

 

Operating segments are defined as components of an entity for which separate financial information is available that is regularly reviewed by the chief operating decision maker (“CODM”). The CODM is composed of several members of its executive management team, including the CEO, President and COO, and the CFO. The CODM uses segment net income from operations to assess the performance of, manage the operations of, and allocate capital and operational resources to the Company’s three reportable segments.

 

Financial Statement Reclassification

 

Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.

 

Use of Estimates

 

The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Concentration of Credit Risk

 

Financial instruments that potentially expose us to concentration of credit risk include cash, accounts receivable, and advances. We place our cash and temporary cash investments with credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit of $250,000. As of March 31, 2025 and December 31, 2024, cash balances that exceeded FDIC limits were $11,306,081 and $10,837,830, respectively. We have not experienced significant losses relating to these concentrations in the past.

 

Cash Equivalents

 

For purposes of reporting cash flows, we consider all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. As of March 31, 2025 and December 31, 2024, we had no cash equivalents.

 

Receivables

 

Receivables are carried at net realizable value, representing the outstanding balance less an allowance for doubtful accounts based on a review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating individual receivables and receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received.

 

8

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Receivables were made up of the following as of each balance sheet date:

 

 SCHEDULE OF RECEIVABLES

   March 31,   December 31, 
   2025   2024 
Due from merchant processors  $236,486   $318,921 
Held in reserve by merchant processors for future returns and chargebacks [1]   1,872,035    1,872,035 
Due from payout service providers   34,202    296,558 
Accounts and other receivables   88,854    47,213 
Receivable, gross   2,231,577    2,534,727 
Allowance for doubtful accounts   -    - 
Receivables  $2,231,577   $2,534,727 

 

[1] We have recently had to pursue collection efforts through litigation against one of our credit card processors and its clearing bank, as we have been unable to timely collect such amounts due through our normal course credit collection practices. See “NOTE 10-Commitments and Contingencies.”

 

Fixed Assets

 

Fixed assets are stated at cost and depreciated using the straight-line method over their estimated useful lives. When retired or otherwise disposed, the carrying value and accumulated depreciation of the fixed asset is removed from its respective accounts and the net difference less any amount realized from disposition is reflected in earnings. Expenditures for maintenance and repairs which do not extend the useful lives of the related assets are expensed as incurred.

 

Fixed assets were made up of the following at each balance sheet date:

 

 

   Estimated        
   Useful        
   Life  March 31,   December 31, 
   (years)  2025   2024 
Furniture, fixtures, and equipment  10  $717   $717 
Computer equipment  3   32,360    28,571 
Data processing equipment  3   11,824,560    11,824,560 
Manufacturing equipment  3-25   1,481,822    1,161,701 
       13,339,459    13,015,549 
Accumulated depreciation      (11,371,410)   (11,147,108)
Net book value     $1,968,049   $1,868,441 

 

Total depreciation expense for the three months ended March 31, 2025 and 2024, was $224,302 and $1,178,430, respectively.

 

Digital Assets

 

Digital assets are included in non-current assets on the Consolidated Balance Sheets due to the Company’s intent to retain and hold bitcoin. Proceeds from the sale of digital assets and the purchase of digital assets are included within investing activities in the accompanying Consolidated Statement of Cash Flows. Digital Assets awarded to the Company through its mining activities and collected for membership revenue are accounted for in connection with the Company’s revenue recognition policy. Following the adoption of ASU 2023-08 effective January 1, 2025, the Company measures digital assets at fair value with changes recognized in other income (expense) in the Consolidated Statement of Operations. The Company tracks its cost basis of digital assets by-wallet in accordance with the first-in-first-out (“FIFO”) method of accounting. Refer to “NOTE 5 – DIGITAL ASSETS”, for further information regarding the Company’s impact of the adoption of ASU 2023-08.

 

9

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Goodwill

 

Goodwill represents the excess of the purchase price over the fair value of the net assets acquired in a business combination. Goodwill is not subject to amortization, and instead, assessed for impairment annually at the end of each fiscal year, or more frequently when events or changes in circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying amount in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350 - Intangibles - Goodwill and Other.

 

The Company has the option to first assess qualitative factors to determine whether events or circumstances indicate it is more likely than not that the fair value of a reporting unit is greater than its carrying amount, in which case a quantitative impairment test is not required.

 

As provided for by ASU 2017-04, Simplifying the Test for Goodwill Impairment, the quantitative goodwill impairment test is performed by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not impaired. An impairment loss is recognized for any excess of the carrying amount of the reporting unit over its fair value up to the amount of goodwill allocated to the reporting unit.

 

Intangible Assets

 

We account for our intangible assets in accordance with FASB ASC 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30 requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Under ASC Subtopic 350-30 any intangible asset with a useful life is required to be amortized over that life and the useful life is to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.

 

Impairment of Long-Lived Assets

 

We have adopted ASC Subtopic 360-10, Property, Plant and Equipment. ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by us be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or when the historical cost carrying value of an asset may no longer be appropriate. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period.

 

We evaluate the recoverability of long-lived assets based upon future net cash flows expected to result from the asset, including eventual disposition. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted and an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposable value. During the three months ended March 31, 2025 and 2024, no impairment was recorded.

 

10

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Fair Value of Financial Instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in the absence of a principal, most advantageous market for the specific asset or liability.

 

U.S. generally accepted accounting principles provide for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows:

 

  Level 1: Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access.
     
  Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including:

 

  - quoted prices for similar assets or liabilities in active markets;
  - quoted prices for identical or similar assets or liabilities in markets that are not active;
  - inputs other than quoted prices that are observable for the asset or liability; and
  - inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

  Level 3: Inputs that are unobservable and reflect management’s own assumptions about the inputs market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows).

 

Our financial instruments consist of cash, accounts receivable and accounts payable, and debt. We have determined that the book value of our outstanding financial instruments as of March 31, 2025 and December 31, 2024, approximates the fair value due to their short-term nature or interest rates that approximate prevailing market rates.

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of March 31, 2025:

 

 

   Level 1   Level 2   Level 3   Total 
Digital assets (see NOTE 5)  $1,676,351   $-   $-   $1,676,351 
Total Assets  $1,676,351   $-   $-   $1,676,351 
                     
Derivative liability  $-   $-   $2,853   $2,853 
Total Liabilities  $-   $-   $2,853   $2,853 

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2024:

 

   Level 1   Level 2   Level 3   Total 
Total Assets  $-   $-   $-   $- 
                     
Derivative liability  $-   $-   $758   $758 
Total Liabilities  $-   $-   $758   $758 

 

11

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Revenue Recognition

 

Membership Revenue

 

Most of our revenue is generated by membership sales and payment is received at the time of purchase. We recognize membership revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation is to provide our tools, products, and content over a fixed membership period; therefore, we recognize revenue ratably over the membership period and deferred revenue is recorded for the portion of the membership period subsequent to each reporting date. Additionally, we offer a designated trial period to first-time membership customers, during which a full refund can be requested if a customer does not wish to continue with the membership. Revenues are deferred during the trial period as collection is not probable until that time has passed. Revenues are presented net of refunds, sales incentives, credits, and known and estimated credit card chargebacks. As of March 31, 2025 and December 31, 2024, our deferred revenues for membership revenue were $1,852,839 and $1,905,734, respectively.

 

Mining Revenue

 

We generate revenue from mining bitcoin. The Company has entered into a digital asset mining pool by executing a contract, as amended from time to time, with the mining pool operator to provide computing power to the mining pool. The contract is terminable at any time by either party without penalty. Further, since the contract is continuously renewing, second by second, the mining contract is considered to have a duration of less than 24 hours for accounting purposes. The Company’s enforceable right to compensation only begins when the Company provides computing power to the mining pool operator. In exchange for providing computing power, we are entitled to a Full-Pay-Per-Share payout of Bitcoin based on a contractual formula, which calculates our share of block rewards, transaction fees, and mining pool operator fees. We are entitled to consideration even if a block is not successfully placed by the mining pool operator.

 

Providing computing power to solve complex cryptographic algorithms in support of the Bitcoin blockchain (in a process known as “solving a block”) is an output of the Company’s ordinary activities. The provision of providing such computing power is the only performance obligation in the Company’s contract with the mining pool operator. The transaction consideration the Company receives is net of a contractually agreed upon mining pool operator fee charged and kept by the mining pool operator and is noncash, in the form of Bitcoin. Given that the contract is continuously renewing, and the duration is considered to be less than 24 hours, the Company measures the transaction consideration at fair value on the date Bitcoin is received. The consideration is variable. The amount of consideration recognized is constrained to the amount of consideration received, which is when it is probable a significant reversal will not occur. There is no significant financing component or risk of a significant revenue reversal in these transactions due to the performance obligations and settlement of the transactions being on a daily basis.

 

Health and Wellness Product Sales and Other Revenue

 

Through our wholly owned subsidiary, Renu Laboratories LLC, we generate revenue by manufacturing and selling health, beauty and wellness products. We recognize health and wellness product sales revenue in accordance with ASC 606-10. The Company’s performance obligation is complete when control of the promised goods is transferred to a customer, at which time the Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for those goods. The Company terms for the sale are based on free on board (FOB) shipping point, where the control passes to the customer once the product leaves our warehouse. The Company determines collectability by requiring certain customers to pay before control is transferred and by performing ongoing credit evaluations and monitoring customer accounts receivable balances. As of March 31, 2025 and December 31, 2024, deposits collected from customers for orders to be filled at a future date were $844,318 and $1,014,164, respectively.

 

Shipping and direct costs charged to customers, along with fees collected from customers for storing their products in our warehouse facility located in Warminster, Pennsylvania are included in revenue as Other Revenue. Shipping and direct costs incurred by the Company are included in Cost of Sales and Service.

 

12

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Revenue generated for the three months ended March 31, 2025, was as follows:

 

 

   Membership
revenue
   Mining revenue   Health and wellness product sales   Other Revenue   Total 
Gross billings/receipts  $9,439,857   $862,944   $368,443   $7,344   $10,678,588 
Refunds, incentives, credits, and chargebacks   (648,414)   -    (122)   -    (648,536)
Net revenue  $8,791,443   $862,944   $368,321   $7,344   $10,030,052 

 

Foreign revenues for the three months ended March 31, 2025 were approximately $7.6 million while domestic revenue for the three months ended March 31, 2025 was approximately $2.4 million.

 

Revenue generated for the three months ended March 31, 2024, was as follows:

 

   Membership
Revenue
   Mining Revenue   Total 
Gross billings/receipts  $13,851,294   $2,642,599   $16,493,893 
Refunds, incentives, credits, and chargebacks   (821,976)   -    (821,976)
Net revenue  $13,029,318   $2,642,599   $15,671,917 

 

Foreign revenues for the three months ended March 31, 2024 were approximately $11.8 million while domestic revenue for the three months ended March 31, 2024 was approximately $3.9 million.

 

Advertising, Selling and Marketing Costs

 

We expense advertising, selling, and marketing costs as incurred. Advertising, selling, and marketing costs include costs of promoting our product worldwide, including promotional events. Advertising, selling, and marketing expenses for the three months ended March 31, 2025 and 2024, totaled $95,103 and $11,795, respectively.

 

Cost of Sales and Service

 

Included in our costs of sales and services is amounts paid to our trading and market experts that provide financial education content and tools to our membership customers, hosting and electricity fees that we pay to vendors to set up our mining equipment at third-party sites in order to generate mining revenue, and the raw material and manufacturing costs of our health and wellness product sales. Costs of sales and services for the three months ended March 31, 2025 and 2024, totaled $1,544,116 and $2,142,334, respectively.

 

Inventory

 

Inventory consists of raw materials, work in progress, and finished goods to be sold as part of our health and wellness product sales. Inventory is valued at the lower of cost or net realizable value using the first-in, first-out (FIFO) method and is inclusive of any shipping and tax costs.

 

Inventory was made up of the following at each balance sheet date:

 

SCHEDULE OF INVENTORY

   March 31,   December 31, 
   2025   2024 
Finished goods  $5,451   $27,802 
Work in process   191,440    312 
Raw materials   659,235    467,751 
Inventory  $856,126   $495,865 

 

13

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Income Taxes

 

Income taxes are recorded in accordance with ASC Topic 740, Income Taxes, which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities, including operating losses and credit carryforwards, using enacted tax rates in effect for the year in which the differences are expected to reverse.

 

Management judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities, and any valuation allowance recorded against our deferred tax assets. Deferred tax assets are reduced by a valuation allowance if, based on the consideration of all available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. Changes in assumptions in future periods may require we adjust our valuation allowance, which could materially impact our financial position and results of operations. The Company recognizes the benefit of an uncertain tax position that it has taken or expects to take on its income tax return, if such a position is more likely than not to be sustained.

 

Net Income (Loss) per Share

 

We follow ASC Subtopic 260-10, Earnings per Share, which specifies the computation, presentation, and disclosure requirements of earnings per share information. Basic loss per share has been calculated based upon the weighted average number of common shares outstanding. Diluted income (loss) per share reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted during the period. Dilutive securities having an anti-dilutive effect on diluted earnings per share are excluded from the calculation.

 

Due to the net loss for the three months ended March 31, 2025, basic and diluted income per share were the same, as all securities had an antidilutive effect.

 

The following table illustrates the computation of diluted earnings per share for the three months ended March 31, 2024.

 

 

   March 31, 2024 
Net income  $1,669,940 
Less: preferred dividends   (204,835)
Add: interest expense on convertible debt   225,129 
Net income available to common shareholders (numerator)  $1,690,234 
      
Basic weighted average number of common shares outstanding   2,053,046,229 
Dilutive impact of convertible notes   471,428,571 
Dilutive impact of non-voting membership interest   565,000,000 
Diluted weighted average number of common shares outstanding (denominator)   3,089,474,800 
      
Diluted income per common share  $0.00 

 

The following table presents potentially dilutive securities that were not included in the computation of diluted net income per share as their inclusion would be anti-dilutive.

 

 

   March 31, 2025   March 31, 2024 
Options to purchase common stock   351,416,665    191,666,665 
Warrants to purchase common stock   1,178,090    1,178,090 
Common stock issuable upon conversion of notes   471,428,571    N/A 
Common stock issuable upon conversion of non-voting membership interest   565,000,000    N/A 

 

14

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Lease Obligation

 

We determine if an arrangement is a lease at inception. Operating leases are included in the operating lease right-of-use asset account, the operating lease liability, current account, and the operating lease liability, long-term account in our balance sheet. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.

 

Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. For leases in which the rate implicit in the lease is not readily determinable, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We have elected to not apply the recognition requirements of ASC 842 to short-term leases (leases with terms of twelve months or less). Lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for operating lease arrangements is recognized on a straight-line basis over the lease term. We have elected the practical expedient and will not separate non-lease components from lease components and will instead account for each separate lease component and non-lease component associated with the lease components as a single lease component.

 

NOTE 3 – RECENT ACCOUNTING PRONOUNCEMENTS

 

In December 2023, the FASB issued ASU No. 2023-08, Intangibles—Goodwill and Other—Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets. The amendments in ASU No. 2023-08 are intended to improve the accounting for certain crypto assets by requiring an entity to measure those crypto assets at fair value each reporting period with changes in fair value recognized in net income. The amendments also improve the information provided to investors about an entity’s crypto asset holdings by requiring disclosure about significant holdings, contractual sale restrictions, and changes during the reporting period. The amendments are effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company adopted ASU No. 2023-08 for the year ended December 31, 2025, effective as of January 1, 2025, which had a material impact on the financial statements.

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 expands existing income tax disclosures for rate reconciliations by requiring disclosure of certain specific categories and additional reconciling items that meet quantitative thresholds and expands disclosures for income taxes paid by requiring disaggregation by certain jurisdictions. ASU 2023-09 is effective for annual periods beginning after December 15, 2024; early adoption is permitted. The Company adopted the ASU for the year ended December 31, 2025. The amendments only impact disclosures and are not expected to have an impact on the Company’s financial condition and results of operations.

 

In December 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires, in the notes to the financial statements, disclosures of specified information about certain costs and expenses specified in the updated guidance. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company did not elect early adoption and is evaluating the impact the updated guidance will have on its disclosures in 2026.

 

We have noted no other recently issued accounting pronouncements that we have not yet adopted that we believe are applicable or would have a material impact on our financial statements.

 

15

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

NOTE 4 – LIQUIDITY

 

Our financial statements are prepared using generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business.

 

During the three months ended March 31, 2025, we met our short-and long-term working capital and capital expenditure requirements. At March 31, 2025, we had a total of $17.5 million in cash and cash equivalents, which we believe is sufficient to meet our debt service, preferred stock dividend payments and all other obligations in a timely manner and be able to meet our objectives.

 

NOTE 5 – DIGITAL ASSETS

 

Adoption of ASU 2023-08, Accounting for and Disclosure of Digital Assets

 

Effective January 1, 2025, the Company adopted ASU 2023-08, which requires entities to measure crypto assets at fair value with changes recognized in the Statement of Operations each reporting period. The Company’s digital assets are within the scope of ASU 2023-08 and the transition guidance requires a cumulative-effect adjustment as of the beginning of the current fiscal year for any difference between the carrying amount of the Company’s digital assets and fair value. As a result of the Company’s early adoption of ASU 2023-08, the Company recorded a $148,346 increase to digital assets and a $148,346 decrease to accumulated deficit on the Balance Sheets as of the beginning of the fiscal year ended December 31, 2025.

 

The following table presents the Company’s Digital Asset holdings as of March 31, 2025:

 

SCHEDULE OF DIGITAL ASSETS

   Quantity   Cost Basis   Fair Value 
Bitcoin   20.30   $1,896,337   $1,676,153 
USDC   198.00    198    198 
Total digital assets held as of March 31, 2025       $1,896,535   $1,676,351 

 

The following table presents a roll-forward of total digital assets for the three months ended March 31, 2025, based on the fair value model under ASU 2023-08:

 

SCHEDULE OF DIGITAL ASSETS ACTIVITY

   Fair Value 
Balance as of December 31, 2024  $1,127,891 
    585,632 
Cumulative effect adjustment upon adoption of ASU 2023-08   148,346 
Revenue recognized from Bitcoin mined (9.12 BTC)   862,944 
Digital assets collected from membership revenue   336,614 
Purchase of digital assets   1,695 
Operating expenses paid with digital assets   (527,058)
Dividends paid via digital assets   (40,645)
Realized gain (loss) on digital assets   (13,252)
Change in fair value of digital assets   (220,184)
Balance as of March 31, 2025  $1,676,351 
    232,834 

 

Prior to Adoption of ASU 2023-08, Accounting for and Disclosure of Digital Assets

 

Digital assets

 

Prior to the adoption of ASU 2023-08, digital assets were accounted for as indefinite-lived intangible assets and were initially measured in accordance with ASC 350 - Intangible-Goodwill and Other. Digital assets were not amortized, but were assessed for impairment annually, or more frequently, when events or changes in circumstances occur indicating that it is more likely than not that the indefinite-lived intangible asset is impaired. Whenever the exchange-traded price of digital assets declined below its carrying value, the Company was required to determine if an impairment existed and to record an impairment equal to the amount by which the carrying value exceeded the fair value.

 

16

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

The following table presents a roll-forward of digital assets for the three months ended March 31, 2024, based on the cost-impairment model under ASC 350:

 

   Cost Basis 
Balance as of December 31, 2023  $585,632 
Revenue recognized from Bitcoin mined (49.82 BTC)   2,642,599 
Digital assets collected from membership revenue   407,138 
Operating expenses paid with digital assets   (3,599,825)
Dividends paid via digital assets   (40,170)
Debt extinguished in exchange for digital assets   (38,767)
Realized (gain) loss on sale of digital assets   276,227 
Balance as of March 31, 2024  $232,834 

 

NOTE 6 – RELATED-PARTY TRANSACTIONS

 

Related Party Debt

 

Our related-party payables consisted of the following:

 

 

  

March 31,

2025

   December 31,
2024
 
Convertible Promissory Note entered into on 4/27/20, net of debt discount of $659,967 as of March 31, 2025 [1]  $640,033   $607,996 
Convertible Promissory Note entered into on 5/27/20, net of debt discount of $358,309 as of March 31, 2025 [2]   341,691    324,304 
Convertible Promissory Note entered into on 11/9/20, net of debt discount of $697,397 as of March 31, 2025 [3]   602,603    568,742 
Working Capital Promissory Note entered into on 3/22/21 [4]   1,204,897    1,204,567 
Total related-party debt   2,789,224    2,705,608 
Less: Current portion   (1,204,897)   (1,204,567)
Related-party debt, long term  $1,584,327   $1,501,041 

 

 

[1]On April 27, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the three months ended March 31, 2025, we recognized $32,037 of the debt discount into interest expense, as well as expensed an additional $65,004 of interest expense on the note, all of which was repaid during the period.

 

[2]On May 27, 2020, we received proceeds of $700,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $700,000. During the three months ended March 31, 2025, we recognized $17,387 of the debt discount into interest expense as well as expensed an additional $35,001 of interest expense on the note, all of which was repaid during the period.

 

[3]On November 9, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 38.5% per annum, made up of a 25% interest rate per annum and a facility fee of 13.5% per annum, payable monthly beginning February 1, 2021, and the principal is due and payable on April 27, 2030. Per the terms of the agreement, the note is convertible into common stock at a conversion price of $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the three months ended March 31, 2025, we recognized $33,861 of the debt discount into interest expense as well as expensed an additional $125,124 of interest expense on the note, all of which was repaid during the period.
  
[4]On March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. (See NOTE 11). Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA only provided advances of $1,200,000, to date. The note bears interest at the rate of 0.11% per annum. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations, and the other damages we sustained as a result of the actions of Mr. Cammarata. During the three months ended March 31, 2025, we recorded interest expense of $330 on the note. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan.

 

17

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

The loans referenced in footnotes 1-3 above were advanced under a Securities Purchase Agreement we entered into on April 27, 2020, with DBR Capital. Under the Securities Purchase Agreement (which was subsequently amended and restated), DBR Capital agreed to advance up to $11 million to us in a series of up to five closings through December 31, 2026, of which the amounts advanced covered in footnotes 1-3 above constituted the first three closings.

 

On February 28, 2025, we and DBR Capital, entered into a Fifth Amendment to the now Amended and Restated Securities Purchase Agreement that extends the deadlines for the fourth and fifth closings under that Agreement from December 31, 2024, to August 31, 2025 and December 31, 2026, respectively. The fourth and fifth closings remain at the sole discretion of DBR Capital, and we cannot provide any assurance that they will occur when contemplated or ever.

 

Other Related Party Arrangements

 

On September 29, 2023, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement dated September 18, 2023 (the “Romano/Raynor Agreement”). Under the Romano/Raynor Agreement, the Company purchased for surrender in a series of private transactions, an aggregate of 302,919,223 shares of the Company’s common stock (the “Romano/Raynor Purchased Shares”) from sellers consisting of Mario Romano, Annette Raynor, and a series of their family members and related entities (collectively, the “Sellers”). The Romano/Raynor Purchased Shares were purchased for aggregate consideration of $2,922,380, representing a price of $0.00964739 per share. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter. As of March 31, 2025, we owed $793,095 under the Romano/Raynor Agreement of which $795,095 is included in Accounts payable and accrued liabilities.

 

In addition to the cash consideration for the Purchased Shares, the Company also agreed to cover a limited amount of the legal fees incurred by the Sellers in the transaction, as well as provide Mr. Romano and Ms. Raynor with a $250,000 expense allowance, payable in installments, to cover legal fees and other expenses on a non-accountable basis, in connection with any matters that may arise in which either or both of Mr. Romano and/or Ms. Raynor served as officers and directors of the Company. In return, Mr. Romano and Ms. Raynor agreed to waive any future entitlement, if at all, to indemnification of costs and expenses, including legal fees under Nevada law or otherwise arising from or relating to any period in which Romano or Raynor were officers and directors of the Company.

 

The consideration paid for the Purchased Shares of $2,922,380 plus the $250,000 expense allowance was allocated to the share purchase for a total of $3,172,380.

 

18

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

On February 7, 2024, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement dated February 6, 2024 (the “Smith/Miller Agreement”). Under the Smith/Miller Agreement, the Company purchased for surrender and cancellation a total of 472,374,710 shares of the Company’s common stock (the “Smith/Miller Purchased Shares”) from Ryan Smith and Chad Miller and certain of their respective affiliates and family members. The Smith/Miller Purchased Shares were purchased for aggregate purchase price of $3,571,146, representing a price of $0.007559985 per share. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter. As of March 31, 2025, we owed $1,339,180 under the Smith/Miller Agreement of which $1,339,180 is included in Accounts payable and accrued liabilities.

 

The consideration paid for the Purchased Shares of $3,571,146 was allocated to the share purchase (see NOTE 10).

 

NOTE 7 – DEBT

 

Our debt consisted of the following:

 

   March 31,
2025
   December 31,
2024
 
Loan with the U.S. Small Business Administration dated 4/19/20 [1]  $517,176   $519,863 
Total debt   517,176    519,863 
Less: Current portion   29,244    29,244 
Debt, long term portion  $487,932   $490,619 

 

 

[1] In April 2020 we received proceeds of $500,000 from a loan entered into with the U.S. Small Business Administration. Under the terms of the loan interest is to accrue at a rate of 3.75% per annum and installment payments of $2,437 monthly will begin twelve months from the date of the loan, with all interest and principal due and payable thirty years from the date of the loan. During the three months ended March 31, 2025, we recorded $4,623 worth of interest on the loan. During the three months ended March 31, 2025, we made repayments on the loan of $7,310.

 

In November of 2020, we entered into notes with third parties for $19,089,500 in exchange for the cancellation of APEX leases previously entered into, which resulted in our purchase of all rights and obligations under the leases. We agreed to settle a portion of the debt during the year ended March 31, 2021, at a discount to the original note terms offered, by making lump sum payments, issuing 48,000,000 shares of our common stock, issuing 49,418 shares of our preferred stock, and issuing digital assets. The remaining notes were due December 31, 2024, and had a fixed monthly payment that is equal to 75% of the face value of the note, divided by 48 months. The monthly payments began the last day of January 2021 and continued until December 31, 2024, when the last monthly payment was made, along with a balloon payment equal to 25% of the face value of the note, to extinguish the debt. During the fourth quarter ended December 31, 2023, we offered all note holders an early payoff option. During the three months ended March 31, 2024, we repaid a portion of the debt with cash payments of $106,950 and issuances of digital assets then valued at $38,767. As of December 31, 2024, the debt was paid in full.

 

NOTE 8 – DERIVATIVE LIABILITY

 

During the three months ended March 31, 2025, we had the following activity in our derivative liability account relating to our warrants:

 

 

Derivative liability at December 31, 2024 $ 758  
Derivative liability recorded on new instruments   -  
Derivative liability reduced by warrant exercise   -  
(Gain) loss on fair value   2,095  
Derivative liability at March 31, 2025 $ 2,853  

 

19

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

We use the binomial option pricing model to estimate fair value for those instruments at inception, at warrant exercise, and at each reporting date. During the three months ended March 31, 2025, the assumptions used in our binomial option pricing model were in the following range:

 

 

Risk free interest rate   4.23% - 4.32%
Expected life in years   0.33 - 1.25 
Expected volatility   132% - 161%

 

NOTE 9 – OPERATING LEASE

 

In July 2021, we entered an operating lease for office space in Wyckoff, New Jersey (the “Wyckoff Lease”), and in September 2021 we assumed an operating lease for office space in Haverford, Pennsylvania (the “Haverford Lease”) in connection with the MPower acquisition. This facility now serves as the headquarters of the company. In November 2024, we entered an operating lease for office, warehouse, and manufacturing space in Warminster, Pennsylvania (“the “Warminster Lease”) and in December 2024, we entered an operating lease for warehouse space in Ivyland, Pennsylvania (the “Ivyland Lease”). The Warminster Lease and the Ivyland Lease were entered for use by our newly formed subsidiary Renu Laboratories LLC.

 

At commencement of the Wyckoff Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $22,034. The original 24.5-month term of the Wyckoff Lease was extended through July 2025 with an option for the Company to terminate with 60 days’ written notice beginning June 1, 2024. The earliest termination date is July 31, 2024. At the extension of the Wyckoff Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $23,520.

 

At date of acquisition of the Haverford Lease, right-of-use assets and lease liabilities obtained amounted to $125,522 and $152,961, respectively. The term of the Haverford Lease was initially extended through December 2024. At the extension of the Haverford Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $172,042. On August 7, 2024, the term of the Haverford Lease was extended through December 31, 2025.

 

At commencement of the Warminster Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $108,327. The Warminster Lease will automatically terminate after the 14-month term.

 

At commencement of the Ivyland Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $115,037. The Ivyland Lease will automatically terminate after the 24-month term.

 

Operating lease expense was $44,124 for the three months ended March 31, 2025. Operating cash flows used for the operating leases during the three months ended March 31, 2025, was $44,187. As of March 31, 2025, the weighted average remaining lease term was 1.27 years, and the weighted average discount rate was 12%.

 

Future minimum lease payments under non-cancellable leases as of March 31, 2025, were as follows:

 

 

      
Remainder of 2025  $126,962 
2026   61,057 
Total   188,019 
Less: Interest   (14,526)
Present value of lease liability   173,493 
Operating lease liability, current [1]   (140,112)
Operating lease liability, long term  $33,381 

 

[1] Represents lease payments to be made in the next 12 months.

 

20

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

NOTE 10 – STOCKHOLDERS’ EQUITY (DEFICIT)

 

Preferred Stock

 

We are authorized to issue up to 50,000,000 shares of preferred stock with a par value of $0.001 and our board of directors has the authority to issue one or more classes of preferred stock with rights senior to those of common stock and to determine the rights, privileges, and preferences of that preferred stock.

 

Our Board of Directors approved the designation of 2,000,000 of the Company’s shares of preferred stock as Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B Preferred Stock”), each with a stated value of $25 per share. Our Series B Preferred Stockholders are entitled to receive cumulative dividends at the annual rate of 13% per annum of the stated value, equal to $3.25 per annum per share. The Series B Preferred Stock is redeemable at our option or upon certain change of control events.

 

During the year ended March 31, 2021, we commenced an offering to sell a total of 2,000,000 units at $25 per unit (“Unit Offering”), with each unit consisting of: (i) one share of our newly authorized Series B Preferred Stock and (ii) five warrants each exercisable to purchase one share of common stock at an exercise price of $0.10 per warrant share. Each Warrant offered is immediately exercisable on the date of issuance, will expire 5 years from the date of issuance, and its value has been classified as a fair value liability due to the terms of the instrument (see NOTE 8). The Unit Offering was completed on or about August 17, 2021, having resulted in the public offer and sale of 252,192 Units.

 

As of March 31, 2025 and December 31, 2024, we had 252,192 shares of preferred stock issued and outstanding.

 

Preferred Stock Dividends

 

During the three months ended March 31, 2025, we declared $204,835 of cumulative cash dividends due to the shareholders of our Series B Preferred Stock. We made payments of $161,854 in cash and issued $40,645 worth of digital assets to reduce the amounts owing. As of March 31, 2025 and December 31, 2024, the dividend liability on our balance sheets was $247,437 and $245,101, respectively.

 

During the three months ended March 31, 2024, we declared $204,835 for cumulative cash dividends due to the shareholders of our Series B Preferred Stock. We made payments of $174,760 in cash and issued $40,170 worth of digital assets to reduce the amounts owing.

 

Common Stock Transactions

 

On March 6, 2025, the Board of Directors authorized a stock repurchase program that will allow the Company to repurchase up to $1,000,000 in aggregate value of shares of the Company’s common stock, par value $0.001 per share, through March 6, 2026. During the three months ended March 31, 2025, 1,089,286 shares have been repurchased for $24,006. These shares are being held by the Company in Treasury.

 

During the three months ended March 31, 2024, we repurchased 472,374,710 shares from two of the original founders of the Company and a series of their family members and related entities in exchange for cash of $446,391 and payables of $3,124,755 (see NOTE 6). We also recognized $8,510 in stock-based compensation based on grant date fair values and vesting terms of awards granted in prior periods.

 

As of March 31, 2025 and December 31, 2024, we had 1,859,231,786 and 1,859,231,786 shares of common stock issued and 1,858,142,500 and 1,859,231,786 shares of common stock outstanding, respectively.

 

21

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Options

 

The 2022 Incentive Plan authorizes a variety of incentive awards consisting of stock options, restricted stock, restricted stock units, and reserves for issuance up to 600,000,000 shares of the Company’s common stock.

 

Transactions involving our options are summarized as follows:

 

 

           Weighted 
           Average 
       Weighted   Grant-Date 
   Number of   Average   Per Share 
   Options   Exercise Price   Fair Value 
Options outstanding at December 31, 2024   351,416,665   $0.05   $0.03 
Granted   -   $-   $- 
Canceled/Expired   -   $-   $- 
Exercised   -   $-   $- 
Options outstanding at March 31, 2025   351,416,665   $0.05   $0.03 

 

Details of our options outstanding as of March 31, 2025, is as follows:

 

 

Options Exercisable   Weighted Average Exercise Price of Options Exercisable   Weighted Average Contractual Life of Options Exercisable (Years)   Weighted Average Contractual Life of Options Outstanding (Years) 
 233,116,665    0.05    4.24    4.38 

 

Total stock compensation expense related to the options for the three months ended March 31, 2025 and 2024, was $387,634 and $422,250, respectively. As of March 31, 2025 there was approximately $2.9 million of unrecognized compensation cost related to the Options, which is expected to be recognized over a remaining weighted-average vesting period of approximately 1.5 years.

 

Warrants

 

Transactions involving our warrants are summarized as follows:

 

 

       Weighted 
   Number of   Average 
   Shares   Exercise Price 
Warrants outstanding at December 31, 2024   1,178,090   $0.10 
Granted   -   $- 
Canceled/Expired   -   $- 
Exercised   -   $- 
Warrants outstanding at March 31, 2025   1,178,090   $0.10 

 

Details of our warrants outstanding as of March 31, 2025, is as follows:

 

 

Warrants Exercisable   Weighted Average Contractual Life of Warrants Outstanding and Exercisable (Years) 
 1,178,090    0.89 

 

22

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Class B Units of Investview Financial Group Holdings, LLC

 

As of March 31, 2025, and December 31, 2024, there were 565,000,000 Units of Class B Investview Financial Group Holdings, LLC issued and outstanding. These units were issued as consideration for the purchase of operating assets and intellectual property rights of MPower, a company controlled and partially owned by David B. Rothrock and James R. Bell, two of our board members. The Class B Redeemable Units have no voting rights but can be exchanged at any time, within 5 years from the date of issuance, for 565,000,000 shares of our common stock on a one-for-one basis and are subject to significant restrictions upon resale through 2025 under the terms of a lock up agreement entered into as part of the purchase agreement. In order to properly account for the purchase transaction on the Company’s financial statements, we were required by applicable financial reporting standards to value the Class B Units issued to MPower in the transaction as of the closing date of the MPower sale transaction (September 3, 2021). For these accounting purposes, we concluded that the “fair value” of the consideration for financial accounting purposes, at the if-converted market value of the underlying common shares was $58.9 million, based on the closing market price of $0.1532 on the closing date of September 3, 2021, as discounted from $86.6 million by 32% (or $27.7 million) to reflect the significant lock up period. The “fair value” valuation of the Class B Units, however, was completed relying on a certain set of methodologies that are accepted for accounting purposes and is not necessarily indicative of the “fair market value” that may be implied relative to such Units in a commercial transaction not governed by financial reporting standards. In particular, the methodology used to value the Class B Units at their “fair value” did not take into account any blockage discounts that may otherwise apply after the expiration of the lock-up period in 2025; while other valuation methodologies, not bound by financial reporting codifications, would possibly determine that the blockage discount associated with the resale of 565 million shares after the expiration of the lock-up period, into a marketplace that has limited market liquidity, could possibly have a material downward influence on the valuation.

 

NOTE 11 – COMMITMENTS AND CONTINGENCIES

 

Litigation and Legal Proceedings

 

In the ordinary course of business, we may be, or have been, involved in material third-party litigation and other legal proceedings and administrative actions, or exposed to material contingencies or commitments in the course of our business, as described below.

 

Settlement of SEC Inquiry

 

On November 9, 2021, the Company received a subpoena from the United States Securities and Exchange Commission (“SEC”) for the production of documents. In the subpoena, the SEC advised that the inquiry did not mean that the SEC concluded that the Company or anyone affiliated with the Company had violated the federal securities laws or any other law. However, in the course of communications with the SEC throughout the inquiry, the Company came to believe that the focus of the SEC’s inquiry involved whether the offer and sale of the Company’s now discontinued Apex sale and leaseback program violated certain federal securities laws. Following a several year review process in which the Company cooperated fully with the SEC, on January 17, 2025, a settlement was reached with the SEC to resolve the inquiry. As part of the settlement, the Company entered into a formal SEC Order for which it neither admitted nor denied the factual and legal conclusions asserted, but paid a civil monetary penalty of $375,000 to conclude the inquiry. The Company considers this matter to be closed.

 

23

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Exposure to potential claims arising from third-party financial protection plan

 

Historically, through our wholly-owned subsidiaries Apex Tek, LLC and SAFETek, LLC, we sold high powered data processing equipment, known as the Apex package, to our customers which was then leased back to us for use in our crypto mining operations. We discontinued sales of the Apex package in June 2020, principally when COVID-19 created certain supply chain-related limitations on that business. Confronted with these limitations in the business, we offered the holders of our Apex leases the opportunity to cancel their leases, in exchange for which, we repurchased substantially all of the data processing equipment (subject to these leases) for approximately $19 million of promissory notes due on or about December 31, 2024 (which amount reflects the principal amount invested by all of such lease holders, plus a 25% premium). During the fourth quarter ended December 31, 2023, we further offered all note holders an early payoff option. By December 31, 2024, we had repaid or settled the approximately $19 million of promissory notes.

 

Included in the Apex sale and leaseback program that was discontinued in 2021, was a “guaranteed assets buy-back product” underwritten, administered and managed by a third-party provider, Total Protection Plus (“TPP”), which was intended to provide customers who participated in the Apex sale and leaseback program with a financial protection program (the “TPP Program”), under which customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five-or-ten year interval after their initial purchase. As part of their sales and marketing materials, TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm that had sufficient capital resources, reserves and liquidity to support any payouts needed to satisfy their obligations under the TPP Program. TPP was paid substantial premiums for the program. In most instances, the premium for the TPP program was included in the package price for the Apex program, at no additional cost to the customer.

 

Separately, iGenius members who purchased ndau through an Oneiro sponsored ndau distribution program, were also given the opportunity to participate in a TPP Program similar to the program offered to our Apex customers; which in this case was intended to provide customers who purchased ndau with a financial protection program under which such customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five- or ten-year interval after their initial purchase. Participation in this program was also in reliance on sales and marketing materials by which TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm that had sufficient capital resources, reserves and liquidity to support any pay-outs needed to satisfy their obligations under the TPP Program. Prior to terminating the distribution of ndau in August 2023, we distributed over $16.6 million in ndau to our members purportedly supported by the TPP Program. As in the same case as had been done with respect to the Apex customers, TPP was paid substantial premiums for the program, and those premiums were included in the purchase price for the ndau program, at no additional cost to the customer.

 

During the fourth calendar quarter of 2021, we suspended any further offering of the TPP Program in connection with the sale of ndau after TPP was unable to comply with our vendor compliance protocols, having cited certain offshore confidentiality entitlements by which it was unwilling to provide evidence of its financial support arrangements. That suspension has remained in place as we have been unable to further validate the continued integrity of the TPP Program and the vendor’s ability to honor its commitments to our members; despite the payment of over $6 million to TPP to secure the benefits of the TPP Program. Our level of concern over the viability of the TPP Program has recently increased materially as we have come to learn that: (i) certain of our customers have been unable to reach TPP in order to process claims for their 5-year promised returns; (ii) certain customers have informed us that the TPP website has been inoperative and customers have been unable to process their claims; and (iii) an email communication purportedly from TPP, or an affiliate thereof, has been received by certain of customers in which the sender asserts that the obligations of TPP under the TPP Program were (unbeknownst to us and our customers) purportedly dependent on the financial wherewithal of another heretofore undisclosed TPP affiliate, that the email claims now has no ability to satisfy the commitments originally made by TPP.

 

24

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

To respond to these concerns, and in an effort to advance the interests of our customers, on March 28, 2025, we commenced an action against Total Protection Plus, UIU Holdings LLC, Jason R. Anderson, Jacob S. Anderson, and Schad E. Brannon (collectively, “TPP”), in the Court of Chancery of the State of Delaware captioned Investview et al., v. UIU Holdings, LLC et al., seeking to, among other things, compel TPP to fulfill the commitments that were made to the Company’s customers under the TPP Program. 

 

We cannot ensure that TPP will comply with its contractual commitments to our customers, in which case these customers may not be able to realize the cash payouts promised by TPP, despite the substantial payments made to TPP to secure the benefits of the TPP Program. As the direct responsibility for compliance with the TPP Program resides with TPP; particularly as the program was underwritten, managed and administered by TPP as an independent third-party vendor (and with respect to ndau, the underlying ndau was developed and marketed by an additional third-party vendor), and in recognition of the customers’ acceptance of their participation in the program, we do not believe that we have any legal responsibility to cover any potential claims of customers who participated in the TPP Program. There is, however, the risk that any failure of TPP to perform its obligations to our customers could expose us to commercial claims of dissatisfied customers, regardless of the legal foundation associated therewith. The possible assertion of those claims could have an adverse effect on our business, financial condition, and operating results.

 

We have instituted a legal proceeding instituted to collect significant balance owed by credit card processor and clearing bank

 

The Company’s financial statements as of March 31, 2025, reflect a receivables balance of $2.23 million. Of that balance, $2.11 million represents receivables that arise out of credit card transactions generated by the Company’s iGenius subsidiary. The credit card transactions that arise out of the ordinary course operations of the Company’s iGenius subsidiary are processed by the Company’s credit card processors, in conjunction with their clearing banks. Over time, the balance of credit card collections being held by one of our credit card processors and its clearing bank, which are legally supposed to be held for the benefit of the Company, subject to coverage for chargebacks and other normal course collection issues, has increased to approximately $1.87 million, an amount that has been generally confirmed by the credit card processor. As they had been unresponsive to our repeated demands for payment, claiming that they were in the process of concluding their internal accounting of the amounts due and status of our accounts, in March 2024, the Company instituted a lawsuit against this credit card processor and its clearing bank seeking, among other things, an accounting for and repayment of the withheld funds. Notwithstanding, to date, we have been unable, through negotiations and through our lawsuit, to recover any amount of the receivable balances owed to us as the credit card processor asserts, among others, that it continues to evaluate possible exposure to chargebacks and other normal course collection issues. Recently, however, the Company’s application for a pre-judgment writ of attachment against both the credit card processor and the clearing bank, has been granted. Although the Company’s collection efforts will likely be enhanced by application of the pre-judgment writ of attachment, there can still be no assurances that the Company will be able to collect some or all of the funds owed to it. Should the Company be unable to collect some or all of the funds owed, it will be caused to incur a corollary bad debt expense of up to the uncollected amount which is currently approximately $1.87 million. Furthermore, the Company may be caused under generally accepted accounting principles, to incur a bad debt expense if it is determined that the amounts owed to the Company are unlikely to be collected, although the Company has not yet reached that conclusion. A charge of up to $1.87 million, which represents less than 10% of the Company’s current assets, would not have a material adverse effect upon the Company’s long-term liquidity, however, could have a material adverse effect upon the Company’s net earnings in the period incurred.

 

25

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Potential exposure to administrative proceeding asserted by Polish regulatory authority relating to Company’s iGenius network

 

Our iGenius products and services are marketed by a global network of independent distributors using a direct selling business model. Although we believe that our direct selling business model is in material compliance with applicable legal standards, direct selling programs similar to ours and others within the industry, in general, have periodically been the target of regulatory scrutiny by federal, state, and local governmental agencies in the United States and foreign countries, including the FTC, whose regulatory authority extends to the prevention of fraudulent or deceptive schemes, often referred to as “pyramid” schemes. Since March 2025 we have been responding to an inquiry from Poland’s Office of Competition and Consumer Protection (“UOKiK”) as it has instituted formal proceedings against iGenius alleging that iGenius is not a bona fide financial education platform and is instead operating a pyramid scheme that is focused more on the recruitment of new members and not the sale or use of the underlying products or services being offered. Based on our analysis of the applicable legal standards, and the tracking of our sales within Poland in which the predominant portion of our sales consist of membership sales driven by our members, we believe that the iGenius direct selling business operating within Poland complies with all applicable legal standards and we disagree with any claims to the contrary. Despite our strong belief in our position, should we not succeed in our defense of the matter, we could, among other things: be subject to material financial fines and penalties (up to 10% of iGenius’ revenue in the year preceding the imposition of the penalty); be required to modify or suspend certain or a material portion of our operations in Poland; and become exposed to similar claims from other European regulators, which itself could cause a cascading and similar adverse impact on our operations in Europe, all of which could have a materially adverse impact on the Company. It is still too early in the proceedings for us to draw a likely conclusion on the outcome of the matter.

 

Outstanding commitments associated with termination of former Chief Executive Officer

 

Joseph Cammarata served as an officer and director of the Company from December 2019 through his termination for cause on or about December 7, 2021. Mr. Cammarata was terminated following the announcement of civil and criminal charges filed against him in connection with his involvement with a class action claims aggregator unrelated to the Company. The Company was unaware of these outside business interests. Based on public reporting of the matter, the Company believes that Mr. Cammarata was convicted of certain of these criminal charges and is presently incarcerated.

 

Prior to his termination, Mr. Cammarata and the Company engaged in certain transactions as described below:

 

We issued a promissory note to Mr. Cammarata, which, following certain modifications, on or about March 30, 2021, was restated in the principal amount of $1,550,000 (the “Cammarata Note”). Although not originally convertible, as per the March 30, 2021, amendment, the Cammarata Note became convertible at $0.02 per share, Thereafter, effective September 21, 2021, and following another modification, the conversion price under the Cammarata Note was reduced to $0.008 per share. During February 2022, we provided 30 days’ notice of our intent to retire and repay the Cammarata Note in cash. Having not timely received a properly executed conversion notice within the proscribed period and citing certain breaches of Mr. Cammarata’s fiduciary duty to us, as well as damages incurred by us arising from Mr. Cammarata’s then ongoing legal proceedings, on or about March 31, 2022, we tendered to Mr. Cammarata cash payment in full for the Cammarata Note. As of the date of this Report, Mr. Cammarata has not accepted our tender of the cash payment, and through his then counsel, has asserted his entitlement to exercise his right to convert the Cammarata Note into our common shares. Although we believe that our cash tender was appropriate under the terms of the Cammarata Note and our claims for damages by Mr. Cammarata have merit, if Mr. Cammarata elects to challenge our cash tender in a court proceeding, and if we are unable to sustain our legal position on the matter, Mr. Cammarata could receive up to approximately 203 million shares of our common stock upon conversion of the Cammarata Note. As a result of his recent incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata.

 

On March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA has only provided advances of $1,200,000 to date. The note bears interest at the rate of 0.11% per annum therefore we recognized $990 worth of interest expense on the loan during the nine months ended September 30, 2024. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan. As a result of his recent incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata.

 

26

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

NOTE 12 – SEGMENT REPORTING

 

The company has three reportable segments, Financial Education and Technology, Blockchain Technology and Crypto Mining Products and Services, and Manufacturing and Development of Health, Beauty and Wellness Products. The reportable segments are identified based on the types of products that generate revenue.

 

The segment performance that the CODM uses to measure performance is net income (loss) from operations. The Company does not allocate assets to the reporting segments as its assets are primarily managed on an entity-wide basis and therefore does not disclose the total assets of its reportable operating segments.

 

For the three months ended March 31, 2025 and 2024, there were no intersegment revenues or costs of revenues that needed to be eliminated in the Consolidated Statements of Operations.

 

The Financial Education and Technology segment generates revenue through membership fees. The Blockchain Technology and Crypto Mining segment generates revenue primarily through its Bitcoin mining operation. The Manufacturing and Development of Health, Beauty and Wellness Products generates revenue primarily through the sale of health and wellness products manufactured to wholesale and retail customers.

 

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the three months ended March 31, 2025.

 

SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE

   Financial Education and Technology   Blockchain Technology and Crypto Mining Products and Services   Manufacturing and Development of Health, Beauty and Wellness Products [1]   Total 
Revenue  $8,791,443   $862,944   $375,665   $10,030,052 
                     
Less:                    
Commissions   5,076,503    -    -    5,076,503 
Market experts   174,520    -    -    174,520 
Credit card processing   407,025    -    -    407,025 
Salary and related   410,290    134,103    298,092    842,485 
Selling and marketing   87,819    -    7,093    94,912 
Energy and hosting   -    1,037,599    -    1,037,599 
Depreciation   450    189,422    -    189,872 
Cost of sales   -    -    331,998    331,998 
General and administrative [2]   489,357    129,945    268,911    888,213 
                     
Segment net income (loss) from operations  $2,145,479   $(628,125)  $(530,429)  $986,925 

 

[1] The Development of Health, Beauty and Wellness Products business was acquired in October 2024.
   
[2] General and administrative costs consist mainly of professional fees, insurance, information technology and software and other payment processing fees.

 

27

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the three months ended March 31, 2024.

 

   Financial Education and Technology   Blockchain Technology and Crypto Mining Products and Services   Total 
Revenue  $13,029,318   $2,642,599   $15,671,917 
                
Less:               
Commissions   7,275,210    -    7,275,210 
Market experts   260,250    -    260,250 
Credit card processing   607,234    -    607,234 
Salary and related   599,111    286,502    885,613 
Selling and marketing   10,770    152    10,922 
Energy and hosting   -    1,882,084    1,882,084 
Depreciation   -    1,177,796    1,177,796 
General and administrative [1]   255,641    76,295    331,936 
                
Segment income (loss) from operations  $4,021,102   $(780,230)  $3,240,872 

 

[1] General and administrative costs consist mainly of professional fees, contracting services, equipment, shipping and tariffs, insurance and information technology and software.

 

The following table illustrates the reconciliation of segment operating income to net income before taxes for the three months ended March 31, 2025 and 2024.

 

SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES 

   March 31,
2025
   March 31,
2024
 
Segment income from operations  $986,925   $3,240,872 
           
Reconciling items          
Bank interest   44,283    4,338 
Event ticket sales   38,553    - 
Leasing income   63,244    167,500 
All other, net   5,583    3,531 
           
Net income before taxes  $1,138,588   $3,416,241 

 

NOTE 13 – ACQUISITION

 

On October 11, 2024, Renu Laboratories LLC (a wholly owned subsidiary of myLife Wellness Company which is a wholly owned subsidiary of Investview, Inc.) closed on the purchase of the business and assets of Renu Labs, Inc. (“Seller”), along with a 100% ownership interest in Goldman’s Pharmaceuticals LLC and a 50% ownership interest in ELRT Technologies, LLC (together known as “Renu Labs”) from Gregg Hanson. Renu Labs is a manufacturer of proprietary and other health, beauty and wellness products. The total purchase price of Renu Labs was $1,780,000.

 

28

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

The transaction was accounted for as a business combination using the acquisition method of accounting in accordance with the ASC Topic 805. The following table summarizes the purchase accounting for the fair value of the assets acquired and liabilities assumed at the date of the acquisition:

 

      
Cash  $1,495 
Customer deposits – intercompany   7,360 
Domain names [1]   40,310 
Raw materials   149,260 
Manufacturing equipment   717,020 
Total assets acquired  $915,445 
      
Accounts payable  $323 
Customer deposits   572,386 
Total liabilities assumed  $572,709 
      
Net assets acquired   342,736 
      
Consideration [2]  $1,207,614 
Fair value of noncontrolling interest in ELRT Technologies, LLC   8,823 
Total   1,216,437 
      
Goodwill  $873,701 

 

[1] Domain names were deemed to have an indefinite life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy.
   
[2] This amount is equal to the $1,780,000 purchase price less $572,386 of customer deposits collected by Renu Labs, Inc. prior to acquisition.

 

NOTE 14 – INCOME TAXES

 

For the periods ended March 31, 2025, and March 31, 2024, the Company used a discrete effective tax rate method for recording income taxes, as compared to an estimated full year annual effective tax rate method, as an estimate of the annual effective tax rate cannot be made.

 

Provision for Income taxes for the three months ended March 31, 2025 was $10,000 resulting in an effective tax rate of (1.5%). Provision for Income taxes for the three months ended March 31, 2024 was $500,075, resulting in an effective tax rate of 23.0%. The provision for income taxes was primarily impacted by pretax book income, permanent differences, and by the change in valuation allowance on deferred tax assets.

 

NOTE 15 – SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, Subsequent Events, we have evaluated subsequent events through the date of this filing and have determined that the following events require disclosure.

 

During the period subsequent to period end, according to the stock repurchase program (see NOTE 10), the Company bought back 282,000 shares of their own common stock for $3,634. These shares are being held by the Company in Treasury.

 

29

 

 

ITEM 2 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

 

The following discussion should be read in conjunction with our consolidated financial statements and notes to our financial statements included elsewhere in this report. This discussion contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, as noted by use of the words “believe,” “expect,” “plan,” “project,” “estimate,” and similar expressions are used, they identify forward-looking statements. These forward-looking statements are based on management’s current beliefs and assumptions and information currently available to management, and involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by these forward-looking statements. Information concerning factors that could cause our actual results to differ materially from these forward-looking statements can be found elsewhere in this Report and in our periodic reports filed with the U.S. Securities and Exchange Commission. The forward-looking statements included are made only as of the date of this report. Except as required by law, we have no obligation and do not undertake to update or revise any such forward-looking statements to reflect events or circumstances after the date of the report.

 

Business Overview

 

We operate a diversified financial technology services company offering multiple business units across key sectors, including a financial education division offering tools, products and content through a global network of independent distributors; a manufacturing division focused on proprietary over-the-counter aesthetics, health, nutrition and cognitive wellness products for wholesale and retail markets, with strategic plans for global expansion; an early-stage online trading platform that intends to offer self-directed retail brokerage services; and a business unit that owns and operates a sustainable blockchain business focused on bitcoin mining.

 

Results of Operations

 

Three Months Ended March 31, 2025 Compared to Three Months Ended March 31, 2024

 

Revenues

 

   Three Months Ended March 31,   Increase 
   2025   2024   (Decrease) 
   (unaudited)   (unaudited)     
Membership revenue, net of refunds, incentives, credits, and chargebacks  $8,791,443   $13,029,318   $(4,237,875)
Mining revenue   862,944    2,642,599    (1,779,655)
Health and wellness product sales   368,321    -    368,321 
Other revenue   7,344    -    7,344 
Total revenue, net  $10,030,052   $15,671,917   $(5,641,865)

 

Total revenue, net, decreased $5,641,865, or 36%, from $15,671,917 for the three months ended March 31, 2024, to $10,030,052 for the three months ended March 31, 2025. The reduction in total revenue, net, can be attributed to a $4.2 million contraction in our membership revenue and a $1.8 million contraction in our mining revenue. The $4.2 million (33%) decrease in membership revenue was largely attributable to a combination of shifts in consumer behavior and demand following the COVID-19 pandemic as individuals re-evaluated their spending priorities, lifestyle habits, and engagement preferences, as well as broader global macroeconomic changes that have caused a general slowdown in direct sales and home-based business. This trend reflects broader market changes and has impacted overall participation and retention rates. The $1.8 million (67%) decrease in mining revenue was a result of “Bitcoin Halving” which occurred on April 19th, 2024, decreasing the reward to 3.125 Bitcoin per block solved from the previous reward rate of 6.25 Bitcoin per block solved, an increase in Bitcoin Network Difficulty and a mandated power curtailment enforced by the government-controlled utility companies in Northern Europe, partially offset by an increase in the price of Bitcoin. These decreases were offset by a $368 thousand increase in health and wellness product sales that arose from our October 2024 acquisition of the purchase of the business and assets of Renu Laboratories, Inc.

 

30

 

 

Operating Costs and Expenses

 

   Three Months Ended March 31,   Increase 
   2025   2024   (Decrease) 
   (unaudited)   (unaudited)     
Cost of sales and service  $1,544,116   $2,142,334   $(598,218)
Commissions   5,076,503    7,275,210    (2,198,707)
Selling and marketing   95,103    11,795    83,308 
Salary and related   1,701,092    1,628,970    72,122 
Professional fees   610,150    406,529    203,621 
General and administrative   1,416,168    2,336,655    (920,487)
Total operating costs and expenses  $10,443,132   $13,801,493   $(3,358,361)

 

Operating costs decreased $3,358,361, or (24%), from $13,801,493 for the three months ended March 31, 2024, to $10,443,132 for the three months ended March 31, 2025. The decrease can be explained by a reduction in commissions of $2.2 million, which was a result of a decrease in our membership revenue, a decrease in cost of sales and services of $600 thousand, which was a result of a power curtailment mandated by the government-controlled utility companies in Northern Europe, and a decrease in general and administrative expenses, which was a result of decreases in credit card processing fees due to the decreases in our membership revenue and decreases in costs related to our mining operations. These decreases were offset by an increase in professional fees.

 

Other Income and Expenses

 

   Three Months Ended March 31,     
   2025   2024   Change 
   (unaudited)   (unaudited)     
Gain (loss) on fair value of derivative liability  $(2,095)  $74   $(2,169)
Realized gain (loss) on digital assets   (13,252)   276,227    (289,479)
Unrealized gain (loss) on digital assets   (220,184)   -    (220,184)
Interest expense   (4,623)   (4,675)   52 
Interest expense, related parties   (308,744)   (309,670)   926 
Other income (expense)   284,125    337,635    (53,510)
Total other income (expense)  $(264,773)  $299,591   $(564,364)

 

We recorded other expense of $264,773 for the three months ended March 31, 2025, which was a decrease of $564,364, or 188%, from the prior year other income of $299,591. The change is due to a realized loss on digital assets in the current period of $13 thousand compared to a gain of $276 thousand in the prior year and an unrealized loss on digital assets in the current period of $220 thousand compared to no unrealized gain or loss in the prior year due to the Company’s adoption of ASU No. 2023-08 for the year ended December 31, 2025, effective as of January 1, 2025. The change is also due to a decrease in other income in the current period of $54 thousand, as a result of a decrease in lease payments received under a structured equipment lease agreement offset by an increase in ticket sales from a promotional event iGenius held during the three months ended March 31, 2025.

 

Liquidity and Capital Resources

 

During the three months ended March 31, 2025, we met our short-and long-term working capital and capital expenditure requirements. At March 31, 2025, we had a total of $17.5 million in cash and cash equivalents, which we believe is sufficient to meet our debt service, preferred stock dividend payments and all other obligations in a timely manner and be able to meet our objectives.

 

During the three months ended March 31, 2025, we recorded net loss from operations of $413,080 and net loss of $687,853. As of March 31, 2025, we have unrestricted cash of $17,506,288. Also, as of March 31, 2025, our current assets exceeded our current liabilities to result in working capital of $14,184,119 and our digital asset balance was reported at a fair value of $1,676,351. Management does not believe there are any liquidity issues as of March 31, 2025.

 

Critical Accounting Policies

 

Basis of Accounting

 

Our policy is to prepare our financial statements on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.

 

31

 

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations (Regulation S-X) of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the three months ended March 31, 2025, are not necessarily indicative of the operating results that may be expected for our year ending December 31, 2025, as will be included in the filing of our Annual Report on Form 10-K for the year ending December 31, 2025. These unaudited condensed consolidated financial statements should be read in conjunction with the December 31, 2024 consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2024.

 

Use of Estimates

 

The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Digital Assets

 

Digital assets are included in non-current assets on the Consolidated Balance Sheets due to the Company’s intent to retain and hold bitcoin. Proceeds from the sale of digital assets and the purchase of digital assets are included within investing activities in the accompanying Consolidated Statement of Cash Flows. Digital Assets awarded to the Company through its mining activities and collected for membership revenue are accounted for in connection with the Company’s revenue recognition policy. Following the adoption of ASU 2023-08 effective January 1, 2025, the Company measures digital assets at fair value with changes recognized in operating expenses in the Consolidated Statement of Operations. The Company tracks its cost basis of digital assets by-wallet in accordance with the first-in-first-out (“FIFO”) method of accounting. Refer to “NOTE 5 – DIGITAL ASSETS”, for further information regarding the Company’s impact of the adoption of ASU 2023-08.

 

Intangible Assets

 

We account for our intangible assets in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30 requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Under ASC Subtopic 350-30 any intangible asset with a useful life is required to be amortized over that life and the useful life is to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.

 

Impairment of Long-Lived Assets

 

We have adopted ASC Subtopic 360-10, Property, Plant and Equipment. ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by us be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or when the historical cost carrying value of an asset may no longer be appropriate. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period.

 

We evaluate the recoverability of long-lived assets based upon future net cash flows expected to result from the asset, including eventual disposition. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted and an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposable value. During the three months ended March 31, 2025 and 2024, no impairment was recorded.

 

Revenue Recognition

 

Membership Revenue

 

Most of our revenue is generated by membership sales and payment is received at the time of purchase. We recognize membership revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation is to provide our tools, products, and content over a fixed membership period; therefore, we recognize revenue ratably over the membership period and deferred revenue is recorded for the portion of the membership period subsequent to each reporting date. Additionally, we offer a designated trial period to first-time membership customers, during which a full refund can be requested if a customer does not wish to continue with the membership. Revenues are deferred during the trial period as collection is not probable until that time has passed. Revenues are presented net of refunds, sales incentives, credits, and known and estimated credit card chargebacks. As of March 31, 2025 and December 31, 2024, our deferred revenues for membership revenue were $1,852,839 and $1,905,734, respectively.

 

32

 

 

Mining Revenue

 

We generate revenue from mining bitcoin. The Company has entered into a digital asset mining pool by executing a contract, as amended from time to time, with the mining pool operator to provide computing power to the mining pool. The contract is terminable at any time by either party without penalty. Further, since the contract is continuously renewing, second by second, the mining contract is considered to have a duration of less than 24 hours for accounting purposes. The Company’s enforceable right to compensation only begins when the Company provides computing power to the mining pool operator. In exchange for providing computing power, we are entitled to a Full-Pay-Per-Share payout of Bitcoin based on a contractual formula, which calculates our share of block rewards, transaction fees, and mining pool operator fees. We are entitled to consideration even if a block is not successfully placed by the mining pool operator.

 

Providing computing power to solve complex cryptographic algorithms in support of the Bitcoin blockchain (in a process known as “solving a block”) is an output of the Company’s ordinary activities. The provision of providing such computing power is the only performance obligation in the Company’s contract with the mining pool operator. The transaction consideration the Company receives is net of a contractually agreed upon mining pool operator fee charged and kept by the mining pool operator and is noncash, in the form of Bitcoin. Given that the contract is continuously renewing, and the duration is considered to be less than 24 hours, the Company measures the transaction consideration at fair value on the date Bitcoin is received. The consideration is variable. The amount of consideration recognized is constrained to the amount of consideration received, which is when it is probable a significant reversal will not occur. There is no significant financing component or risk of a significant revenue reversal in these transactions due to the performance obligations and settlement of the transactions being on a daily basis.

 

Health and Wellness Product Sales and Other Revenue

 

Through our wholly owned subsidiary, Renu Laboratories LLC, we generate revenue by manufacturing and selling health, beauty and wellness products. We recognize health and wellness product sales revenue in accordance with ASC 606-10. The Company’s performance obligation is complete when control of the promised goods is transferred to a customer, at which time the Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for those goods. The Company terms for the sale are based on free on board (FOB) shipping point, where the control passes to the customer once the product leaves our warehouse. The Company determines collectability by requiring certain customers to pay before control is transferred and by performing ongoing credit evaluations and monitoring customer accounts receivable balances. As of March 31, 2025 and December 31, 2024, deposits collected from customers for orders to be filled at a future date were $844,318 and $1,014,164, respectively.

 

Shipping and direct costs charged to customers, along with fees collected from customers for storing their products in our warehouse facility located in Warminster, Pennsylvania are included in revenue as Other Revenue. Shipping and direct costs incurred by the Company are included in Cost of Sales and Service.

 

Revenue generated for the three months ended March 31, 2025, was as follows:

 

   Membership
revenue
   Mining revenue   Health and wellness product sales   Other Revenue   Total 
Gross billings/receipts  $9,439,857   $862,944   $368,443   $7,344   $10,678,588 
Refunds, incentives, credits, and chargebacks   (648,414)   -    (122)   -    (648,536)
Net revenue  $8,791,443   $862,944   $368,321   $7,344   $10,030,052 

 

Foreign revenues for the three months ended March 31, 2025 were approximately $7.6 million while domestic revenue for the three months ended March 31, 2025 was approximately $2.4 million.

 

Revenue generated for the three months ended March 31, 2024, was as follows:

 

   Membership
Revenue
   Mining Revenue   Total 
Gross billings/receipts  $13,851,294   $2,642,599   $16,493,893 
Refunds, incentives, credits, and chargebacks   (821,976)   -    (821,976)
Net revenue  $13,029,318   $2,642,599   $15,671,917 

 

Foreign revenues for the three months ended March 31, 2024 were approximately $11.8 million while domestic revenue for the three months ended March 31, 2024 was approximately $3.9 million.

 

33

 

 

Recent Accounting Pronouncements

 

In December 2023, the FASB issued ASU No. 2023-08, Intangibles—Goodwill and Other—Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets. The amendments in ASU No. 2023-08 are intended to improve the accounting for certain crypto assets by requiring an entity to measure those crypto assets at fair value each reporting period with changes in fair value recognized in net income. The amendments also improve the information provided to investors about an entity’s crypto asset holdings by requiring disclosure about significant holdings, contractual sale restrictions, and changes during the reporting period. The amendments are effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company adopted ASU No. 2023-08 for the year ended December 31, 2025, effective as of January 1, 2025, which had a material impact on the financial statements.

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 expands existing income tax disclosures for rate reconciliations by requiring disclosure of certain specific categories and additional reconciling items that meet quantitative thresholds and expands disclosures for income taxes paid by requiring disaggregation by certain jurisdictions. ASU 2023-09 is effective for annual periods beginning after December 15, 2024; early adoption is permitted. The Company adopted the ASU for the year ended December 31, 2025. The amendments only impact disclosures and are not expected to have an impact on the Company’s financial condition and results of operations.

 

In December 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires, in the notes to the financial statements, disclosures of specified information about certain costs and expenses specified in the updated guidance. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company did not elect early adoption and is evaluating the impact the updated guidance will have on its disclosures in 2026.

 

We have noted no other recently issued accounting pronouncements that we have not yet adopted that we believe are applicable or would have a material impact on our financial statements.

 

ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this item.

 

ITEM 4 – CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15 under the Securities Exchange Act of 1934 (the “Exchange Act”) as of the end of the period covered by this Quarterly Report on Form 10-Q. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 

Our disclosure controls and procedures are designed to provide reasonable, not absolute, assurance that the objectives of our disclosure control system are met. Because of inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within a company have been detected. Our Chief Executive Officer and Chief Financial Officer have concluded, based on their evaluation as of the end of the period covered by this report, that our disclosure controls and procedures were effective.

 

Changes in Internal Controls

 

There were no changes in our internal controls over financial reporting during the fiscal quarter ended March 31, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

34

 

 

PART II – OTHER INFORMATION

 

ITEM 1 – LEGAL PROCEEDINGS

 

There have been no material changes to this information since reported on in the Annual Report on Form 10-K for the year ended December 31, 2024.

 

ITEM 1.A – RISK FACTORS

 

Except as set forth below, there have been no material changes in the risk factors disclosed by us under Part I, Item 1A. Risk Factors contained in the Annual Report on Form 10-K for the year ended December 31, 2024. 

 

Our business may be adversely impacted due to an administrative proceeding initiated by a Polish governmental agency, which has raised concerns regarding the nature of our direct selling activities, including potential allegations that such activities may be construed as inconsistent with public interest or regulatory standards.

 

Our iGenius products and services are marketed by a global network of independent distributors using a direct selling business model. Although we believe that our direct selling business model is in material compliance with applicable legal standards, direct selling programs similar to ours and others within the industry, in general, have periodically been the target of regulatory scrutiny by federal, state, and local governmental agencies in the United States and foreign countries, including the FTC. These laws and regulations are generally intended to prevent fraudulent or deceptive schemes, often referred to as “pyramid” schemes, which compensate participants primarily for recruiting additional participants without significant emphasis on product sales, whereas the more successful direct selling business models have and emphasize sales of products and services. The regulatory requirements concerning direct selling programs do not include “bright line” rules and are inherently fact-based and, thus, we are subject to the risk that these regulations or the enforcement or interpretation of these regulations by regulators or courts can change. The adoption of new regulations, or changes in the interpretations or enforcement of existing regulations, may result in significant compliance costs or require us to change or cease aspects of our network marketing program. In addition, the ambiguity surrounding these regulations can also affect the public perception of our business.

 

In the normal course of operations, we have periodically received inquiries from foreign regulators relative to matters of this nature. In that regard, since March 2025 we have been responding to such an inquiry from in Poland’s Office of Competition and Consumer Protection (“UOKiK”) as it has instituted formal proceedings against iGenius alleging that iGenius is not a bona fide financial education platform and is instead operating a pyramid scheme that is focused more on the recruitment of new members and not the sale or use of the underlying products or services being offered. By Polish statute, UOKiK is permitted to impose a fine of up to 10% of iGenius’ revenue in the year preceding the imposition of the penalty.

 

Based on our analysis of the applicable legal standards, and the tracking of our sales within Poland in which the predominant portion of our sales consist of membership sales driven by our members, we believe that the iGenius direct selling business operating within Poland complies with all applicable legal standards and we disagree with any claims to the contrary. Towards that end, we have retained Polish counsel to vigorously defend us in the proceeding with the UOKiK. Despite our strong belief in our position, should we not succeed in our defense of the matter, we could, among other things: be subject to financial fines and penalties; be required to modify or suspend certain or a material portion of our operations in Poland; and become exposed to similar claims from other European regulators, which itself could cause a cascading and similar adverse impact on our operations in Europe, all of which could have a materially adverse impact on the Company. It is still too early in the proceedings for us to draw a likely conclusion on the outcome of the matter.

 

We have recently had to respond to allegations from Canadian Securities regulators that our iGenius business unit engaged in unlicensed regulated securities activities; Our business could be negatively affected if we are required to defend similar allegations from securities regulators in the United States or in other foreign countries in which we do business.

 

From time to time, we receive notices or formal actions from foreign or domestic regulatory authorities or administrative agencies, which assert that certain activities of our iGenius business constitute unlicensed activities as an unregistered securities dealer or advisor under local laws. However, we do not believe that our iGenius business unit violates any such laws as we believe we are merely a provider of financial education and related tools that access information that is available publicly or without a licensing requirement, or that through affinity programs provide access to lawful services or products offered by third parties neither owned or operated by iGenius. When we are confronted with such allegations, we may either elect to challenge the legal basis thereof when we believe it is appropriate or economically compelling, or in the instances in which the financial impact of the relief sought is de minimis, we may elect to settle with any such regulator, often without admitting any violation of law. Towards that end, we have recently been the target of regulatory scrutiny by securities regulators in Canada. During 2024, we received a letter of inquiry from the Ontario Securities Commission (“OSC”) in which they questioned whether iGenius was engaged in securities activities without being registered under their securities act. Specifically, the OSC identified concerns that iGenius was selling ndau – which they considered an investment contract – and also noted that they had concerns about certain third-party product offerings and access to market experts that were made available to iGenius customers. Even though we believe that our iGenius business fully complies with all applicable securities laws, due to the immaterial scope and scale of our operations in Ontario, Canada, we elected to settle the matter with the OSC and conclude the inquiry by implementing a geoblock throughout Ontario such that no Ontario-based customers would be able to access any of the disputed product offerings.

 

35

 

 

Later in 2024, we and one of our independent distributors received an enforcement action from the financial regulators in Quebec, Canada, known as the Autorité des marchés financiers (the “AMF”), in which they challenged certain inappropriate marketing communications they characterized as “inappropriate” made by this particular distributor, and as well alleged that iGenius was inappropriately engaging in regulated securities activity without being appropriately registered to do so in Quebec. In discussions with the AMF, it became clear that the focus of their inquiry was on certain “touting” of financial results by this particular distributor which we concluded was unauthorized and in violation of our own internal policies and we terminated the distributor. As well, the AMF asserted that iGenius acted in contravention of securities regulations that require registration to effectuate the sale of securities in Quebec, by failing to register with the AMF while enabling its members to gain access to certain third-party “robotic” trading platforms, even though iGenius, among others: (x) derives no direct financial benefit from these introductions; and (b) has no involvement with the provision of services by the third-party to whom its members are introduced. Even though we believe that our iGenius business fully complies with all applicable securities laws, due to the immaterial scope and scale of our operations in Quebec, Canada, we have engaged in settlement discussions with the AMF in order to avoid a protracted and costly legal dispute. In addition to the termination of our distributor, the preliminary settlement discussions have focused on the following three elements: the payment by iGenius of a CAD $15,000 fine; the implementation by iGenius of the same type of geoblock that we implemented in Ontario and the admission by iGenius that by introducing its customers to the third-party service providers offering the “robotic” trading platforms, it committed a violation of Canadian securities law. Discussions between the AMF and iGenius are ongoing, and no formal agreement has been signed at this time.

 

We have carefully evaluated the basis for the claims asserted by the OSC and the AMF and we have concluded that our iGenius business unit operates generally in compliance with applicable securities rules and regulations. Our completed and pending settlements, however, with the OSC and AMF could expose us to similar claims from other securities regulators in the United States and in other foreign countries in which we operate. Were such claims to be made, we could be exposed to having to defend our business model in protracted and costly legal disputes, or else engage in similar settlements in which we agree to limit the geographic scope of our operations, either of which alternatives could have an adverse effect on our liquidity and operations.

 

ITEM 2 – UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3 – DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4 – MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5 – OTHER INFORMATION

 

During the first three months of the fiscal year ended December 31, 2025, no director of “officer” as defined in Rule 16a-1(f) under the Exchange Act adopted or terminated any Rule 10b5-1 trading plan or arrangements or any non-Rule 10b5-1 trading plan or arrangements, in both cases as defined in Item 408 of Regulation S-K.

 

36

 

 

ITEM 6 – EXHIBITS

 

The following exhibits are filed as a part of this report:

 

Exhibit
Number*
  Title of Document   Location
         
Item 31   Rule 13a-14(a)/15d-14(a) Certifications    
         
31.01   Certification of Principal Executive Officer Pursuant to Rule 13a-14   This filing.
         
31.02   Certification of Principal Financial Officer Pursuant to Rule 13a-14   This filing.
         
Item 32   Section 1350 Certifications    
         
32.01   Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002   This filing.
         
32.02   Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002   This filing.
         
Item 101***   Interactive Data File    
         
101.INS   Inline XBRL Instance Document   This filing.
         
101.SCH   Inline XBRL Taxonomy Extension Schema   This filing.
         
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase   This filing.
         
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase   This filing.
         
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase   This filing.
         
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase   This filing.
         
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)   This filing.

 

 

 

* All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document. Omitted numbers in the sequence refer to documents previously filed as an exhibit.

 

*** Users of this data are advised that, pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or Annual Report for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Exchange Act of 1934 and otherwise are not subject to liability.

 

37

 

 

SIGNATURE PAGE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  INVESTVIEW, INC.
     
Dated: May 14, 2025 By: /s/ Victor M. Oviedo
    Victor M. Oviedo
    Chief Executive Officer
    (Principal Executive Officer)
     
Dated: May 14, 2025 By: /s/ Ralph R. Valvano
    Ralph R. Valvano
    Chief Financial Officer
    (Principal Financial Officer and Accounting Officer)

 

38

 

EX-31.01 2 ex31-01.htm EX-31.01

 

Exhibit 31.01

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

 

I, Victor M. Oviedo, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 of Investview, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

 

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: May 14, 2025  
   
/s/ Victor M. Oviedo  
Victor M. Oviedo  
Chief Executive Officer (Principal Executive Officer)  

 

 

EX-31.02 3 ex31-02.htm EX-31.02

 

Exhibit 31.02

 

CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER

PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

 

I, Ralph R. Valvano, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 of Investview, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

 

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: May 14, 2025  
   
/s/ Ralph R. Valvano  
Ralph R. Valvano  
Chief Financial Officer (Principal Financial and Accounting Officer)  

 

 

EX-32.01 4 ex32-01.htm EX-32.01

 

Exhibit 32.01

 

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Investview, Inc. (the “Company”) for the Quarter ended March 31, 2025, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Victor M. Oviedo, the Chief Executive Officer, of the Company, do hereby certify pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief that:

 

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: May 14, 2025

 

/s/ Victor M. Oviedo  
Victor M. Oviedo  
Chief Executive Officer (Principal Executive Officer)  

 

 
EX-32.02 5 ex32-02.htm EX-32.02

 

Exhibit 32.02

 

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Investview, Inc. (the “Company”) for the Quarter ended March 31, 2025, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ralph R. Valvano, the Chief Financial Officer, of the Company, do hereby certify pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief that:

 

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: May 14, 2025

 

/s/ Ralph R. Valvano  
Ralph R. Valvano  
 Chief Financial Officer (Principal Financial and Accounting Officer)  

 

 

 

EX-101.SCH 6 invu-20250331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 999012 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 999013 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 999014 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS link:presentationLink link:calculationLink link:definitionLink 999015 - Disclosure - LIQUIDITY link:presentationLink link:calculationLink link:definitionLink 999016 - Disclosure - DIGITAL ASSETS link:presentationLink link:calculationLink link:definitionLink 999017 - Disclosure - RELATED-PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 999018 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 999019 - Disclosure - DERIVATIVE LIABILITY link:presentationLink link:calculationLink link:definitionLink 999020 - Disclosure - OPERATING LEASE link:presentationLink link:calculationLink link:definitionLink 999021 - Disclosure - STOCKHOLDERS’ EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 999022 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 999023 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 999024 - Disclosure - ACQUISITION link:presentationLink link:calculationLink link:definitionLink 999025 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 999026 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 999027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 999028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 999029 - Disclosure - DIGITAL ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 999030 - Disclosure - RELATED-PARTY TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 999031 - Disclosure - DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 999032 - Disclosure - DERIVATIVE LIABILITY (Tables) link:presentationLink link:calculationLink link:definitionLink 999033 - Disclosure - OPERATING LEASE (Tables) link:presentationLink link:calculationLink link:definitionLink 999034 - Disclosure - STOCKHOLDERS’ EQUITY (DEFICIT) (Tables) link:presentationLink link:calculationLink link:definitionLink 999035 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 999036 - Disclosure - ACQUISITION (Tables) link:presentationLink link:calculationLink link:definitionLink 999037 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999038 - Disclosure - SCHEDULE OF RECEIVABLES (Details) link:presentationLink link:calculationLink link:definitionLink 999039 - Disclosure - SCHEDULE OF FIXED ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 999040 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) link:presentationLink link:calculationLink link:definitionLink 999041 - Disclosure - SCHEDULE OF REVENUE GENERATED (Details) link:presentationLink link:calculationLink link:definitionLink 999042 - Disclosure - SCHEDULE OF INVENTORY (Details) link:presentationLink link:calculationLink link:definitionLink 999043 - Disclosure - SCHEDULE OF DILUTED EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 999044 - Disclosure - SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details) link:presentationLink link:calculationLink link:definitionLink 999045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999046 - Disclosure - LIQUIDITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999047 - Disclosure - SCHEDULE OF DIGITAL ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 999048 - Disclosure - SCHEDULE OF DIGITAL ASSETS ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 999049 - Disclosure - DIGITAL ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999050 - Disclosure - SCHEDULE OF RELATED PARTY PAYABLES (Details) link:presentationLink link:calculationLink link:definitionLink 999051 - Disclosure - SCHEDULE OF RELATED PARTY PAYABLES (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 999052 - Disclosure - RELATED-PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999053 - Disclosure - SCHEDULE OF DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 999054 - Disclosure - SCHEDULE OF DEBT (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 999055 - Disclosure - DEBT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999056 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 999057 - Disclosure - SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL (Details) link:presentationLink link:calculationLink link:definitionLink 999058 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 999059 - Disclosure - OPERATING LEASE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999060 - Disclosure - SCHEDULE OF OPTIONS ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 999061 - Disclosure - SCHEDULE OF OPTIONS OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 999062 - Disclosure - SCHEDULE OF WARRANTS ISSUED (Details) link:presentationLink link:calculationLink link:definitionLink 999063 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 999064 - Disclosure - STOCKHOLDERS’ EQUITY (DEFICIT) (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999065 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999066 - Disclosure - SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 999067 - Disclosure - SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 999068 - Disclosure - SEGMENT REPORTING (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999069 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) link:presentationLink link:calculationLink link:definitionLink 999070 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 999071 - Disclosure - ACQUISITION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999072 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999073 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 invu-20250331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 invu-20250331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 invu-20250331_lab.xml XBRL LABEL FILE Related and Nonrelated Parties [Axis] Related Party [Member] Nonrelated Party [Member] Product and Service [Axis] Membership Revenue [Member] Mining Revenue [Member] Health and Wellness Revenue [Member] Other [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Treasury Stock, Common [Member] AOCI Attributable to Parent [Member] Retained Earnings [Member] Noncontrolling Interest [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Contribution Agreement [Member] Business Acquisition [Axis] Wealth Generators LLC [Member] Acquisition Agreement [Member] Market Trend Strategies LLC [Member] Foreign Revenue [Member] Domestic Revenue [Member] Long-Lived Tangible Asset [Axis] Furniture, Fixtures and Equipment [Member] Computer Equipment [Member] Data Processing Equipment [Member] Manufacturing Equipment [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Warrant [Member] Convertible Debt Securities [Member] Conversion of Non-voting Membership Interest [Member] Crypto Asset [Axis] Bitcoin [Member] USDC [Member] Long-Term Debt, Type [Axis] Convertible Promissory Note One [Member] Convertible Promissory Note Two [Member] Convertible Promissory Note Three [Member] Working Capital Promissory Note [Member] Debt Instrument [Axis] Related Party Transaction [Axis] DBR Capital LLC [Member] Securities Purchase Agreements [Member] SSA Technologies LLC [Member] Stock Purchase and Release Agreement [Member] Mario Romano and Annette Raynor [Member] Statement of Financial Position Location, Balance [Axis] Accounts Payable and Accrued Liabilities [Member] Ryan Smith and Chand Miller [Member] US Small Business Administration [Member] APEX Tex LLC [Member] Measurement Input Type [Axis] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Expected Term [Member] Measurement Input, Price Volatility [Member] Lease Contractual Term [Axis] Wyckoff Lease [Member] Haverford Lease [Member] Warminster Lease [Member] Ivyland Lease [Member] Class of Stock [Axis] Series B Preferred Stock [Member] Sale of Stock [Axis] Unit Offering [Member] Share Repurchase Program [Axis] Stock Repurchase Program [Member] Investview Financial Group Holding LLC [Member] Class B Units [Member] Promissory Note [Member] Consolidated Entities [Axis] iGenius, LLC [Member] Credit Card [Member] Title and Position [Axis] Joseph Cammarata [Member] Subsegments Consolidation Items [Axis] Reportable Subsegments [Member] Subsegments [Axis] Financial Education and Technology [Member] Blockchain Technology and Crypto Mining Products and Services [Member] Manufacturing and Development of Health Beauty and Wellness Products [Member] Ownership [Axis] Goldman's Pharmaceuticals LLC [Member] ELRT Technologies, LLC [Member] Legal Entity [Axis] Renu Laboratories, Inc [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Listing, Par Value Per Share Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] ASSETS Current assets: Cash and cash equivalents Prepaid assets Deposits, current Receivables Inventory Income tax paid in advance Total current assets Fixed assets, net Other assets: Digital assets Goodwill Intangible assets, net Operating lease right-of-use asset Deposits Total other assets Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) Current liabilities: Accounts payable and accrued liabilities Payroll liabilities Income tax payable Deferred revenue Derivative liability Dividend liability Operating lease liability, current Debt, net of discounts, current Total current liabilities Operating lease liability, long term Accrued liabilities, long term Debt, net of discounts, long term Total long-term liabilities Total liabilities Commitments and contingencies Stockholders’ equity (deficit): Preferred stock, par value: $0.001; 50,000,000 shares authorized, 252,192 and 252,192 issued and outstanding as of March 31, 2025 and December 31, 2024, respectively Common stock, par value $0.001; 10,000,000,000 shares authorized; 1,859,231,786 and 1,859,231,786 shares issued and 1,858,142,500 and 1,859,231,786 outstanding as of March 31, 2025 and December 31, 2024, respectively Additional paid in capital Treasury stock, at cost, 1,089,286 and 0 shares as of March 31, 2025 and December 31, 2024, respectively Accumulated other comprehensive income (loss) Accumulated deficit Accumulated noncontrolling interest Total stockholders’ equity (deficit) Total liabilities and stockholders’ equity (deficit) Statement of Financial Position [Abstract] Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Treasury stock common, shares Statement [Table] Statement [Line Items] Revenue: Total revenue, net Operating costs and expenses: Cost of sales and service Commissions Advertising, selling, and marketing Salary and related Professional fees General and administrative Total operating costs and expenses Net income (loss) from operations Other income (expense): Gain (loss) on fair value of derivative liability Realized gain (loss) on digital assets Unrealized gain (loss) on digital assets Interest expense Other income (expense) Total other income (expense) Income (loss) before income taxes Income tax expense Net income (loss) Net income (loss) attributable to noncontrolling interest Net income (loss) attributable to Investview, Inc. Dividends on Preferred Stock Net income (loss) applicable to common shareholders Basic income (loss) per common share Diluted income (loss) per common share Basic weighted average number of common shares outstanding Diluted weighted average number of common shares outstanding Balance Balance, shares Treasury stock Balance, shares Common stock issued for services and other stock-based compensation Common stock repurchased from former related parties and canceled Common stock repurchased from related parties and canceled, shares Dividends Net income (loss) Cumulative effect adjustment upon adoption of ASU 2023-08 Common stock repurchased and held as treasury stock Common stock repurchased and held as treasury stock, shares Balance Balance, shares Treasury stock Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation Amortization of debt discount Stock issued for services and other stock-based compensation Lease cost, net of repayment (Gain) loss on fair value of derivative liability Change in fair value of digital assets Realized (gain) loss on digital assets Digital assets collected for membership revenue Revenue recognized from bitcoin mined Operating expenses paid with digital assets Changes in operating assets and liabilities: Receivables Inventory Prepaid assets Deposits Accounts payable and accrued liabilities Income tax payable Deferred revenue Accrued interest Accrued interest, related parties Net cash provided by (used in) operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of digital currencies Purchase of Treasury Stock Cash paid for fixed assets Net cash provided by (used in) investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Repayments for related party debt Repayments for debt Payments for shares repurchased from former related parties Dividends paid Net cash provided by (used in) financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents - beginning of period Cash and cash equivalents - end of period SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Cash paid during the period for: Interest Income taxes Non-cash investing and financing activities: Common stock repurchased for payables Dividends declared Dividends paid with digital assets Debt extinguished in exchange for digital assets Cumulative effect adjustment upon adoption of ASU 2023-08 Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Type [Axis] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND NATURE OF BUSINESS Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Accounting Changes and Error Corrections [Abstract] RECENT ACCOUNTING PRONOUNCEMENTS LIQUIDITY Goodwill and Intangible Assets Disclosure [Abstract] DIGITAL ASSETS Related Party Transactions [Abstract] RELATED-PARTY TRANSACTIONS Debt Disclosure [Abstract] DEBT Derivative Instruments and Hedging Activities Disclosure [Abstract] DERIVATIVE LIABILITY Operating Lease OPERATING LEASE Equity [Abstract] STOCKHOLDERS’ EQUITY (DEFICIT) Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Segment Reporting [Abstract] SEGMENT REPORTING Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] ACQUISITION Income Tax Disclosure [Abstract] INCOME TAXES Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Accounting Principles of Consolidation Operating Segments Financial Statement Reclassification Use of Estimates Concentration of Credit Risk Cash Equivalents Receivables Fixed Assets Digital Assets Goodwill Intangible Assets Impairment of Long-Lived Assets Fair Value of Financial Instruments Revenue Recognition Advertising, Selling and Marketing Costs Cost of Sales and Service Inventory Income Taxes Net Income (Loss) per Share Lease Obligation SCHEDULE OF RECEIVABLES SCHEDULE OF FIXED ASSETS SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS SCHEDULE OF REVENUE GENERATED SCHEDULE OF INVENTORY SCHEDULE OF DILUTED EARNINGS PER SHARE SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES SCHEDULE OF DIGITAL ASSETS SCHEDULE OF DIGITAL ASSETS ACTIVITY SCHEDULE OF RELATED PARTY PAYABLES SCHEDULE OF DEBT SCHEDULE OF DERIVATIVE LIABILITY SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES SCHEDULE OF OPTIONS ACTIVITY SCHEDULE OF OPTIONS OUTSTANDING SCHEDULE OF WARRANTS ISSUED SCHEDULE OF WARRANTS OUTSTANDING SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Entity incorporation, date of incorporation Percentage of shares contributed Number of shares exchanged for common stock Value pre-merger liabilities Due from merchant processors Held in reserve by merchant processors for future returns and chargebacks Due from payout service providers Accounts and other receivables Receivable, gross Allowance for doubtful accounts Receivables Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Estimated useful life of fixed assets Gross book value Accumulated depreciation Net book value Platform Operator, Crypto Asset [Table] Platform Operator, Crypto Asset [Line Items] Digital assets (see NOTE 5) Total Assets Derivative liability Total Liabilities Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Gross billings/receipts Refunds, incentives, credits, and chargebacks Net revenue Finished goods Work in process Raw materials Inventory Net income Less: preferred dividends Add: interest expense on convertible debt Net income available to common shareholders (numerator) Dilutive impact of convertible notes Dilutive impact of non-voting membership interest Diluted weighted average number of common shares outstanding (denominator) Diluted income per common share Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive securities Number of reportable segments Cash, FDIC insured amount Cash balances exceeded FDIC limits Cash equivalents Depreciation expense Impairment of long-lived assets Deferred revenues Deposits collected from customers for orders to be filled at future date Revenues Advertising, selling, and marketing expenses Crypto Asset, Holding [Table] Crypto Asset, Holding [Line Items] Digital assets held, Quantity Digital assets held, Cost basis Digital assets held, Fair value Beginning balance, Fair Value Beginning balance, Cost Basis Revenue recognized from Bitcoin mined Digital assets collected from membership revenue Purchase of digital assets Operating expenses paid with digital assets Dividends paid via digital assets Debt extinguished in exchange for digital assets Realized (gain) loss on sale of digital assets Change in fair value of digital assets Ending balance, Fair Value Ending balance, Cost Basis Increase in digital assets Decrease in accumulated deficit Related Party Transaction [Table] Related Party Transaction [Line Items] Total related-party debt Less: Current portion Related-party debt, long term Debt discount Received proceeds from related party debt Debt interest rate Debt instrument maturity date Debt conversion price per share Beneficial conversion feature and debt discount Debt discount into interest expense Interest expense Debt interest rate Facility fee percentage Acquired percentage Debt instrument face amount Debt secured by common stock Related party transaction amounts of advance Number of shares repurchased Shares purchased value Share price Amount owed Legal fees Consideration paid for purchased shares Consideration paid for purchased shares and expenses Shares purchased and cancelled Purchase price Purchase price per share Short-Term Debt [Table] Short-Term Debt [Line Items] Total debt Less: Current portion Debt, long term portion Proceeds from debt Debt instrument interest rate Monthly installment payments Repayments on loan Note amount Shares issued for debt Debt payment terms Repayments of debt Digital assets issued value Derivative liability Derivative liability recorded on new instruments Derivative liability reduced by warrant exercise (Gain) loss on fair value Derivative liability Derivative [Table] Derivative [Line Items] Derivative liability measurement input Schedule Of Future Minimum Lease Payments Under Non-cancellable Leases Remainder of 2025 2026 Total Less: Interest Present value of lease liability Operating lease liability, current Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Right-of-use assets obtained in exchange for new operating lease liabilities Weighted average remaining lease term Operating lease right of use asset Operating lease liability Operating lease expense Operating cash flows used for operating leases Weighted average discount rate Number of Options, Options outstanding, beginning Weighted Average Exercise Price, Options outstanding, beginning Weighted Average Grant-Date Per Share Fair Value, Options outstanding beginning Number of Options, Granted Weighted Average Exercise Price, Granted Number of Options, Canceled/Expired Weighted Average Exercise Price, Canceled/Expired Number of Options, Exercised Weighted Average Exercise Price, Exercised Number of Options, Options outstanding, ending Weighted Average Exercise Price, Options outstanding, ending Weighted Average Grant-Date Per Share Fair Value, Options outstanding ending Options Exercisable Weighted Average Exercise Price of Options Exercisable Weighted Average Contractual Life of Options Exercisable (Years) Weighted Average Contractual Life of Options Outstanding (Years) Number of Warrants Outstanding, beginning Weighted Average Exercise Price Outstanding, beginning Number of Warrants Granted Weighted Average Exercise Price Granted Number of Warrants Canceled/Expired Weighted Average Exercise Price, Canceled/Expired Number of Warrants Exercised Weighted Average Exercise Price Exercised Number of Warrants Outstanding, ending Weighted Average Exercise Price Outstanding, ending Warrants Exercisable Weighted Average Contractual Life (Years) Stock, Class of Stock [Table] Class of Stock [Line Items] Preferred stock par value Preferred stock designated Cumulative dividends annual rate percentage Preferred stock, dividend price per share Number of shares issued in transaction Sale of stock, price per share Description of offering Dividends, cash Dividends paid in cash Digital assets issued for dividend payment Dividend liability Value of shares authorized for repurchase Par value of shares repurchased Value of shares repurchased Exchange for cash Consideration payable for purchased shares and expenses Stock-based compensation Common stock reserves for issuance Stock compensation expense Unrecognized compensation cost Weighted average period for recognition Units, issued Units, outstanding Conversion description Converted market value Closing market price per share Transaction cost Fair value discounted percentage Business acquisition, transaction costs discount value Number of exchange shares issuable Product Liability Contingency [Table] Product Liability Contingency [Line Items] Penalty amount paid Notes issued value Notes maturity date Debt premium percentage Repayment of debt Distribution of digital currencies prior to termination Receivable balance Credit card receivables Debt instrument, principal amount Debt conversion description Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Revenue Market experts Credit card processing Selling and marketing Energy and hosting Cost of sales Segment income from operations Bank interest Event ticket sales Leasing income All other, net Description of Products and Services Cash Customer deposits – intercompany Domain names Raw materials Manufacturing equipment Total assets acquired Accounts payable Customer deposits Total liabilities assumed Net assets acquired Consideration Fair value of noncontrolling interest in ELRT Technologies, LLC Total Purchase price Customer deposits Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Ownership interest, percentage Income tax provision Effective tax rate Subsequent Event [Table] Subsequent Event [Line Items] Number of shares bought back Value of shares bought back Income tax paid in advance. Accrued liabilities long term. Accumulated noncontrolling interest. Commissions. Gain loss on lease cost net of repayment. Increase decrease in interest payable related parties net. Cash Paid During The Period For [Abstract] Common stock repurchased for payables. Dividends paid with digital assets. Debt and related party debt extinguished in exchange for cryptocurrency. Cumulative effect adjustment uponadoption of asu 202308. Digital assets collected for membership revenue. Operating expenses paid with digital assets. Contribution Agreement [Member] Wealth Generators LLC [Member] Acquisition Agreement [Member] Market Trend Strategies LLC [Member] Due from merchant processors. Held in reserve by merchant processors for future returns and charge backs. Due from payout service providers. Furniture, Fixtures and Equipment [Member] Data Processing Equipment [Member] Manufacturing Equipment [Member] Digital Assets [Policy Text Block] Deposits collected from customers for orders to be filled at future date. Membership Revenue [Member] Mining Revenue [Member] Health and Wellness Revenue [Member] Other [Member] Gross billings/receipts. Represents the monetary amount of Refunds, Incentives, Credits, and Chargebacks, during the indicated time period. Foreign Revenue [Member] Domestic Revenue [Member] Conversion of Non-voting Membership Interest [Member] Bitcoin [Member] USDC [Member] Crypto assets number of units. Convertible Promissory Note One [Member] Convertible Promissory Note Two [Member] DBR Capital LLC [Member] Securities Purchase Agreements [Member] Convertible Promissory Note Three [Member] SSA Technologies LLC [Member] Stock Purchase and Release Agreement [Member] Mario Romano and Annette Raynor [Member] Payments for repurchase of equity and legal fee. Ryan Smith and Chand Miller [Member] US Small Business Administration [Member] APEX Tex LLC [Member] Derivative liability recorded on new instruments. Warrant exercise. Wyckoff Lease [Member] Haverford Lease [Member] Warminster Lease [Member] Ivyland Lease [Member] Preferred stock designated. Unit Offering [Member] Share based compensation arrangement by share based payment award non-option equity instruments outstanding weighted average exercise price. Share based compensation arrangement by share based payment award non-option equity instruments outstanding weighted average exercise price granted. Share based compensation arrangement by share based payment award non-option equity instruments outstanding weighted average exercise price canceled. Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price exercised. Summary Of Warrants Outstanding [Table Text Block] Investview Financial Group Holding LLC [Member] Class B Units [Member] Fair value discounted percentage. Business Acquisition Cost Of Acquired Entity Transaction Fair Value Discount. Promissory Note [Member] Debt premium percentage. Distribution of digital currencies prior to termination. iGenius, LLC [Member] Joseph Cammarata [Member] Financial Education and Technology [Member] Blockchain Technology and Crypto Mining Products and Services [Member] Manufacturing and Development of Health Beauty and Wellness Products [Member] Market experts. Credit card processing. Energy and Hosting. Segment reporting reconciling item bank interest. Segment reporting reconciling item event ticket sales. Segment reporting reconciling item leasing income. Segment reporting reconciling item all other net. Goldman's Pharmaceuticals LLC [Member] ELRT Technologies, LLC [Member] Renu Laboratories, Inc [Member] Business combination recognized identifiable assets acquired and liabilities assumed customer deposits inter company. Business combination recognized identifiable assets acquired and liabilities assumed current liabilities customer deposits. Working Capital Promissory Note [Member] Stock Repurchase Program [Member] Assets, Current Other Assets, Noncurrent Assets Liabilities, Current Liabilities, Noncurrent Liabilities Treasury Stock, Value Equity, Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Interest Expense, Other Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Preferred Stock Dividends, Income Statement Impact Net Income (Loss) Available to Common Stockholders, Basic Equity, Including Portion Attributable to Noncontrolling Interest Shares, Outstanding Stock Repurchased and Retired During Period, Value Stock Repurchased and Retired During Period, Shares Treasury Stock, Value, Acquired, Cost Method GainLossonLeaseCostNetofRepayment Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense Increase (Decrease) in Deposit Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Income Taxes Payable Increase (Decrease) in Contract with Customer, Liability Net Cash Provided by (Used in) Operating Activities Payments to Acquire Other Investments Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Related Party Debt Payments of Dividends Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations CumulativeEffectAdjustmentUponAdoptionOfASU202308 Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Receivable [Policy Text Block] Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Accounts Receivable, before Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss Accounts Receivable, after Allowance for Credit Loss Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Derivative Liability Refunds, Incentives, Credits, and Chargebacks Net Income (Loss) Available to Common Stockholders, Diluted Debt Instrument, Interest Rate During Period Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceCanceled Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Dividends Payable SegmentReportingReconcilingItemBankInterest SegmentReportingReconcilingItemEventTicketSales SegmentReportingReconcilingItemLeasingIncome SegmentReportingReconcilingItemAllOtherNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Payments to Acquire Businesses, Gross EX-101.PRE 10 invu-20250331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Cover - $ / shares
3 Months Ended
Mar. 31, 2025
May 09, 2025
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2025  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2025  
Current Fiscal Year End Date --12-31  
Entity File Number 000-27019  
Entity Registrant Name Investview, Inc.  
Entity Central Index Key 0000862651  
Entity Tax Identification Number 87-0369205  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 521 West Lancaster Avenue  
Entity Address, Address Line Two Second Floor  
Entity Address, City or Town Haverford  
Entity Address, State or Province PA  
Entity Address, Postal Zip Code 19041  
City Area Code 732  
Local Phone Number 889-4300  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   1,857,910,500
Entity Listing, Par Value Per Share $ 0.001  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 17,506,288 $ 22,467,710
Prepaid assets 1,294,048 497,620
Deposits, current 2,807,780 936,434
Receivables 2,231,577 2,534,727
Inventory 856,126 495,865
Income tax paid in advance 459,872 459,872
Total current assets 25,155,691 27,392,228
Fixed assets, net 1,968,049 1,868,441
Other assets:    
Digital assets 1,676,351 1,127,891
Goodwill 873,701 873,701
Intangible assets, net 40,310 40,310
Operating lease right-of-use asset 173,412 211,996
Deposits 57,028 57,028
Total other assets 2,820,802 2,310,926
Total assets 29,944,542 31,571,595
Current liabilities:    
Accounts payable and accrued liabilities 6,152,883 7,139,684
Payroll liabilities 149,742 271,606
Income tax payable 209,646 202,573
Deferred revenue 2,834,758 3,029,145
Derivative liability 2,853 758
Dividend liability 247,437 245,101
Operating lease liability, current 140,112 [1] 165,707
Total current liabilities 10,971,572 12,288,385
Operating lease liability, long term 33,381 46,433
Accrued liabilities, long term 48,459 45,532
Total long-term liabilities 2,154,099 2,083,625
Total liabilities 13,125,671 14,372,010
Commitments and contingencies
Stockholders’ equity (deficit):    
Preferred stock, par value: $0.001; 50,000,000 shares authorized, 252,192 and 252,192 issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 252 252
Common stock, par value $0.001; 10,000,000,000 shares authorized; 1,859,231,786 and 1,859,231,786 shares issued and 1,858,142,500 and 1,859,231,786 outstanding as of March 31, 2025 and December 31, 2024, respectively 1,859,231 1,859,231
Additional paid in capital 102,947,954 102,560,320
Treasury stock, at cost, 1,089,286 and 0 shares as of March 31, 2025 and December 31, 2024, respectively (24,006)
Accumulated other comprehensive income (loss) (23,218) (23,218)
Accumulated deficit (87,947,425) (87,205,070)
Accumulated noncontrolling interest 6,083 8,070
Total stockholders’ equity (deficit) 16,818,871 17,199,585
Total liabilities and stockholders’ equity (deficit) 29,944,542 31,571,595
Related Party [Member]    
Current liabilities:    
Debt, net of discounts, current 1,204,897 1,204,567
Debt, net of discounts, long term 1,584,327 1,501,041
Nonrelated Party [Member]    
Current liabilities:    
Debt, net of discounts, current 29,244 29,244
Debt, net of discounts, long term $ 487,932 $ 490,619
[1] Represents lease payments to be made in the next 12 months.
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2025
Dec. 31, 2024
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 50,000,000 50,000,000
Preferred stock, shares issued 252,192 252,192
Preferred stock, shares outstanding 252,192 252,192
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 10,000,000,000 10,000,000,000
Common stock, shares issued 1,859,231,786 1,859,231,786
Common stock, shares outstanding 1,858,142,500 1,859,231,786
Treasury stock common, shares 1,089,286 0
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue:    
Total revenue, net $ 10,030,052 $ 15,671,917
Operating costs and expenses:    
Cost of sales and service 1,544,116 2,142,334
Commissions 5,076,503 7,275,210
Advertising, selling, and marketing 95,103 11,795
Salary and related 1,701,092 1,628,970
Professional fees 610,150 406,529
General and administrative 1,416,168 2,336,655
Total operating costs and expenses 10,443,132 13,801,493
Net income (loss) from operations (413,080) 1,870,424
Other income (expense):    
Gain (loss) on fair value of derivative liability (2,095) 74
Realized gain (loss) on digital assets (13,252) 276,227
Unrealized gain (loss) on digital assets (220,184)
Other income (expense) 284,125 337,635
Total other income (expense) (264,773) 299,591
Income (loss) before income taxes (677,853) 2,170,015
Income tax expense (10,000) (500,075)
Net income (loss) (687,853) 1,669,940
Net income (loss) attributable to noncontrolling interest (1,987)
Net income (loss) attributable to Investview, Inc. (685,866) 1,669,940
Dividends on Preferred Stock (204,835) (204,835)
Net income (loss) applicable to common shareholders $ (890,701) $ 1,465,105
Basic income (loss) per common share $ (0.00) $ 0.00
Diluted income (loss) per common share $ (0.00) $ 0.00
Basic weighted average number of common shares outstanding 1,859,076,249 2,053,046,229
Diluted weighted average number of common shares outstanding 1,859,076,249 3,089,474,800
Nonrelated Party [Member]    
Other income (expense):    
Interest expense $ (4,623) $ (4,675)
Related Party [Member]    
Other income (expense):    
Interest expense (308,744) (309,670)
Membership Revenue [Member]    
Revenue:    
Total revenue, net 8,791,443 13,029,318
Mining Revenue [Member]    
Revenue:    
Total revenue, net 862,944 2,642,599
Health and Wellness Revenue [Member]    
Revenue:    
Total revenue, net 368,321
Other [Member]    
Revenue:    
Total revenue, net $ 7,344
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2023 $ 252 $ 2,333,356 $ 104,056,807 $ (23,218) $ (87,576,899) $ 18,790,298
Balance, shares at Dec. 31, 2023 252,192 2,333,356,496            
Treasury stock Balance, shares at Dec. 31, 2023              
Common stock issued for services and other stock-based compensation 430,760 430,760
Common stock repurchased from former related parties and canceled $ (472,374) (3,098,772) (3,571,146)
Common stock repurchased from related parties and canceled, shares   (472,374,710)            
Dividends (204,835) (204,835)
Net income (loss) 1,669,940 1,669,940
Balance at Mar. 31, 2024 $ 252 $ 1,860,982 101,388,795 (23,218) (86,111,794) 17,115,017
Balance, shares at Mar. 31, 2024 252,192 1,860,981,786            
Treasury stock Balance, shares at Mar. 31, 2024              
Balance at Dec. 31, 2024 $ 252 $ 1,859,231 102,560,320 (23,218) (87,205,070) 8,070 $ 17,199,585
Balance, shares at Dec. 31, 2024 252,192 1,859,231,786            
Treasury stock Balance, shares at Dec. 31, 2024             0
Common stock issued for services and other stock-based compensation 387,634 $ 387,634
Dividends (204,835) (204,835)
Net income (loss) (685,866) (1,987) (687,853)
Cumulative effect adjustment upon adoption of ASU 2023-08 148,346 148,346
Common stock repurchased and held as treasury stock $ (24,006) (24,006)
Common stock repurchased and held as treasury stock, shares       1,089,286        
Balance at Mar. 31, 2025 $ 252 $ 1,859,231 $ 102,947,954 $ (24,006) $ (23,218) $ (87,947,425) $ 6,083 $ 16,818,871
Balance, shares at Mar. 31, 2025 252,192 1,859,231,786            
Treasury stock Balance, shares at Mar. 31, 2025       1,089,286       1,089,286
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ (687,853) $ 1,669,940
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation 224,302 1,178,430
Amortization of debt discount 83,286 84,210
Stock issued for services and other stock-based compensation 387,634 430,760
Lease cost, net of repayment (63) 14,215
(Gain) loss on fair value of derivative liability 2,095 (74)
Change in fair value of digital assets 220,184
Realized (gain) loss on digital assets 13,252 (276,227)
Digital assets collected for membership revenue (336,614) (407,138)
Revenue recognized from bitcoin mined (862,944) (2,642,599)
Operating expenses paid with digital assets 527,058 3,599,825
Changes in operating assets and liabilities:    
Receivables 303,150 (108,312)
Inventory (360,261)
Prepaid assets (796,428) (151,192)
Deposits (1,871,346) (935)
Accounts payable and accrued liabilities (262,798) 676,274
Income tax payable 7,073 498,280
Deferred revenue (194,387) 4,020
Accrued interest 4,623 4,675
Accrued interest, related parties 225,459 225,459
Net cash provided by (used in) operating activities (3,374,578) 4,799,611
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of digital currencies (1,695)
Purchase of Treasury Stock (24,006)
Cash paid for fixed assets (323,910) (2,903)
Net cash provided by (used in) investing activities (349,611) (2,903)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayments for related party debt (225,129) (225,129)
Repayments for debt (7,310) (114,261)
Payments for shares repurchased from former related parties (842,940) (842,940)
Dividends paid (161,854) (174,760)
Net cash provided by (used in) financing activities (1,237,233) (1,357,090)
Net increase (decrease) in cash and cash equivalents (4,961,422) 3,439,618
Cash and cash equivalents - beginning of period 22,467,710 21,142,630
Cash and cash equivalents - end of period 17,506,288 24,582,248
Cash paid during the period for:    
Interest 232,440 232,440
Income taxes 2,927 1,795
Non-cash investing and financing activities:    
Common stock repurchased for payables 3,571,146
Dividends declared 204,835 204,835
Dividends paid with digital assets 40,645 40,170
Debt extinguished in exchange for digital assets 38,767
Cumulative effect adjustment upon adoption of ASU 2023-08 $ 148,346
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Pay vs Performance Disclosure - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Pay vs Performance Disclosure [Table]    
Net Income (Loss) $ (685,866) $ 1,669,940
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2025
Insider Trading Arrangements [Line Items]  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.25.1
ORGANIZATION AND NATURE OF BUSINESS
3 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND NATURE OF BUSINESS

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

 

Organization

 

Investview, Inc. was incorporated on January 30, 1946, under the laws of the state of Utah as the Uintah Mountain Copper Mining Company. In January 2005, we changed domicile to Nevada and changed our name to Voxpath Holding, Inc. In September of 2006, we merged with The Retirement Solution Inc. and then changed our name to TheRetirementSolution.Com, Inc. Subsequently, in October 2008 we changed our name to Global Investor Services, Inc., before changing our name to Investview, Inc., on March 27, 2012.

 

Effective April 1, 2017, we closed on a Contribution Agreement with the members of Wealth Generators, LLC, a limited liability company (“Wealth Generators”), pursuant to which the Wealth Generators members contributed 100% of the outstanding securities of Wealth Generators in exchange for an aggregate of 1,358,670,942 shares of our common stock. Following this transaction, Wealth Generators became our wholly owned subsidiary, and the former members of Wealth Generators became our stockholders and controlled the majority of our outstanding common stock.

 

On June 6, 2017, we entered into an Acquisition Agreement with Market Trend Strategies, LLC, a company whose members are also former members of our management. Under the Acquisition Agreement, we spun-off our operations that existed prior to the merger with Wealth Generators and sold the intangible assets used in those pre-merger operations in exchange for Market Trend Strategies’ assumption of $419,139 in pre-merger liabilities.

 

On February 28, 2018, we filed a name change for Wealth Generators, LLC to Kuvera, LLC (“Kuvera”).

 

On January 17, 2019, we renamed our non-operating wholly owned subsidiary WealthGen Global, LLC to SAFETek, LLC, a Utah limited liability company.

 

On January 11, 2021, we filed a name change for Kuvera, LLC to iGenius, LLC (“iGenius”) and on February 2, 2021, we filed a name change for Kuvera (N.I.) Limited to iGenius Global LTD.

 

On September 20, 2021, the Board of Directors approved a change in our fiscal year from March 31 to December 31.

 

Nature of Business

 

We operate a diversified financial technology services company offering multiple business units across key sectors, including a financial education division offering tools, products and content through a global network of independent distributors; a manufacturing division focused on proprietary over-the-counter aesthetics, health, nutrition and cognitive wellness products for wholesale and retail markets, with strategic plans for global expansion: an early-stage online trading platform that intends to offer self-directed retail brokerage services; and a business unit that owns and operates a sustainable blockchain business focused on bitcoin mining.

 

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Accounting

 

Our policy is to prepare our financial statements on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations (Regulation S-X) of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the three months ended March 31, 2025, are not necessarily indicative of the operating results that may be expected for our year ending December 31, 2025, as will be included in the filing of our Annual Report on Form 10-K for the year ending December 31, 2025. These unaudited condensed consolidated financial statements should be read in conjunction with the December 31, 2024 consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2024.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of Investview, Inc., and our wholly owned subsidiaries: iGenius, LLC, SAFETek, LLC, Investview Financial Group Holdings, LLC, Opencash Finance, Inc., Opencash Securities, LLC, Investview MTS, LLC, myLife Wellness Company, Renu Laboratories LLC, and Goldman’s Pharmaceuticals LLC. The Company also owns 50% of ELRT Technologies, LLC, which has been included in the consolidated financial statements and the Company has recorded a noncontrolling interest for the 50% interest that it does not own. All intercompany transactions and balances have been eliminated in consolidation.

 

Operating Segments

 

Operating segments are defined as components of an entity for which separate financial information is available that is regularly reviewed by the chief operating decision maker (“CODM”). The CODM is composed of several members of its executive management team, including the CEO, President and COO, and the CFO. The CODM uses segment net income from operations to assess the performance of, manage the operations of, and allocate capital and operational resources to the Company’s three reportable segments.

 

Financial Statement Reclassification

 

Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.

 

Use of Estimates

 

The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Concentration of Credit Risk

 

Financial instruments that potentially expose us to concentration of credit risk include cash, accounts receivable, and advances. We place our cash and temporary cash investments with credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit of $250,000. As of March 31, 2025 and December 31, 2024, cash balances that exceeded FDIC limits were $11,306,081 and $10,837,830, respectively. We have not experienced significant losses relating to these concentrations in the past.

 

Cash Equivalents

 

For purposes of reporting cash flows, we consider all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. As of March 31, 2025 and December 31, 2024, we had no cash equivalents.

 

Receivables

 

Receivables are carried at net realizable value, representing the outstanding balance less an allowance for doubtful accounts based on a review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating individual receivables and receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Receivables were made up of the following as of each balance sheet date:

 

 SCHEDULE OF RECEIVABLES

   March 31,   December 31, 
   2025   2024 
Due from merchant processors  $236,486   $318,921 
Held in reserve by merchant processors for future returns and chargebacks [1]   1,872,035    1,872,035 
Due from payout service providers   34,202    296,558 
Accounts and other receivables   88,854    47,213 
Receivable, gross   2,231,577    2,534,727 
Allowance for doubtful accounts   -    - 
Receivables  $2,231,577   $2,534,727 

 

[1] We have recently had to pursue collection efforts through litigation against one of our credit card processors and its clearing bank, as we have been unable to timely collect such amounts due through our normal course credit collection practices. See “NOTE 10-Commitments and Contingencies.”

 

Fixed Assets

 

Fixed assets are stated at cost and depreciated using the straight-line method over their estimated useful lives. When retired or otherwise disposed, the carrying value and accumulated depreciation of the fixed asset is removed from its respective accounts and the net difference less any amount realized from disposition is reflected in earnings. Expenditures for maintenance and repairs which do not extend the useful lives of the related assets are expensed as incurred.

 

Fixed assets were made up of the following at each balance sheet date:

 

 

   Estimated        
   Useful        
   Life  March 31,   December 31, 
   (years)  2025   2024 
Furniture, fixtures, and equipment  10  $717   $717 
Computer equipment  3   32,360    28,571 
Data processing equipment  3   11,824,560    11,824,560 
Manufacturing equipment  3-25   1,481,822    1,161,701 
       13,339,459    13,015,549 
Accumulated depreciation      (11,371,410)   (11,147,108)
Net book value     $1,968,049   $1,868,441 

 

Total depreciation expense for the three months ended March 31, 2025 and 2024, was $224,302 and $1,178,430, respectively.

 

Digital Assets

 

Digital assets are included in non-current assets on the Consolidated Balance Sheets due to the Company’s intent to retain and hold bitcoin. Proceeds from the sale of digital assets and the purchase of digital assets are included within investing activities in the accompanying Consolidated Statement of Cash Flows. Digital Assets awarded to the Company through its mining activities and collected for membership revenue are accounted for in connection with the Company’s revenue recognition policy. Following the adoption of ASU 2023-08 effective January 1, 2025, the Company measures digital assets at fair value with changes recognized in other income (expense) in the Consolidated Statement of Operations. The Company tracks its cost basis of digital assets by-wallet in accordance with the first-in-first-out (“FIFO”) method of accounting. Refer to “NOTE 5 – DIGITAL ASSETS”, for further information regarding the Company’s impact of the adoption of ASU 2023-08.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Goodwill

 

Goodwill represents the excess of the purchase price over the fair value of the net assets acquired in a business combination. Goodwill is not subject to amortization, and instead, assessed for impairment annually at the end of each fiscal year, or more frequently when events or changes in circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying amount in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350 - Intangibles - Goodwill and Other.

 

The Company has the option to first assess qualitative factors to determine whether events or circumstances indicate it is more likely than not that the fair value of a reporting unit is greater than its carrying amount, in which case a quantitative impairment test is not required.

 

As provided for by ASU 2017-04, Simplifying the Test for Goodwill Impairment, the quantitative goodwill impairment test is performed by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not impaired. An impairment loss is recognized for any excess of the carrying amount of the reporting unit over its fair value up to the amount of goodwill allocated to the reporting unit.

 

Intangible Assets

 

We account for our intangible assets in accordance with FASB ASC 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30 requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Under ASC Subtopic 350-30 any intangible asset with a useful life is required to be amortized over that life and the useful life is to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.

 

Impairment of Long-Lived Assets

 

We have adopted ASC Subtopic 360-10, Property, Plant and Equipment. ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by us be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or when the historical cost carrying value of an asset may no longer be appropriate. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period.

 

We evaluate the recoverability of long-lived assets based upon future net cash flows expected to result from the asset, including eventual disposition. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted and an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposable value. During the three months ended March 31, 2025 and 2024, no impairment was recorded.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Fair Value of Financial Instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in the absence of a principal, most advantageous market for the specific asset or liability.

 

U.S. generally accepted accounting principles provide for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows:

 

  Level 1: Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access.
     
  Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including:

 

  - quoted prices for similar assets or liabilities in active markets;
  - quoted prices for identical or similar assets or liabilities in markets that are not active;
  - inputs other than quoted prices that are observable for the asset or liability; and
  - inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

  Level 3: Inputs that are unobservable and reflect management’s own assumptions about the inputs market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows).

 

Our financial instruments consist of cash, accounts receivable and accounts payable, and debt. We have determined that the book value of our outstanding financial instruments as of March 31, 2025 and December 31, 2024, approximates the fair value due to their short-term nature or interest rates that approximate prevailing market rates.

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of March 31, 2025:

 

 

   Level 1   Level 2   Level 3   Total 
Digital assets (see NOTE 5)  $1,676,351   $-   $-   $1,676,351 
Total Assets  $1,676,351   $-   $-   $1,676,351 
                     
Derivative liability  $-   $-   $2,853   $2,853 
Total Liabilities  $-   $-   $2,853   $2,853 

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2024:

 

   Level 1   Level 2   Level 3   Total 
Total Assets  $-   $-   $-   $- 
                     
Derivative liability  $-   $-   $758   $758 
Total Liabilities  $-   $-   $758   $758 

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Revenue Recognition

 

Membership Revenue

 

Most of our revenue is generated by membership sales and payment is received at the time of purchase. We recognize membership revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation is to provide our tools, products, and content over a fixed membership period; therefore, we recognize revenue ratably over the membership period and deferred revenue is recorded for the portion of the membership period subsequent to each reporting date. Additionally, we offer a designated trial period to first-time membership customers, during which a full refund can be requested if a customer does not wish to continue with the membership. Revenues are deferred during the trial period as collection is not probable until that time has passed. Revenues are presented net of refunds, sales incentives, credits, and known and estimated credit card chargebacks. As of March 31, 2025 and December 31, 2024, our deferred revenues for membership revenue were $1,852,839 and $1,905,734, respectively.

 

Mining Revenue

 

We generate revenue from mining bitcoin. The Company has entered into a digital asset mining pool by executing a contract, as amended from time to time, with the mining pool operator to provide computing power to the mining pool. The contract is terminable at any time by either party without penalty. Further, since the contract is continuously renewing, second by second, the mining contract is considered to have a duration of less than 24 hours for accounting purposes. The Company’s enforceable right to compensation only begins when the Company provides computing power to the mining pool operator. In exchange for providing computing power, we are entitled to a Full-Pay-Per-Share payout of Bitcoin based on a contractual formula, which calculates our share of block rewards, transaction fees, and mining pool operator fees. We are entitled to consideration even if a block is not successfully placed by the mining pool operator.

 

Providing computing power to solve complex cryptographic algorithms in support of the Bitcoin blockchain (in a process known as “solving a block”) is an output of the Company’s ordinary activities. The provision of providing such computing power is the only performance obligation in the Company’s contract with the mining pool operator. The transaction consideration the Company receives is net of a contractually agreed upon mining pool operator fee charged and kept by the mining pool operator and is noncash, in the form of Bitcoin. Given that the contract is continuously renewing, and the duration is considered to be less than 24 hours, the Company measures the transaction consideration at fair value on the date Bitcoin is received. The consideration is variable. The amount of consideration recognized is constrained to the amount of consideration received, which is when it is probable a significant reversal will not occur. There is no significant financing component or risk of a significant revenue reversal in these transactions due to the performance obligations and settlement of the transactions being on a daily basis.

 

Health and Wellness Product Sales and Other Revenue

 

Through our wholly owned subsidiary, Renu Laboratories LLC, we generate revenue by manufacturing and selling health, beauty and wellness products. We recognize health and wellness product sales revenue in accordance with ASC 606-10. The Company’s performance obligation is complete when control of the promised goods is transferred to a customer, at which time the Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for those goods. The Company terms for the sale are based on free on board (FOB) shipping point, where the control passes to the customer once the product leaves our warehouse. The Company determines collectability by requiring certain customers to pay before control is transferred and by performing ongoing credit evaluations and monitoring customer accounts receivable balances. As of March 31, 2025 and December 31, 2024, deposits collected from customers for orders to be filled at a future date were $844,318 and $1,014,164, respectively.

 

Shipping and direct costs charged to customers, along with fees collected from customers for storing their products in our warehouse facility located in Warminster, Pennsylvania are included in revenue as Other Revenue. Shipping and direct costs incurred by the Company are included in Cost of Sales and Service.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Revenue generated for the three months ended March 31, 2025, was as follows:

 

 

   Membership
revenue
   Mining revenue   Health and wellness product sales   Other Revenue   Total 
Gross billings/receipts  $9,439,857   $862,944   $368,443   $7,344   $10,678,588 
Refunds, incentives, credits, and chargebacks   (648,414)   -    (122)   -    (648,536)
Net revenue  $8,791,443   $862,944   $368,321   $7,344   $10,030,052 

 

Foreign revenues for the three months ended March 31, 2025 were approximately $7.6 million while domestic revenue for the three months ended March 31, 2025 was approximately $2.4 million.

 

Revenue generated for the three months ended March 31, 2024, was as follows:

 

   Membership
Revenue
   Mining Revenue   Total 
Gross billings/receipts  $13,851,294   $2,642,599   $16,493,893 
Refunds, incentives, credits, and chargebacks   (821,976)   -    (821,976)
Net revenue  $13,029,318   $2,642,599   $15,671,917 

 

Foreign revenues for the three months ended March 31, 2024 were approximately $11.8 million while domestic revenue for the three months ended March 31, 2024 was approximately $3.9 million.

 

Advertising, Selling and Marketing Costs

 

We expense advertising, selling, and marketing costs as incurred. Advertising, selling, and marketing costs include costs of promoting our product worldwide, including promotional events. Advertising, selling, and marketing expenses for the three months ended March 31, 2025 and 2024, totaled $95,103 and $11,795, respectively.

 

Cost of Sales and Service

 

Included in our costs of sales and services is amounts paid to our trading and market experts that provide financial education content and tools to our membership customers, hosting and electricity fees that we pay to vendors to set up our mining equipment at third-party sites in order to generate mining revenue, and the raw material and manufacturing costs of our health and wellness product sales. Costs of sales and services for the three months ended March 31, 2025 and 2024, totaled $1,544,116 and $2,142,334, respectively.

 

Inventory

 

Inventory consists of raw materials, work in progress, and finished goods to be sold as part of our health and wellness product sales. Inventory is valued at the lower of cost or net realizable value using the first-in, first-out (FIFO) method and is inclusive of any shipping and tax costs.

 

Inventory was made up of the following at each balance sheet date:

 

SCHEDULE OF INVENTORY

   March 31,   December 31, 
   2025   2024 
Finished goods  $5,451   $27,802 
Work in process   191,440    312 
Raw materials   659,235    467,751 
Inventory  $856,126   $495,865 

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Income Taxes

 

Income taxes are recorded in accordance with ASC Topic 740, Income Taxes, which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities, including operating losses and credit carryforwards, using enacted tax rates in effect for the year in which the differences are expected to reverse.

 

Management judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities, and any valuation allowance recorded against our deferred tax assets. Deferred tax assets are reduced by a valuation allowance if, based on the consideration of all available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. Changes in assumptions in future periods may require we adjust our valuation allowance, which could materially impact our financial position and results of operations. The Company recognizes the benefit of an uncertain tax position that it has taken or expects to take on its income tax return, if such a position is more likely than not to be sustained.

 

Net Income (Loss) per Share

 

We follow ASC Subtopic 260-10, Earnings per Share, which specifies the computation, presentation, and disclosure requirements of earnings per share information. Basic loss per share has been calculated based upon the weighted average number of common shares outstanding. Diluted income (loss) per share reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted during the period. Dilutive securities having an anti-dilutive effect on diluted earnings per share are excluded from the calculation.

 

Due to the net loss for the three months ended March 31, 2025, basic and diluted income per share were the same, as all securities had an antidilutive effect.

 

The following table illustrates the computation of diluted earnings per share for the three months ended March 31, 2024.

 

 

   March 31, 2024 
Net income  $1,669,940 
Less: preferred dividends   (204,835)
Add: interest expense on convertible debt   225,129 
Net income available to common shareholders (numerator)  $1,690,234 
      
Basic weighted average number of common shares outstanding   2,053,046,229 
Dilutive impact of convertible notes   471,428,571 
Dilutive impact of non-voting membership interest   565,000,000 
Diluted weighted average number of common shares outstanding (denominator)   3,089,474,800 
      
Diluted income per common share  $0.00 

 

The following table presents potentially dilutive securities that were not included in the computation of diluted net income per share as their inclusion would be anti-dilutive.

 

 

   March 31, 2025   March 31, 2024 
Options to purchase common stock   351,416,665    191,666,665 
Warrants to purchase common stock   1,178,090    1,178,090 
Common stock issuable upon conversion of notes   471,428,571    N/A 
Common stock issuable upon conversion of non-voting membership interest   565,000,000    N/A 

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Lease Obligation

 

We determine if an arrangement is a lease at inception. Operating leases are included in the operating lease right-of-use asset account, the operating lease liability, current account, and the operating lease liability, long-term account in our balance sheet. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.

 

Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. For leases in which the rate implicit in the lease is not readily determinable, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We have elected to not apply the recognition requirements of ASC 842 to short-term leases (leases with terms of twelve months or less). Lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for operating lease arrangements is recognized on a straight-line basis over the lease term. We have elected the practical expedient and will not separate non-lease components from lease components and will instead account for each separate lease component and non-lease component associated with the lease components as a single lease component.

 

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.25.1
RECENT ACCOUNTING PRONOUNCEMENTS
3 Months Ended
Mar. 31, 2025
Accounting Changes and Error Corrections [Abstract]  
RECENT ACCOUNTING PRONOUNCEMENTS

NOTE 3 – RECENT ACCOUNTING PRONOUNCEMENTS

 

In December 2023, the FASB issued ASU No. 2023-08, Intangibles—Goodwill and Other—Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets. The amendments in ASU No. 2023-08 are intended to improve the accounting for certain crypto assets by requiring an entity to measure those crypto assets at fair value each reporting period with changes in fair value recognized in net income. The amendments also improve the information provided to investors about an entity’s crypto asset holdings by requiring disclosure about significant holdings, contractual sale restrictions, and changes during the reporting period. The amendments are effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company adopted ASU No. 2023-08 for the year ended December 31, 2025, effective as of January 1, 2025, which had a material impact on the financial statements.

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 expands existing income tax disclosures for rate reconciliations by requiring disclosure of certain specific categories and additional reconciling items that meet quantitative thresholds and expands disclosures for income taxes paid by requiring disaggregation by certain jurisdictions. ASU 2023-09 is effective for annual periods beginning after December 15, 2024; early adoption is permitted. The Company adopted the ASU for the year ended December 31, 2025. The amendments only impact disclosures and are not expected to have an impact on the Company’s financial condition and results of operations.

 

In December 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires, in the notes to the financial statements, disclosures of specified information about certain costs and expenses specified in the updated guidance. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company did not elect early adoption and is evaluating the impact the updated guidance will have on its disclosures in 2026.

 

We have noted no other recently issued accounting pronouncements that we have not yet adopted that we believe are applicable or would have a material impact on our financial statements.

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.25.1
LIQUIDITY
3 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
LIQUIDITY

NOTE 4 – LIQUIDITY

 

Our financial statements are prepared using generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business.

 

During the three months ended March 31, 2025, we met our short-and long-term working capital and capital expenditure requirements. At March 31, 2025, we had a total of $17.5 million in cash and cash equivalents, which we believe is sufficient to meet our debt service, preferred stock dividend payments and all other obligations in a timely manner and be able to meet our objectives.

 

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.25.1
DIGITAL ASSETS
3 Months Ended
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
DIGITAL ASSETS

NOTE 5 – DIGITAL ASSETS

 

Adoption of ASU 2023-08, Accounting for and Disclosure of Digital Assets

 

Effective January 1, 2025, the Company adopted ASU 2023-08, which requires entities to measure crypto assets at fair value with changes recognized in the Statement of Operations each reporting period. The Company’s digital assets are within the scope of ASU 2023-08 and the transition guidance requires a cumulative-effect adjustment as of the beginning of the current fiscal year for any difference between the carrying amount of the Company’s digital assets and fair value. As a result of the Company’s early adoption of ASU 2023-08, the Company recorded a $148,346 increase to digital assets and a $148,346 decrease to accumulated deficit on the Balance Sheets as of the beginning of the fiscal year ended December 31, 2025.

 

The following table presents the Company’s Digital Asset holdings as of March 31, 2025:

 

SCHEDULE OF DIGITAL ASSETS

   Quantity   Cost Basis   Fair Value 
Bitcoin   20.30   $1,896,337   $1,676,153 
USDC   198.00    198    198 
Total digital assets held as of March 31, 2025       $1,896,535   $1,676,351 

 

The following table presents a roll-forward of total digital assets for the three months ended March 31, 2025, based on the fair value model under ASU 2023-08:

 

SCHEDULE OF DIGITAL ASSETS ACTIVITY

   Fair Value 
Balance as of December 31, 2024  $1,127,891 
    585,632 
Cumulative effect adjustment upon adoption of ASU 2023-08   148,346 
Revenue recognized from Bitcoin mined (9.12 BTC)   862,944 
Digital assets collected from membership revenue   336,614 
Purchase of digital assets   1,695 
Operating expenses paid with digital assets   (527,058)
Dividends paid via digital assets   (40,645)
Realized gain (loss) on digital assets   (13,252)
Change in fair value of digital assets   (220,184)
Balance as of March 31, 2025  $1,676,351 
    232,834 

 

Prior to Adoption of ASU 2023-08, Accounting for and Disclosure of Digital Assets

 

Digital assets

 

Prior to the adoption of ASU 2023-08, digital assets were accounted for as indefinite-lived intangible assets and were initially measured in accordance with ASC 350 - Intangible-Goodwill and Other. Digital assets were not amortized, but were assessed for impairment annually, or more frequently, when events or changes in circumstances occur indicating that it is more likely than not that the indefinite-lived intangible asset is impaired. Whenever the exchange-traded price of digital assets declined below its carrying value, the Company was required to determine if an impairment existed and to record an impairment equal to the amount by which the carrying value exceeded the fair value.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

The following table presents a roll-forward of digital assets for the three months ended March 31, 2024, based on the cost-impairment model under ASC 350:

 

   Cost Basis 
Balance as of December 31, 2023  $585,632 
Revenue recognized from Bitcoin mined (49.82 BTC)   2,642,599 
Digital assets collected from membership revenue   407,138 
Operating expenses paid with digital assets   (3,599,825)
Dividends paid via digital assets   (40,170)
Debt extinguished in exchange for digital assets   (38,767)
Realized (gain) loss on sale of digital assets   276,227 
Balance as of March 31, 2024  $232,834 

 

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.25.1
RELATED-PARTY TRANSACTIONS
3 Months Ended
Mar. 31, 2025
Related Party Transactions [Abstract]  
RELATED-PARTY TRANSACTIONS

NOTE 6 – RELATED-PARTY TRANSACTIONS

 

Related Party Debt

 

Our related-party payables consisted of the following:

 

 

  

March 31,

2025

   December 31,
2024
 
Convertible Promissory Note entered into on 4/27/20, net of debt discount of $659,967 as of March 31, 2025 [1]  $640,033   $607,996 
Convertible Promissory Note entered into on 5/27/20, net of debt discount of $358,309 as of March 31, 2025 [2]   341,691    324,304 
Convertible Promissory Note entered into on 11/9/20, net of debt discount of $697,397 as of March 31, 2025 [3]   602,603    568,742 
Working Capital Promissory Note entered into on 3/22/21 [4]   1,204,897    1,204,567 
Total related-party debt   2,789,224    2,705,608 
Less: Current portion   (1,204,897)   (1,204,567)
Related-party debt, long term  $1,584,327   $1,501,041 

 

 

[1]On April 27, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the three months ended March 31, 2025, we recognized $32,037 of the debt discount into interest expense, as well as expensed an additional $65,004 of interest expense on the note, all of which was repaid during the period.

 

[2]On May 27, 2020, we received proceeds of $700,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $700,000. During the three months ended March 31, 2025, we recognized $17,387 of the debt discount into interest expense as well as expensed an additional $35,001 of interest expense on the note, all of which was repaid during the period.

 

[3]On November 9, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 38.5% per annum, made up of a 25% interest rate per annum and a facility fee of 13.5% per annum, payable monthly beginning February 1, 2021, and the principal is due and payable on April 27, 2030. Per the terms of the agreement, the note is convertible into common stock at a conversion price of $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the three months ended March 31, 2025, we recognized $33,861 of the debt discount into interest expense as well as expensed an additional $125,124 of interest expense on the note, all of which was repaid during the period.
  
[4]On March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. (See NOTE 11). Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA only provided advances of $1,200,000, to date. The note bears interest at the rate of 0.11% per annum. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations, and the other damages we sustained as a result of the actions of Mr. Cammarata. During the three months ended March 31, 2025, we recorded interest expense of $330 on the note. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

The loans referenced in footnotes 1-3 above were advanced under a Securities Purchase Agreement we entered into on April 27, 2020, with DBR Capital. Under the Securities Purchase Agreement (which was subsequently amended and restated), DBR Capital agreed to advance up to $11 million to us in a series of up to five closings through December 31, 2026, of which the amounts advanced covered in footnotes 1-3 above constituted the first three closings.

 

On February 28, 2025, we and DBR Capital, entered into a Fifth Amendment to the now Amended and Restated Securities Purchase Agreement that extends the deadlines for the fourth and fifth closings under that Agreement from December 31, 2024, to August 31, 2025 and December 31, 2026, respectively. The fourth and fifth closings remain at the sole discretion of DBR Capital, and we cannot provide any assurance that they will occur when contemplated or ever.

 

Other Related Party Arrangements

 

On September 29, 2023, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement dated September 18, 2023 (the “Romano/Raynor Agreement”). Under the Romano/Raynor Agreement, the Company purchased for surrender in a series of private transactions, an aggregate of 302,919,223 shares of the Company’s common stock (the “Romano/Raynor Purchased Shares”) from sellers consisting of Mario Romano, Annette Raynor, and a series of their family members and related entities (collectively, the “Sellers”). The Romano/Raynor Purchased Shares were purchased for aggregate consideration of $2,922,380, representing a price of $0.00964739 per share. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter. As of March 31, 2025, we owed $793,095 under the Romano/Raynor Agreement of which $795,095 is included in Accounts payable and accrued liabilities.

 

In addition to the cash consideration for the Purchased Shares, the Company also agreed to cover a limited amount of the legal fees incurred by the Sellers in the transaction, as well as provide Mr. Romano and Ms. Raynor with a $250,000 expense allowance, payable in installments, to cover legal fees and other expenses on a non-accountable basis, in connection with any matters that may arise in which either or both of Mr. Romano and/or Ms. Raynor served as officers and directors of the Company. In return, Mr. Romano and Ms. Raynor agreed to waive any future entitlement, if at all, to indemnification of costs and expenses, including legal fees under Nevada law or otherwise arising from or relating to any period in which Romano or Raynor were officers and directors of the Company.

 

The consideration paid for the Purchased Shares of $2,922,380 plus the $250,000 expense allowance was allocated to the share purchase for a total of $3,172,380.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

On February 7, 2024, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement dated February 6, 2024 (the “Smith/Miller Agreement”). Under the Smith/Miller Agreement, the Company purchased for surrender and cancellation a total of 472,374,710 shares of the Company’s common stock (the “Smith/Miller Purchased Shares”) from Ryan Smith and Chad Miller and certain of their respective affiliates and family members. The Smith/Miller Purchased Shares were purchased for aggregate purchase price of $3,571,146, representing a price of $0.007559985 per share. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter. As of March 31, 2025, we owed $1,339,180 under the Smith/Miller Agreement of which $1,339,180 is included in Accounts payable and accrued liabilities.

 

The consideration paid for the Purchased Shares of $3,571,146 was allocated to the share purchase (see NOTE 10).

 

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.25.1
DEBT
3 Months Ended
Mar. 31, 2025
Debt Disclosure [Abstract]  
DEBT

NOTE 7 – DEBT

 

Our debt consisted of the following:

 

   March 31,
2025
   December 31,
2024
 
Loan with the U.S. Small Business Administration dated 4/19/20 [1]  $517,176   $519,863 
Total debt   517,176    519,863 
Less: Current portion   29,244    29,244 
Debt, long term portion  $487,932   $490,619 

 

 

[1] In April 2020 we received proceeds of $500,000 from a loan entered into with the U.S. Small Business Administration. Under the terms of the loan interest is to accrue at a rate of 3.75% per annum and installment payments of $2,437 monthly will begin twelve months from the date of the loan, with all interest and principal due and payable thirty years from the date of the loan. During the three months ended March 31, 2025, we recorded $4,623 worth of interest on the loan. During the three months ended March 31, 2025, we made repayments on the loan of $7,310.

 

In November of 2020, we entered into notes with third parties for $19,089,500 in exchange for the cancellation of APEX leases previously entered into, which resulted in our purchase of all rights and obligations under the leases. We agreed to settle a portion of the debt during the year ended March 31, 2021, at a discount to the original note terms offered, by making lump sum payments, issuing 48,000,000 shares of our common stock, issuing 49,418 shares of our preferred stock, and issuing digital assets. The remaining notes were due December 31, 2024, and had a fixed monthly payment that is equal to 75% of the face value of the note, divided by 48 months. The monthly payments began the last day of January 2021 and continued until December 31, 2024, when the last monthly payment was made, along with a balloon payment equal to 25% of the face value of the note, to extinguish the debt. During the fourth quarter ended December 31, 2023, we offered all note holders an early payoff option. During the three months ended March 31, 2024, we repaid a portion of the debt with cash payments of $106,950 and issuances of digital assets then valued at $38,767. As of December 31, 2024, the debt was paid in full.

 

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.25.1
DERIVATIVE LIABILITY
3 Months Ended
Mar. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE LIABILITY

NOTE 8 – DERIVATIVE LIABILITY

 

During the three months ended March 31, 2025, we had the following activity in our derivative liability account relating to our warrants:

 

 

Derivative liability at December 31, 2024 $ 758  
Derivative liability recorded on new instruments   -  
Derivative liability reduced by warrant exercise   -  
(Gain) loss on fair value   2,095  
Derivative liability at March 31, 2025 $ 2,853  

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

We use the binomial option pricing model to estimate fair value for those instruments at inception, at warrant exercise, and at each reporting date. During the three months ended March 31, 2025, the assumptions used in our binomial option pricing model were in the following range:

 

 

Risk free interest rate   4.23% - 4.32%
Expected life in years   0.33 - 1.25 
Expected volatility   132% - 161%

 

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.25.1
OPERATING LEASE
3 Months Ended
Mar. 31, 2025
Operating Lease  
OPERATING LEASE

NOTE 9 – OPERATING LEASE

 

In July 2021, we entered an operating lease for office space in Wyckoff, New Jersey (the “Wyckoff Lease”), and in September 2021 we assumed an operating lease for office space in Haverford, Pennsylvania (the “Haverford Lease”) in connection with the MPower acquisition. This facility now serves as the headquarters of the company. In November 2024, we entered an operating lease for office, warehouse, and manufacturing space in Warminster, Pennsylvania (“the “Warminster Lease”) and in December 2024, we entered an operating lease for warehouse space in Ivyland, Pennsylvania (the “Ivyland Lease”). The Warminster Lease and the Ivyland Lease were entered for use by our newly formed subsidiary Renu Laboratories LLC.

 

At commencement of the Wyckoff Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $22,034. The original 24.5-month term of the Wyckoff Lease was extended through July 2025 with an option for the Company to terminate with 60 days’ written notice beginning June 1, 2024. The earliest termination date is July 31, 2024. At the extension of the Wyckoff Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $23,520.

 

At date of acquisition of the Haverford Lease, right-of-use assets and lease liabilities obtained amounted to $125,522 and $152,961, respectively. The term of the Haverford Lease was initially extended through December 2024. At the extension of the Haverford Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $172,042. On August 7, 2024, the term of the Haverford Lease was extended through December 31, 2025.

 

At commencement of the Warminster Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $108,327. The Warminster Lease will automatically terminate after the 14-month term.

 

At commencement of the Ivyland Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $115,037. The Ivyland Lease will automatically terminate after the 24-month term.

 

Operating lease expense was $44,124 for the three months ended March 31, 2025. Operating cash flows used for the operating leases during the three months ended March 31, 2025, was $44,187. As of March 31, 2025, the weighted average remaining lease term was 1.27 years, and the weighted average discount rate was 12%.

 

Future minimum lease payments under non-cancellable leases as of March 31, 2025, were as follows:

 

 

      
Remainder of 2025  $126,962 
2026   61,057 
Total   188,019 
Less: Interest   (14,526)
Present value of lease liability   173,493 
Operating lease liability, current [1]   (140,112)
Operating lease liability, long term  $33,381 

 

[1] Represents lease payments to be made in the next 12 months.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY (DEFICIT)
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
STOCKHOLDERS’ EQUITY (DEFICIT)

NOTE 10 – STOCKHOLDERS’ EQUITY (DEFICIT)

 

Preferred Stock

 

We are authorized to issue up to 50,000,000 shares of preferred stock with a par value of $0.001 and our board of directors has the authority to issue one or more classes of preferred stock with rights senior to those of common stock and to determine the rights, privileges, and preferences of that preferred stock.

 

Our Board of Directors approved the designation of 2,000,000 of the Company’s shares of preferred stock as Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B Preferred Stock”), each with a stated value of $25 per share. Our Series B Preferred Stockholders are entitled to receive cumulative dividends at the annual rate of 13% per annum of the stated value, equal to $3.25 per annum per share. The Series B Preferred Stock is redeemable at our option or upon certain change of control events.

 

During the year ended March 31, 2021, we commenced an offering to sell a total of 2,000,000 units at $25 per unit (“Unit Offering”), with each unit consisting of: (i) one share of our newly authorized Series B Preferred Stock and (ii) five warrants each exercisable to purchase one share of common stock at an exercise price of $0.10 per warrant share. Each Warrant offered is immediately exercisable on the date of issuance, will expire 5 years from the date of issuance, and its value has been classified as a fair value liability due to the terms of the instrument (see NOTE 8). The Unit Offering was completed on or about August 17, 2021, having resulted in the public offer and sale of 252,192 Units.

 

As of March 31, 2025 and December 31, 2024, we had 252,192 shares of preferred stock issued and outstanding.

 

Preferred Stock Dividends

 

During the three months ended March 31, 2025, we declared $204,835 of cumulative cash dividends due to the shareholders of our Series B Preferred Stock. We made payments of $161,854 in cash and issued $40,645 worth of digital assets to reduce the amounts owing. As of March 31, 2025 and December 31, 2024, the dividend liability on our balance sheets was $247,437 and $245,101, respectively.

 

During the three months ended March 31, 2024, we declared $204,835 for cumulative cash dividends due to the shareholders of our Series B Preferred Stock. We made payments of $174,760 in cash and issued $40,170 worth of digital assets to reduce the amounts owing.

 

Common Stock Transactions

 

On March 6, 2025, the Board of Directors authorized a stock repurchase program that will allow the Company to repurchase up to $1,000,000 in aggregate value of shares of the Company’s common stock, par value $0.001 per share, through March 6, 2026. During the three months ended March 31, 2025, 1,089,286 shares have been repurchased for $24,006. These shares are being held by the Company in Treasury.

 

During the three months ended March 31, 2024, we repurchased 472,374,710 shares from two of the original founders of the Company and a series of their family members and related entities in exchange for cash of $446,391 and payables of $3,124,755 (see NOTE 6). We also recognized $8,510 in stock-based compensation based on grant date fair values and vesting terms of awards granted in prior periods.

 

As of March 31, 2025 and December 31, 2024, we had 1,859,231,786 and 1,859,231,786 shares of common stock issued and 1,858,142,500 and 1,859,231,786 shares of common stock outstanding, respectively.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Options

 

The 2022 Incentive Plan authorizes a variety of incentive awards consisting of stock options, restricted stock, restricted stock units, and reserves for issuance up to 600,000,000 shares of the Company’s common stock.

 

Transactions involving our options are summarized as follows:

 

 

           Weighted 
           Average 
       Weighted   Grant-Date 
   Number of   Average   Per Share 
   Options   Exercise Price   Fair Value 
Options outstanding at December 31, 2024   351,416,665   $0.05   $0.03 
Granted   -   $-   $- 
Canceled/Expired   -   $-   $- 
Exercised   -   $-   $- 
Options outstanding at March 31, 2025   351,416,665   $0.05   $0.03 

 

Details of our options outstanding as of March 31, 2025, is as follows:

 

 

Options Exercisable   Weighted Average Exercise Price of Options Exercisable   Weighted Average Contractual Life of Options Exercisable (Years)   Weighted Average Contractual Life of Options Outstanding (Years) 
 233,116,665    0.05    4.24    4.38 

 

Total stock compensation expense related to the options for the three months ended March 31, 2025 and 2024, was $387,634 and $422,250, respectively. As of March 31, 2025 there was approximately $2.9 million of unrecognized compensation cost related to the Options, which is expected to be recognized over a remaining weighted-average vesting period of approximately 1.5 years.

 

Warrants

 

Transactions involving our warrants are summarized as follows:

 

 

       Weighted 
   Number of   Average 
   Shares   Exercise Price 
Warrants outstanding at December 31, 2024   1,178,090   $0.10 
Granted   -   $- 
Canceled/Expired   -   $- 
Exercised   -   $- 
Warrants outstanding at March 31, 2025   1,178,090   $0.10 

 

Details of our warrants outstanding as of March 31, 2025, is as follows:

 

 

Warrants Exercisable   Weighted Average Contractual Life of Warrants Outstanding and Exercisable (Years) 
 1,178,090    0.89 

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Class B Units of Investview Financial Group Holdings, LLC

 

As of March 31, 2025, and December 31, 2024, there were 565,000,000 Units of Class B Investview Financial Group Holdings, LLC issued and outstanding. These units were issued as consideration for the purchase of operating assets and intellectual property rights of MPower, a company controlled and partially owned by David B. Rothrock and James R. Bell, two of our board members. The Class B Redeemable Units have no voting rights but can be exchanged at any time, within 5 years from the date of issuance, for 565,000,000 shares of our common stock on a one-for-one basis and are subject to significant restrictions upon resale through 2025 under the terms of a lock up agreement entered into as part of the purchase agreement. In order to properly account for the purchase transaction on the Company’s financial statements, we were required by applicable financial reporting standards to value the Class B Units issued to MPower in the transaction as of the closing date of the MPower sale transaction (September 3, 2021). For these accounting purposes, we concluded that the “fair value” of the consideration for financial accounting purposes, at the if-converted market value of the underlying common shares was $58.9 million, based on the closing market price of $0.1532 on the closing date of September 3, 2021, as discounted from $86.6 million by 32% (or $27.7 million) to reflect the significant lock up period. The “fair value” valuation of the Class B Units, however, was completed relying on a certain set of methodologies that are accepted for accounting purposes and is not necessarily indicative of the “fair market value” that may be implied relative to such Units in a commercial transaction not governed by financial reporting standards. In particular, the methodology used to value the Class B Units at their “fair value” did not take into account any blockage discounts that may otherwise apply after the expiration of the lock-up period in 2025; while other valuation methodologies, not bound by financial reporting codifications, would possibly determine that the blockage discount associated with the resale of 565 million shares after the expiration of the lock-up period, into a marketplace that has limited market liquidity, could possibly have a material downward influence on the valuation.

 

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.25.1
COMMITMENTS AND CONTINGENCIES
3 Months Ended
Mar. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 11 – COMMITMENTS AND CONTINGENCIES

 

Litigation and Legal Proceedings

 

In the ordinary course of business, we may be, or have been, involved in material third-party litigation and other legal proceedings and administrative actions, or exposed to material contingencies or commitments in the course of our business, as described below.

 

Settlement of SEC Inquiry

 

On November 9, 2021, the Company received a subpoena from the United States Securities and Exchange Commission (“SEC”) for the production of documents. In the subpoena, the SEC advised that the inquiry did not mean that the SEC concluded that the Company or anyone affiliated with the Company had violated the federal securities laws or any other law. However, in the course of communications with the SEC throughout the inquiry, the Company came to believe that the focus of the SEC’s inquiry involved whether the offer and sale of the Company’s now discontinued Apex sale and leaseback program violated certain federal securities laws. Following a several year review process in which the Company cooperated fully with the SEC, on January 17, 2025, a settlement was reached with the SEC to resolve the inquiry. As part of the settlement, the Company entered into a formal SEC Order for which it neither admitted nor denied the factual and legal conclusions asserted, but paid a civil monetary penalty of $375,000 to conclude the inquiry. The Company considers this matter to be closed.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Exposure to potential claims arising from third-party financial protection plan

 

Historically, through our wholly-owned subsidiaries Apex Tek, LLC and SAFETek, LLC, we sold high powered data processing equipment, known as the Apex package, to our customers which was then leased back to us for use in our crypto mining operations. We discontinued sales of the Apex package in June 2020, principally when COVID-19 created certain supply chain-related limitations on that business. Confronted with these limitations in the business, we offered the holders of our Apex leases the opportunity to cancel their leases, in exchange for which, we repurchased substantially all of the data processing equipment (subject to these leases) for approximately $19 million of promissory notes due on or about December 31, 2024 (which amount reflects the principal amount invested by all of such lease holders, plus a 25% premium). During the fourth quarter ended December 31, 2023, we further offered all note holders an early payoff option. By December 31, 2024, we had repaid or settled the approximately $19 million of promissory notes.

 

Included in the Apex sale and leaseback program that was discontinued in 2021, was a “guaranteed assets buy-back product” underwritten, administered and managed by a third-party provider, Total Protection Plus (“TPP”), which was intended to provide customers who participated in the Apex sale and leaseback program with a financial protection program (the “TPP Program”), under which customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five-or-ten year interval after their initial purchase. As part of their sales and marketing materials, TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm that had sufficient capital resources, reserves and liquidity to support any payouts needed to satisfy their obligations under the TPP Program. TPP was paid substantial premiums for the program. In most instances, the premium for the TPP program was included in the package price for the Apex program, at no additional cost to the customer.

 

Separately, iGenius members who purchased ndau through an Oneiro sponsored ndau distribution program, were also given the opportunity to participate in a TPP Program similar to the program offered to our Apex customers; which in this case was intended to provide customers who purchased ndau with a financial protection program under which such customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five- or ten-year interval after their initial purchase. Participation in this program was also in reliance on sales and marketing materials by which TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm that had sufficient capital resources, reserves and liquidity to support any pay-outs needed to satisfy their obligations under the TPP Program. Prior to terminating the distribution of ndau in August 2023, we distributed over $16.6 million in ndau to our members purportedly supported by the TPP Program. As in the same case as had been done with respect to the Apex customers, TPP was paid substantial premiums for the program, and those premiums were included in the purchase price for the ndau program, at no additional cost to the customer.

 

During the fourth calendar quarter of 2021, we suspended any further offering of the TPP Program in connection with the sale of ndau after TPP was unable to comply with our vendor compliance protocols, having cited certain offshore confidentiality entitlements by which it was unwilling to provide evidence of its financial support arrangements. That suspension has remained in place as we have been unable to further validate the continued integrity of the TPP Program and the vendor’s ability to honor its commitments to our members; despite the payment of over $6 million to TPP to secure the benefits of the TPP Program. Our level of concern over the viability of the TPP Program has recently increased materially as we have come to learn that: (i) certain of our customers have been unable to reach TPP in order to process claims for their 5-year promised returns; (ii) certain customers have informed us that the TPP website has been inoperative and customers have been unable to process their claims; and (iii) an email communication purportedly from TPP, or an affiliate thereof, has been received by certain of customers in which the sender asserts that the obligations of TPP under the TPP Program were (unbeknownst to us and our customers) purportedly dependent on the financial wherewithal of another heretofore undisclosed TPP affiliate, that the email claims now has no ability to satisfy the commitments originally made by TPP.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

To respond to these concerns, and in an effort to advance the interests of our customers, on March 28, 2025, we commenced an action against Total Protection Plus, UIU Holdings LLC, Jason R. Anderson, Jacob S. Anderson, and Schad E. Brannon (collectively, “TPP”), in the Court of Chancery of the State of Delaware captioned Investview et al., v. UIU Holdings, LLC et al., seeking to, among other things, compel TPP to fulfill the commitments that were made to the Company’s customers under the TPP Program. 

 

We cannot ensure that TPP will comply with its contractual commitments to our customers, in which case these customers may not be able to realize the cash payouts promised by TPP, despite the substantial payments made to TPP to secure the benefits of the TPP Program. As the direct responsibility for compliance with the TPP Program resides with TPP; particularly as the program was underwritten, managed and administered by TPP as an independent third-party vendor (and with respect to ndau, the underlying ndau was developed and marketed by an additional third-party vendor), and in recognition of the customers’ acceptance of their participation in the program, we do not believe that we have any legal responsibility to cover any potential claims of customers who participated in the TPP Program. There is, however, the risk that any failure of TPP to perform its obligations to our customers could expose us to commercial claims of dissatisfied customers, regardless of the legal foundation associated therewith. The possible assertion of those claims could have an adverse effect on our business, financial condition, and operating results.

 

We have instituted a legal proceeding instituted to collect significant balance owed by credit card processor and clearing bank

 

The Company’s financial statements as of March 31, 2025, reflect a receivables balance of $2.23 million. Of that balance, $2.11 million represents receivables that arise out of credit card transactions generated by the Company’s iGenius subsidiary. The credit card transactions that arise out of the ordinary course operations of the Company’s iGenius subsidiary are processed by the Company’s credit card processors, in conjunction with their clearing banks. Over time, the balance of credit card collections being held by one of our credit card processors and its clearing bank, which are legally supposed to be held for the benefit of the Company, subject to coverage for chargebacks and other normal course collection issues, has increased to approximately $1.87 million, an amount that has been generally confirmed by the credit card processor. As they had been unresponsive to our repeated demands for payment, claiming that they were in the process of concluding their internal accounting of the amounts due and status of our accounts, in March 2024, the Company instituted a lawsuit against this credit card processor and its clearing bank seeking, among other things, an accounting for and repayment of the withheld funds. Notwithstanding, to date, we have been unable, through negotiations and through our lawsuit, to recover any amount of the receivable balances owed to us as the credit card processor asserts, among others, that it continues to evaluate possible exposure to chargebacks and other normal course collection issues. Recently, however, the Company’s application for a pre-judgment writ of attachment against both the credit card processor and the clearing bank, has been granted. Although the Company’s collection efforts will likely be enhanced by application of the pre-judgment writ of attachment, there can still be no assurances that the Company will be able to collect some or all of the funds owed to it. Should the Company be unable to collect some or all of the funds owed, it will be caused to incur a corollary bad debt expense of up to the uncollected amount which is currently approximately $1.87 million. Furthermore, the Company may be caused under generally accepted accounting principles, to incur a bad debt expense if it is determined that the amounts owed to the Company are unlikely to be collected, although the Company has not yet reached that conclusion. A charge of up to $1.87 million, which represents less than 10% of the Company’s current assets, would not have a material adverse effect upon the Company’s long-term liquidity, however, could have a material adverse effect upon the Company’s net earnings in the period incurred.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Potential exposure to administrative proceeding asserted by Polish regulatory authority relating to Company’s iGenius network

 

Our iGenius products and services are marketed by a global network of independent distributors using a direct selling business model. Although we believe that our direct selling business model is in material compliance with applicable legal standards, direct selling programs similar to ours and others within the industry, in general, have periodically been the target of regulatory scrutiny by federal, state, and local governmental agencies in the United States and foreign countries, including the FTC, whose regulatory authority extends to the prevention of fraudulent or deceptive schemes, often referred to as “pyramid” schemes. Since March 2025 we have been responding to an inquiry from Poland’s Office of Competition and Consumer Protection (“UOKiK”) as it has instituted formal proceedings against iGenius alleging that iGenius is not a bona fide financial education platform and is instead operating a pyramid scheme that is focused more on the recruitment of new members and not the sale or use of the underlying products or services being offered. Based on our analysis of the applicable legal standards, and the tracking of our sales within Poland in which the predominant portion of our sales consist of membership sales driven by our members, we believe that the iGenius direct selling business operating within Poland complies with all applicable legal standards and we disagree with any claims to the contrary. Despite our strong belief in our position, should we not succeed in our defense of the matter, we could, among other things: be subject to material financial fines and penalties (up to 10% of iGenius’ revenue in the year preceding the imposition of the penalty); be required to modify or suspend certain or a material portion of our operations in Poland; and become exposed to similar claims from other European regulators, which itself could cause a cascading and similar adverse impact on our operations in Europe, all of which could have a materially adverse impact on the Company. It is still too early in the proceedings for us to draw a likely conclusion on the outcome of the matter.

 

Outstanding commitments associated with termination of former Chief Executive Officer

 

Joseph Cammarata served as an officer and director of the Company from December 2019 through his termination for cause on or about December 7, 2021. Mr. Cammarata was terminated following the announcement of civil and criminal charges filed against him in connection with his involvement with a class action claims aggregator unrelated to the Company. The Company was unaware of these outside business interests. Based on public reporting of the matter, the Company believes that Mr. Cammarata was convicted of certain of these criminal charges and is presently incarcerated.

 

Prior to his termination, Mr. Cammarata and the Company engaged in certain transactions as described below:

 

We issued a promissory note to Mr. Cammarata, which, following certain modifications, on or about March 30, 2021, was restated in the principal amount of $1,550,000 (the “Cammarata Note”). Although not originally convertible, as per the March 30, 2021, amendment, the Cammarata Note became convertible at $0.02 per share, Thereafter, effective September 21, 2021, and following another modification, the conversion price under the Cammarata Note was reduced to $0.008 per share. During February 2022, we provided 30 days’ notice of our intent to retire and repay the Cammarata Note in cash. Having not timely received a properly executed conversion notice within the proscribed period and citing certain breaches of Mr. Cammarata’s fiduciary duty to us, as well as damages incurred by us arising from Mr. Cammarata’s then ongoing legal proceedings, on or about March 31, 2022, we tendered to Mr. Cammarata cash payment in full for the Cammarata Note. As of the date of this Report, Mr. Cammarata has not accepted our tender of the cash payment, and through his then counsel, has asserted his entitlement to exercise his right to convert the Cammarata Note into our common shares. Although we believe that our cash tender was appropriate under the terms of the Cammarata Note and our claims for damages by Mr. Cammarata have merit, if Mr. Cammarata elects to challenge our cash tender in a court proceeding, and if we are unable to sustain our legal position on the matter, Mr. Cammarata could receive up to approximately 203 million shares of our common stock upon conversion of the Cammarata Note. As a result of his recent incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata.

 

On March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA has only provided advances of $1,200,000 to date. The note bears interest at the rate of 0.11% per annum therefore we recognized $990 worth of interest expense on the loan during the nine months ended September 30, 2024. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan. As a result of his recent incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT REPORTING
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
SEGMENT REPORTING

NOTE 12 – SEGMENT REPORTING

 

The company has three reportable segments, Financial Education and Technology, Blockchain Technology and Crypto Mining Products and Services, and Manufacturing and Development of Health, Beauty and Wellness Products. The reportable segments are identified based on the types of products that generate revenue.

 

The segment performance that the CODM uses to measure performance is net income (loss) from operations. The Company does not allocate assets to the reporting segments as its assets are primarily managed on an entity-wide basis and therefore does not disclose the total assets of its reportable operating segments.

 

For the three months ended March 31, 2025 and 2024, there were no intersegment revenues or costs of revenues that needed to be eliminated in the Consolidated Statements of Operations.

 

The Financial Education and Technology segment generates revenue through membership fees. The Blockchain Technology and Crypto Mining segment generates revenue primarily through its Bitcoin mining operation. The Manufacturing and Development of Health, Beauty and Wellness Products generates revenue primarily through the sale of health and wellness products manufactured to wholesale and retail customers.

 

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the three months ended March 31, 2025.

 

SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE

   Financial Education and Technology   Blockchain Technology and Crypto Mining Products and Services   Manufacturing and Development of Health, Beauty and Wellness Products [1]   Total 
Revenue  $8,791,443   $862,944   $375,665   $10,030,052 
                     
Less:                    
Commissions   5,076,503    -    -    5,076,503 
Market experts   174,520    -    -    174,520 
Credit card processing   407,025    -    -    407,025 
Salary and related   410,290    134,103    298,092    842,485 
Selling and marketing   87,819    -    7,093    94,912 
Energy and hosting   -    1,037,599    -    1,037,599 
Depreciation   450    189,422    -    189,872 
Cost of sales   -    -    331,998    331,998 
General and administrative [2]   489,357    129,945    268,911    888,213 
                     
Segment net income (loss) from operations  $2,145,479   $(628,125)  $(530,429)  $986,925 

 

[1] The Development of Health, Beauty and Wellness Products business was acquired in October 2024.
   
[2] General and administrative costs consist mainly of professional fees, insurance, information technology and software and other payment processing fees.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the three months ended March 31, 2024.

 

   Financial Education and Technology   Blockchain Technology and Crypto Mining Products and Services   Total 
Revenue  $13,029,318   $2,642,599   $15,671,917 
                
Less:               
Commissions   7,275,210    -    7,275,210 
Market experts   260,250    -    260,250 
Credit card processing   607,234    -    607,234 
Salary and related   599,111    286,502    885,613 
Selling and marketing   10,770    152    10,922 
Energy and hosting   -    1,882,084    1,882,084 
Depreciation   -    1,177,796    1,177,796 
General and administrative [1]   255,641    76,295    331,936 
                
Segment income (loss) from operations  $4,021,102   $(780,230)  $3,240,872 

 

[1] General and administrative costs consist mainly of professional fees, contracting services, equipment, shipping and tariffs, insurance and information technology and software.

 

The following table illustrates the reconciliation of segment operating income to net income before taxes for the three months ended March 31, 2025 and 2024.

 

SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES 

   March 31,
2025
   March 31,
2024
 
Segment income from operations  $986,925   $3,240,872 
           
Reconciling items          
Bank interest   44,283    4,338 
Event ticket sales   38,553    - 
Leasing income   63,244    167,500 
All other, net   5,583    3,531 
           
Net income before taxes  $1,138,588   $3,416,241 

 

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.1
ACQUISITION
3 Months Ended
Mar. 31, 2025
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
ACQUISITION

NOTE 13 – ACQUISITION

 

On October 11, 2024, Renu Laboratories LLC (a wholly owned subsidiary of myLife Wellness Company which is a wholly owned subsidiary of Investview, Inc.) closed on the purchase of the business and assets of Renu Labs, Inc. (“Seller”), along with a 100% ownership interest in Goldman’s Pharmaceuticals LLC and a 50% ownership interest in ELRT Technologies, LLC (together known as “Renu Labs”) from Gregg Hanson. Renu Labs is a manufacturer of proprietary and other health, beauty and wellness products. The total purchase price of Renu Labs was $1,780,000.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

The transaction was accounted for as a business combination using the acquisition method of accounting in accordance with the ASC Topic 805. The following table summarizes the purchase accounting for the fair value of the assets acquired and liabilities assumed at the date of the acquisition:

 

      
Cash  $1,495 
Customer deposits – intercompany   7,360 
Domain names [1]   40,310 
Raw materials   149,260 
Manufacturing equipment   717,020 
Total assets acquired  $915,445 
      
Accounts payable  $323 
Customer deposits   572,386 
Total liabilities assumed  $572,709 
      
Net assets acquired   342,736 
      
Consideration [2]  $1,207,614 
Fair value of noncontrolling interest in ELRT Technologies, LLC   8,823 
Total   1,216,437 
      
Goodwill  $873,701 

 

[1] Domain names were deemed to have an indefinite life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy.
   
[2] This amount is equal to the $1,780,000 purchase price less $572,386 of customer deposits collected by Renu Labs, Inc. prior to acquisition.

 

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.1
INCOME TAXES
3 Months Ended
Mar. 31, 2025
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 14 – INCOME TAXES

 

For the periods ended March 31, 2025, and March 31, 2024, the Company used a discrete effective tax rate method for recording income taxes, as compared to an estimated full year annual effective tax rate method, as an estimate of the annual effective tax rate cannot be made.

 

Provision for Income taxes for the three months ended March 31, 2025 was $10,000 resulting in an effective tax rate of (1.5%). Provision for Income taxes for the three months ended March 31, 2024 was $500,075, resulting in an effective tax rate of 23.0%. The provision for income taxes was primarily impacted by pretax book income, permanent differences, and by the change in valuation allowance on deferred tax assets.

 

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.25.1
SUBSEQUENT EVENTS
3 Months Ended
Mar. 31, 2025
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 15 – SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, Subsequent Events, we have evaluated subsequent events through the date of this filing and have determined that the following events require disclosure.

 

During the period subsequent to period end, according to the stock repurchase program (see NOTE 10), the Company bought back 282,000 shares of their own common stock for $3,634. These shares are being held by the Company in Treasury.

XML 35 R24.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
Basis of Accounting

Basis of Accounting

 

Our policy is to prepare our financial statements on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations (Regulation S-X) of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the three months ended March 31, 2025, are not necessarily indicative of the operating results that may be expected for our year ending December 31, 2025, as will be included in the filing of our Annual Report on Form 10-K for the year ending December 31, 2025. These unaudited condensed consolidated financial statements should be read in conjunction with the December 31, 2024 consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2024.

Principles of Consolidation

Principles of Consolidation

 

The consolidated financial statements include the accounts of Investview, Inc., and our wholly owned subsidiaries: iGenius, LLC, SAFETek, LLC, Investview Financial Group Holdings, LLC, Opencash Finance, Inc., Opencash Securities, LLC, Investview MTS, LLC, myLife Wellness Company, Renu Laboratories LLC, and Goldman’s Pharmaceuticals LLC. The Company also owns 50% of ELRT Technologies, LLC, which has been included in the consolidated financial statements and the Company has recorded a noncontrolling interest for the 50% interest that it does not own. All intercompany transactions and balances have been eliminated in consolidation.

 

Operating Segments

Operating Segments

 

Operating segments are defined as components of an entity for which separate financial information is available that is regularly reviewed by the chief operating decision maker (“CODM”). The CODM is composed of several members of its executive management team, including the CEO, President and COO, and the CFO. The CODM uses segment net income from operations to assess the performance of, manage the operations of, and allocate capital and operational resources to the Company’s three reportable segments.

 

Financial Statement Reclassification

Financial Statement Reclassification

 

Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.

 

Use of Estimates

Use of Estimates

 

The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Concentration of Credit Risk

Concentration of Credit Risk

 

Financial instruments that potentially expose us to concentration of credit risk include cash, accounts receivable, and advances. We place our cash and temporary cash investments with credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit of $250,000. As of March 31, 2025 and December 31, 2024, cash balances that exceeded FDIC limits were $11,306,081 and $10,837,830, respectively. We have not experienced significant losses relating to these concentrations in the past.

 

Cash Equivalents

Cash Equivalents

 

For purposes of reporting cash flows, we consider all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. As of March 31, 2025 and December 31, 2024, we had no cash equivalents.

 

Receivables

Receivables

 

Receivables are carried at net realizable value, representing the outstanding balance less an allowance for doubtful accounts based on a review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating individual receivables and receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Receivables were made up of the following as of each balance sheet date:

 

 SCHEDULE OF RECEIVABLES

   March 31,   December 31, 
   2025   2024 
Due from merchant processors  $236,486   $318,921 
Held in reserve by merchant processors for future returns and chargebacks [1]   1,872,035    1,872,035 
Due from payout service providers   34,202    296,558 
Accounts and other receivables   88,854    47,213 
Receivable, gross   2,231,577    2,534,727 
Allowance for doubtful accounts   -    - 
Receivables  $2,231,577   $2,534,727 

 

[1] We have recently had to pursue collection efforts through litigation against one of our credit card processors and its clearing bank, as we have been unable to timely collect such amounts due through our normal course credit collection practices. See “NOTE 10-Commitments and Contingencies.”

 

Fixed Assets

Fixed Assets

 

Fixed assets are stated at cost and depreciated using the straight-line method over their estimated useful lives. When retired or otherwise disposed, the carrying value and accumulated depreciation of the fixed asset is removed from its respective accounts and the net difference less any amount realized from disposition is reflected in earnings. Expenditures for maintenance and repairs which do not extend the useful lives of the related assets are expensed as incurred.

 

Fixed assets were made up of the following at each balance sheet date:

 

 

   Estimated        
   Useful        
   Life  March 31,   December 31, 
   (years)  2025   2024 
Furniture, fixtures, and equipment  10  $717   $717 
Computer equipment  3   32,360    28,571 
Data processing equipment  3   11,824,560    11,824,560 
Manufacturing equipment  3-25   1,481,822    1,161,701 
       13,339,459    13,015,549 
Accumulated depreciation      (11,371,410)   (11,147,108)
Net book value     $1,968,049   $1,868,441 

 

Total depreciation expense for the three months ended March 31, 2025 and 2024, was $224,302 and $1,178,430, respectively.

 

Digital Assets

Digital Assets

 

Digital assets are included in non-current assets on the Consolidated Balance Sheets due to the Company’s intent to retain and hold bitcoin. Proceeds from the sale of digital assets and the purchase of digital assets are included within investing activities in the accompanying Consolidated Statement of Cash Flows. Digital Assets awarded to the Company through its mining activities and collected for membership revenue are accounted for in connection with the Company’s revenue recognition policy. Following the adoption of ASU 2023-08 effective January 1, 2025, the Company measures digital assets at fair value with changes recognized in other income (expense) in the Consolidated Statement of Operations. The Company tracks its cost basis of digital assets by-wallet in accordance with the first-in-first-out (“FIFO”) method of accounting. Refer to “NOTE 5 – DIGITAL ASSETS”, for further information regarding the Company’s impact of the adoption of ASU 2023-08.

Goodwill

Goodwill

 

Goodwill represents the excess of the purchase price over the fair value of the net assets acquired in a business combination. Goodwill is not subject to amortization, and instead, assessed for impairment annually at the end of each fiscal year, or more frequently when events or changes in circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying amount in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350 - Intangibles - Goodwill and Other.

 

The Company has the option to first assess qualitative factors to determine whether events or circumstances indicate it is more likely than not that the fair value of a reporting unit is greater than its carrying amount, in which case a quantitative impairment test is not required.

 

As provided for by ASU 2017-04, Simplifying the Test for Goodwill Impairment, the quantitative goodwill impairment test is performed by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not impaired. An impairment loss is recognized for any excess of the carrying amount of the reporting unit over its fair value up to the amount of goodwill allocated to the reporting unit.

 

Intangible Assets

Intangible Assets

 

We account for our intangible assets in accordance with FASB ASC 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30 requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Under ASC Subtopic 350-30 any intangible asset with a useful life is required to be amortized over that life and the useful life is to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.

 

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

We have adopted ASC Subtopic 360-10, Property, Plant and Equipment. ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by us be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or when the historical cost carrying value of an asset may no longer be appropriate. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period.

 

We evaluate the recoverability of long-lived assets based upon future net cash flows expected to result from the asset, including eventual disposition. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted and an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposable value. During the three months ended March 31, 2025 and 2024, no impairment was recorded.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in the absence of a principal, most advantageous market for the specific asset or liability.

 

U.S. generally accepted accounting principles provide for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows:

 

  Level 1: Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access.
     
  Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including:

 

  - quoted prices for similar assets or liabilities in active markets;
  - quoted prices for identical or similar assets or liabilities in markets that are not active;
  - inputs other than quoted prices that are observable for the asset or liability; and
  - inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

  Level 3: Inputs that are unobservable and reflect management’s own assumptions about the inputs market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows).

 

Our financial instruments consist of cash, accounts receivable and accounts payable, and debt. We have determined that the book value of our outstanding financial instruments as of March 31, 2025 and December 31, 2024, approximates the fair value due to their short-term nature or interest rates that approximate prevailing market rates.

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of March 31, 2025:

 

 

   Level 1   Level 2   Level 3   Total 
Digital assets (see NOTE 5)  $1,676,351   $-   $-   $1,676,351 
Total Assets  $1,676,351   $-   $-   $1,676,351 
                     
Derivative liability  $-   $-   $2,853   $2,853 
Total Liabilities  $-   $-   $2,853   $2,853 

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2024:

 

   Level 1   Level 2   Level 3   Total 
Total Assets  $-   $-   $-   $- 
                     
Derivative liability  $-   $-   $758   $758 
Total Liabilities  $-   $-   $758   $758 

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Revenue Recognition

Revenue Recognition

 

Membership Revenue

 

Most of our revenue is generated by membership sales and payment is received at the time of purchase. We recognize membership revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation is to provide our tools, products, and content over a fixed membership period; therefore, we recognize revenue ratably over the membership period and deferred revenue is recorded for the portion of the membership period subsequent to each reporting date. Additionally, we offer a designated trial period to first-time membership customers, during which a full refund can be requested if a customer does not wish to continue with the membership. Revenues are deferred during the trial period as collection is not probable until that time has passed. Revenues are presented net of refunds, sales incentives, credits, and known and estimated credit card chargebacks. As of March 31, 2025 and December 31, 2024, our deferred revenues for membership revenue were $1,852,839 and $1,905,734, respectively.

 

Mining Revenue

 

We generate revenue from mining bitcoin. The Company has entered into a digital asset mining pool by executing a contract, as amended from time to time, with the mining pool operator to provide computing power to the mining pool. The contract is terminable at any time by either party without penalty. Further, since the contract is continuously renewing, second by second, the mining contract is considered to have a duration of less than 24 hours for accounting purposes. The Company’s enforceable right to compensation only begins when the Company provides computing power to the mining pool operator. In exchange for providing computing power, we are entitled to a Full-Pay-Per-Share payout of Bitcoin based on a contractual formula, which calculates our share of block rewards, transaction fees, and mining pool operator fees. We are entitled to consideration even if a block is not successfully placed by the mining pool operator.

 

Providing computing power to solve complex cryptographic algorithms in support of the Bitcoin blockchain (in a process known as “solving a block”) is an output of the Company’s ordinary activities. The provision of providing such computing power is the only performance obligation in the Company’s contract with the mining pool operator. The transaction consideration the Company receives is net of a contractually agreed upon mining pool operator fee charged and kept by the mining pool operator and is noncash, in the form of Bitcoin. Given that the contract is continuously renewing, and the duration is considered to be less than 24 hours, the Company measures the transaction consideration at fair value on the date Bitcoin is received. The consideration is variable. The amount of consideration recognized is constrained to the amount of consideration received, which is when it is probable a significant reversal will not occur. There is no significant financing component or risk of a significant revenue reversal in these transactions due to the performance obligations and settlement of the transactions being on a daily basis.

 

Health and Wellness Product Sales and Other Revenue

 

Through our wholly owned subsidiary, Renu Laboratories LLC, we generate revenue by manufacturing and selling health, beauty and wellness products. We recognize health and wellness product sales revenue in accordance with ASC 606-10. The Company’s performance obligation is complete when control of the promised goods is transferred to a customer, at which time the Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for those goods. The Company terms for the sale are based on free on board (FOB) shipping point, where the control passes to the customer once the product leaves our warehouse. The Company determines collectability by requiring certain customers to pay before control is transferred and by performing ongoing credit evaluations and monitoring customer accounts receivable balances. As of March 31, 2025 and December 31, 2024, deposits collected from customers for orders to be filled at a future date were $844,318 and $1,014,164, respectively.

 

Shipping and direct costs charged to customers, along with fees collected from customers for storing their products in our warehouse facility located in Warminster, Pennsylvania are included in revenue as Other Revenue. Shipping and direct costs incurred by the Company are included in Cost of Sales and Service.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Revenue generated for the three months ended March 31, 2025, was as follows:

 

 

   Membership
revenue
   Mining revenue   Health and wellness product sales   Other Revenue   Total 
Gross billings/receipts  $9,439,857   $862,944   $368,443   $7,344   $10,678,588 
Refunds, incentives, credits, and chargebacks   (648,414)   -    (122)   -    (648,536)
Net revenue  $8,791,443   $862,944   $368,321   $7,344   $10,030,052 

 

Foreign revenues for the three months ended March 31, 2025 were approximately $7.6 million while domestic revenue for the three months ended March 31, 2025 was approximately $2.4 million.

 

Revenue generated for the three months ended March 31, 2024, was as follows:

 

   Membership
Revenue
   Mining Revenue   Total 
Gross billings/receipts  $13,851,294   $2,642,599   $16,493,893 
Refunds, incentives, credits, and chargebacks   (821,976)   -    (821,976)
Net revenue  $13,029,318   $2,642,599   $15,671,917 

 

Foreign revenues for the three months ended March 31, 2024 were approximately $11.8 million while domestic revenue for the three months ended March 31, 2024 was approximately $3.9 million.

 

Advertising, Selling and Marketing Costs

Advertising, Selling and Marketing Costs

 

We expense advertising, selling, and marketing costs as incurred. Advertising, selling, and marketing costs include costs of promoting our product worldwide, including promotional events. Advertising, selling, and marketing expenses for the three months ended March 31, 2025 and 2024, totaled $95,103 and $11,795, respectively.

 

Cost of Sales and Service

Cost of Sales and Service

 

Included in our costs of sales and services is amounts paid to our trading and market experts that provide financial education content and tools to our membership customers, hosting and electricity fees that we pay to vendors to set up our mining equipment at third-party sites in order to generate mining revenue, and the raw material and manufacturing costs of our health and wellness product sales. Costs of sales and services for the three months ended March 31, 2025 and 2024, totaled $1,544,116 and $2,142,334, respectively.

 

Inventory

Inventory

 

Inventory consists of raw materials, work in progress, and finished goods to be sold as part of our health and wellness product sales. Inventory is valued at the lower of cost or net realizable value using the first-in, first-out (FIFO) method and is inclusive of any shipping and tax costs.

 

Inventory was made up of the following at each balance sheet date:

 

SCHEDULE OF INVENTORY

   March 31,   December 31, 
   2025   2024 
Finished goods  $5,451   $27,802 
Work in process   191,440    312 
Raw materials   659,235    467,751 
Inventory  $856,126   $495,865 

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Income Taxes

Income Taxes

 

Income taxes are recorded in accordance with ASC Topic 740, Income Taxes, which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities, including operating losses and credit carryforwards, using enacted tax rates in effect for the year in which the differences are expected to reverse.

 

Management judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities, and any valuation allowance recorded against our deferred tax assets. Deferred tax assets are reduced by a valuation allowance if, based on the consideration of all available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. Changes in assumptions in future periods may require we adjust our valuation allowance, which could materially impact our financial position and results of operations. The Company recognizes the benefit of an uncertain tax position that it has taken or expects to take on its income tax return, if such a position is more likely than not to be sustained.

 

Net Income (Loss) per Share

Net Income (Loss) per Share

 

We follow ASC Subtopic 260-10, Earnings per Share, which specifies the computation, presentation, and disclosure requirements of earnings per share information. Basic loss per share has been calculated based upon the weighted average number of common shares outstanding. Diluted income (loss) per share reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted during the period. Dilutive securities having an anti-dilutive effect on diluted earnings per share are excluded from the calculation.

 

Due to the net loss for the three months ended March 31, 2025, basic and diluted income per share were the same, as all securities had an antidilutive effect.

 

The following table illustrates the computation of diluted earnings per share for the three months ended March 31, 2024.

 

 

   March 31, 2024 
Net income  $1,669,940 
Less: preferred dividends   (204,835)
Add: interest expense on convertible debt   225,129 
Net income available to common shareholders (numerator)  $1,690,234 
      
Basic weighted average number of common shares outstanding   2,053,046,229 
Dilutive impact of convertible notes   471,428,571 
Dilutive impact of non-voting membership interest   565,000,000 
Diluted weighted average number of common shares outstanding (denominator)   3,089,474,800 
      
Diluted income per common share  $0.00 

 

The following table presents potentially dilutive securities that were not included in the computation of diluted net income per share as their inclusion would be anti-dilutive.

 

 

   March 31, 2025   March 31, 2024 
Options to purchase common stock   351,416,665    191,666,665 
Warrants to purchase common stock   1,178,090    1,178,090 
Common stock issuable upon conversion of notes   471,428,571    N/A 
Common stock issuable upon conversion of non-voting membership interest   565,000,000    N/A 

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

Lease Obligation

Lease Obligation

 

We determine if an arrangement is a lease at inception. Operating leases are included in the operating lease right-of-use asset account, the operating lease liability, current account, and the operating lease liability, long-term account in our balance sheet. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.

 

Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. For leases in which the rate implicit in the lease is not readily determinable, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We have elected to not apply the recognition requirements of ASC 842 to short-term leases (leases with terms of twelve months or less). Lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for operating lease arrangements is recognized on a straight-line basis over the lease term. We have elected the practical expedient and will not separate non-lease components from lease components and will instead account for each separate lease component and non-lease component associated with the lease components as a single lease component.

XML 36 R25.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
SCHEDULE OF RECEIVABLES

Receivables were made up of the following as of each balance sheet date:

 

 SCHEDULE OF RECEIVABLES

   March 31,   December 31, 
   2025   2024 
Due from merchant processors  $236,486   $318,921 
Held in reserve by merchant processors for future returns and chargebacks [1]   1,872,035    1,872,035 
Due from payout service providers   34,202    296,558 
Accounts and other receivables   88,854    47,213 
Receivable, gross   2,231,577    2,534,727 
Allowance for doubtful accounts   -    - 
Receivables  $2,231,577   $2,534,727 

 

[1] We have recently had to pursue collection efforts through litigation against one of our credit card processors and its clearing bank, as we have been unable to timely collect such amounts due through our normal course credit collection practices. See “NOTE 10-Commitments and Contingencies.”
SCHEDULE OF FIXED ASSETS

Fixed assets were made up of the following at each balance sheet date:

 

 

   Estimated        
   Useful        
   Life  March 31,   December 31, 
   (years)  2025   2024 
Furniture, fixtures, and equipment  10  $717   $717 
Computer equipment  3   32,360    28,571 
Data processing equipment  3   11,824,560    11,824,560 
Manufacturing equipment  3-25   1,481,822    1,161,701 
       13,339,459    13,015,549 
Accumulated depreciation      (11,371,410)   (11,147,108)
Net book value     $1,968,049   $1,868,441 
SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of March 31, 2025:

 

 

   Level 1   Level 2   Level 3   Total 
Digital assets (see NOTE 5)  $1,676,351   $-   $-   $1,676,351 
Total Assets  $1,676,351   $-   $-   $1,676,351 
                     
Derivative liability  $-   $-   $2,853   $2,853 
Total Liabilities  $-   $-   $2,853   $2,853 

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2024:

 

   Level 1   Level 2   Level 3   Total 
Total Assets  $-   $-   $-   $- 
                     
Derivative liability  $-   $-   $758   $758 
Total Liabilities  $-   $-   $758   $758 
SCHEDULE OF REVENUE GENERATED

Revenue generated for the three months ended March 31, 2025, was as follows:

 

 

   Membership
revenue
   Mining revenue   Health and wellness product sales   Other Revenue   Total 
Gross billings/receipts  $9,439,857   $862,944   $368,443   $7,344   $10,678,588 
Refunds, incentives, credits, and chargebacks   (648,414)   -    (122)   -    (648,536)
Net revenue  $8,791,443   $862,944   $368,321   $7,344   $10,030,052 

 

Foreign revenues for the three months ended March 31, 2025 were approximately $7.6 million while domestic revenue for the three months ended March 31, 2025 was approximately $2.4 million.

 

Revenue generated for the three months ended March 31, 2024, was as follows:

 

   Membership
Revenue
   Mining Revenue   Total 
Gross billings/receipts  $13,851,294   $2,642,599   $16,493,893 
Refunds, incentives, credits, and chargebacks   (821,976)   -    (821,976)
Net revenue  $13,029,318   $2,642,599   $15,671,917 
SCHEDULE OF INVENTORY

Inventory was made up of the following at each balance sheet date:

 

SCHEDULE OF INVENTORY

   March 31,   December 31, 
   2025   2024 
Finished goods  $5,451   $27,802 
Work in process   191,440    312 
Raw materials   659,235    467,751 
Inventory  $856,126   $495,865 
SCHEDULE OF DILUTED EARNINGS PER SHARE

The following table illustrates the computation of diluted earnings per share for the three months ended March 31, 2024.

 

 

   March 31, 2024 
Net income  $1,669,940 
Less: preferred dividends   (204,835)
Add: interest expense on convertible debt   225,129 
Net income available to common shareholders (numerator)  $1,690,234 
      
Basic weighted average number of common shares outstanding   2,053,046,229 
Dilutive impact of convertible notes   471,428,571 
Dilutive impact of non-voting membership interest   565,000,000 
Diluted weighted average number of common shares outstanding (denominator)   3,089,474,800 
      
Diluted income per common share  $0.00 
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES

The following table presents potentially dilutive securities that were not included in the computation of diluted net income per share as their inclusion would be anti-dilutive.

 

 

   March 31, 2025   March 31, 2024 
Options to purchase common stock   351,416,665    191,666,665 
Warrants to purchase common stock   1,178,090    1,178,090 
Common stock issuable upon conversion of notes   471,428,571    N/A 
Common stock issuable upon conversion of non-voting membership interest   565,000,000    N/A 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.25.1
DIGITAL ASSETS (Tables)
3 Months Ended
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF DIGITAL ASSETS

The following table presents the Company’s Digital Asset holdings as of March 31, 2025:

 

SCHEDULE OF DIGITAL ASSETS

   Quantity   Cost Basis   Fair Value 
Bitcoin   20.30   $1,896,337   $1,676,153 
USDC   198.00    198    198 
Total digital assets held as of March 31, 2025       $1,896,535   $1,676,351 
SCHEDULE OF DIGITAL ASSETS ACTIVITY

The following table presents a roll-forward of total digital assets for the three months ended March 31, 2025, based on the fair value model under ASU 2023-08:

 

SCHEDULE OF DIGITAL ASSETS ACTIVITY

   Fair Value 
Balance as of December 31, 2024  $1,127,891 
    585,632 
Cumulative effect adjustment upon adoption of ASU 2023-08   148,346 
Revenue recognized from Bitcoin mined (9.12 BTC)   862,944 
Digital assets collected from membership revenue   336,614 
Purchase of digital assets   1,695 
Operating expenses paid with digital assets   (527,058)
Dividends paid via digital assets   (40,645)
Realized gain (loss) on digital assets   (13,252)
Change in fair value of digital assets   (220,184)
Balance as of March 31, 2025  $1,676,351 
    232,834 
 

The following table presents a roll-forward of digital assets for the three months ended March 31, 2024, based on the cost-impairment model under ASC 350:

 

   Cost Basis 
Balance as of December 31, 2023  $585,632 
Revenue recognized from Bitcoin mined (49.82 BTC)   2,642,599 
Digital assets collected from membership revenue   407,138 
Operating expenses paid with digital assets   (3,599,825)
Dividends paid via digital assets   (40,170)
Debt extinguished in exchange for digital assets   (38,767)
Realized (gain) loss on sale of digital assets   276,227 
Balance as of March 31, 2024  $232,834 
 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.1
RELATED-PARTY TRANSACTIONS (Tables)
3 Months Ended
Mar. 31, 2025
Related Party Transactions [Abstract]  
SCHEDULE OF RELATED PARTY PAYABLES

Our related-party payables consisted of the following:

 

 

  

March 31,

2025

   December 31,
2024
 
Convertible Promissory Note entered into on 4/27/20, net of debt discount of $659,967 as of March 31, 2025 [1]  $640,033   $607,996 
Convertible Promissory Note entered into on 5/27/20, net of debt discount of $358,309 as of March 31, 2025 [2]   341,691    324,304 
Convertible Promissory Note entered into on 11/9/20, net of debt discount of $697,397 as of March 31, 2025 [3]   602,603    568,742 
Working Capital Promissory Note entered into on 3/22/21 [4]   1,204,897    1,204,567 
Total related-party debt   2,789,224    2,705,608 
Less: Current portion   (1,204,897)   (1,204,567)
Related-party debt, long term  $1,584,327   $1,501,041 

 

 

[1]On April 27, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the three months ended March 31, 2025, we recognized $32,037 of the debt discount into interest expense, as well as expensed an additional $65,004 of interest expense on the note, all of which was repaid during the period.

 

[2]On May 27, 2020, we received proceeds of $700,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $700,000. During the three months ended March 31, 2025, we recognized $17,387 of the debt discount into interest expense as well as expensed an additional $35,001 of interest expense on the note, all of which was repaid during the period.

 

[3]On November 9, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 38.5% per annum, made up of a 25% interest rate per annum and a facility fee of 13.5% per annum, payable monthly beginning February 1, 2021, and the principal is due and payable on April 27, 2030. Per the terms of the agreement, the note is convertible into common stock at a conversion price of $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the three months ended March 31, 2025, we recognized $33,861 of the debt discount into interest expense as well as expensed an additional $125,124 of interest expense on the note, all of which was repaid during the period.
  
[4]On March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. (See NOTE 11). Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA only provided advances of $1,200,000, to date. The note bears interest at the rate of 0.11% per annum. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations, and the other damages we sustained as a result of the actions of Mr. Cammarata. During the three months ended March 31, 2025, we recorded interest expense of $330 on the note. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan.
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.1
DEBT (Tables)
3 Months Ended
Mar. 31, 2025
Debt Disclosure [Abstract]  
SCHEDULE OF DEBT

Our debt consisted of the following:

 

   March 31,
2025
   December 31,
2024
 
Loan with the U.S. Small Business Administration dated 4/19/20 [1]  $517,176   $519,863 
Total debt   517,176    519,863 
Less: Current portion   29,244    29,244 
Debt, long term portion  $487,932   $490,619 

 

 

[1] In April 2020 we received proceeds of $500,000 from a loan entered into with the U.S. Small Business Administration. Under the terms of the loan interest is to accrue at a rate of 3.75% per annum and installment payments of $2,437 monthly will begin twelve months from the date of the loan, with all interest and principal due and payable thirty years from the date of the loan. During the three months ended March 31, 2025, we recorded $4,623 worth of interest on the loan. During the three months ended March 31, 2025, we made repayments on the loan of $7,310.
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.25.1
DERIVATIVE LIABILITY (Tables)
3 Months Ended
Mar. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
SCHEDULE OF DERIVATIVE LIABILITY

During the three months ended March 31, 2025, we had the following activity in our derivative liability account relating to our warrants:

 

 

Derivative liability at December 31, 2024 $ 758  
Derivative liability recorded on new instruments   -  
Derivative liability reduced by warrant exercise   -  
(Gain) loss on fair value   2,095  
Derivative liability at March 31, 2025 $ 2,853  
SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL

We use the binomial option pricing model to estimate fair value for those instruments at inception, at warrant exercise, and at each reporting date. During the three months ended March 31, 2025, the assumptions used in our binomial option pricing model were in the following range:

 

 

Risk free interest rate   4.23% - 4.32%
Expected life in years   0.33 - 1.25 
Expected volatility   132% - 161%
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.25.1
OPERATING LEASE (Tables)
3 Months Ended
Mar. 31, 2025
Operating Lease  
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES

Future minimum lease payments under non-cancellable leases as of March 31, 2025, were as follows:

 

 

      
Remainder of 2025  $126,962 
2026   61,057 
Total   188,019 
Less: Interest   (14,526)
Present value of lease liability   173,493 
Operating lease liability, current [1]   (140,112)
Operating lease liability, long term  $33,381 

 

[1] Represents lease payments to be made in the next 12 months.
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
SCHEDULE OF OPTIONS ACTIVITY

Transactions involving our options are summarized as follows:

 

 

           Weighted 
           Average 
       Weighted   Grant-Date 
   Number of   Average   Per Share 
   Options   Exercise Price   Fair Value 
Options outstanding at December 31, 2024   351,416,665   $0.05   $0.03 
Granted   -   $-   $- 
Canceled/Expired   -   $-   $- 
Exercised   -   $-   $- 
Options outstanding at March 31, 2025   351,416,665   $0.05   $0.03 
SCHEDULE OF OPTIONS OUTSTANDING

Details of our options outstanding as of March 31, 2025, is as follows:

 

 

Options Exercisable   Weighted Average Exercise Price of Options Exercisable   Weighted Average Contractual Life of Options Exercisable (Years)   Weighted Average Contractual Life of Options Outstanding (Years) 
 233,116,665    0.05    4.24    4.38 
SCHEDULE OF WARRANTS ISSUED

Transactions involving our warrants are summarized as follows:

 

 

       Weighted 
   Number of   Average 
   Shares   Exercise Price 
Warrants outstanding at December 31, 2024   1,178,090   $0.10 
Granted   -   $- 
Canceled/Expired   -   $- 
Exercised   -   $- 
Warrants outstanding at March 31, 2025   1,178,090   $0.10 
SCHEDULE OF WARRANTS OUTSTANDING

Details of our warrants outstanding as of March 31, 2025, is as follows:

 

 

Warrants Exercisable   Weighted Average Contractual Life of Warrants Outstanding and Exercisable (Years) 
 1,178,090    0.89 
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT REPORTING (Tables)
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the three months ended March 31, 2025.

 

SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE

   Financial Education and Technology   Blockchain Technology and Crypto Mining Products and Services   Manufacturing and Development of Health, Beauty and Wellness Products [1]   Total 
Revenue  $8,791,443   $862,944   $375,665   $10,030,052 
                     
Less:                    
Commissions   5,076,503    -    -    5,076,503 
Market experts   174,520    -    -    174,520 
Credit card processing   407,025    -    -    407,025 
Salary and related   410,290    134,103    298,092    842,485 
Selling and marketing   87,819    -    7,093    94,912 
Energy and hosting   -    1,037,599    -    1,037,599 
Depreciation   450    189,422    -    189,872 
Cost of sales   -    -    331,998    331,998 
General and administrative [2]   489,357    129,945    268,911    888,213 
                     
Segment net income (loss) from operations  $2,145,479   $(628,125)  $(530,429)  $986,925 

 

[1] The Development of Health, Beauty and Wellness Products business was acquired in October 2024.
   
[2] General and administrative costs consist mainly of professional fees, insurance, information technology and software and other payment processing fees.

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

 

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the three months ended March 31, 2024.

 

   Financial Education and Technology   Blockchain Technology and Crypto Mining Products and Services   Total 
Revenue  $13,029,318   $2,642,599   $15,671,917 
                
Less:               
Commissions   7,275,210    -    7,275,210 
Market experts   260,250    -    260,250 
Credit card processing   607,234    -    607,234 
Salary and related   599,111    286,502    885,613 
Selling and marketing   10,770    152    10,922 
Energy and hosting   -    1,882,084    1,882,084 
Depreciation   -    1,177,796    1,177,796 
General and administrative [1]   255,641    76,295    331,936 
                
Segment income (loss) from operations  $4,021,102   $(780,230)  $3,240,872 

 

[1] General and administrative costs consist mainly of professional fees, contracting services, equipment, shipping and tariffs, insurance and information technology and software.
SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES

The following table illustrates the reconciliation of segment operating income to net income before taxes for the three months ended March 31, 2025 and 2024.

 

SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES 

   March 31,
2025
   March 31,
2024
 
Segment income from operations  $986,925   $3,240,872 
           
Reconciling items          
Bank interest   44,283    4,338 
Event ticket sales   38,553    - 
Leasing income   63,244    167,500 
All other, net   5,583    3,531 
           
Net income before taxes  $1,138,588   $3,416,241 
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.25.1
ACQUISITION (Tables)
3 Months Ended
Mar. 31, 2025
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION
      
Cash  $1,495 
Customer deposits – intercompany   7,360 
Domain names [1]   40,310 
Raw materials   149,260 
Manufacturing equipment   717,020 
Total assets acquired  $915,445 
      
Accounts payable  $323 
Customer deposits   572,386 
Total liabilities assumed  $572,709 
      
Net assets acquired   342,736 
      
Consideration [2]  $1,207,614 
Fair value of noncontrolling interest in ELRT Technologies, LLC   8,823 
Total   1,216,437 
      
Goodwill  $873,701 

 

[1] Domain names were deemed to have an indefinite life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy.
   
[2] This amount is equal to the $1,780,000 purchase price less $572,386 of customer deposits collected by Renu Labs, Inc. prior to acquisition.
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.25.1
ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) - USD ($)
3 Months Ended
Jun. 06, 2017
Apr. 01, 2017
Mar. 31, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Entity incorporation, date of incorporation     Jan. 30, 1946
Contribution Agreement [Member] | Wealth Generators LLC [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Percentage of shares contributed   100.00%  
Number of shares exchanged for common stock   1,358,670,942  
Acquisition Agreement [Member] | Market Trend Strategies LLC [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Value pre-merger liabilities $ 419,139    
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF RECEIVABLES (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Accounting Policies [Abstract]    
Due from merchant processors $ 236,486 $ 318,921
Held in reserve by merchant processors for future returns and chargebacks [1] 1,872,035 1,872,035
Due from payout service providers 34,202 296,558
Accounts and other receivables 88,854 47,213
Receivable, gross 2,231,577 2,534,727
Allowance for doubtful accounts
Receivables $ 2,231,577 $ 2,534,727
[1] We have recently had to pursue collection efforts through litigation against one of our credit card processors and its clearing bank, as we have been unable to timely collect such amounts due through our normal course credit collection practices. See “NOTE 10-Commitments and Contingencies.”
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF FIXED ASSETS (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Property, Plant and Equipment [Line Items]    
Gross book value $ 13,339,459 $ 13,015,549
Accumulated depreciation (11,371,410) (11,147,108)
Net book value $ 1,968,049 1,868,441
Furniture, Fixtures and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life of fixed assets 10 years  
Gross book value $ 717 717
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life of fixed assets 3 years  
Gross book value $ 32,360 28,571
Data Processing Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life of fixed assets 3 years  
Gross book value $ 11,824,560 11,824,560
Manufacturing Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Gross book value $ 1,481,822 $ 1,161,701
Manufacturing Equipment [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life of fixed assets 3 years  
Manufacturing Equipment [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life of fixed assets 25 years  
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Platform Operator, Crypto Asset [Line Items]    
Digital assets (see NOTE 5) $ 1,676,351 $ 1,127,891
Fair Value, Recurring [Member]    
Platform Operator, Crypto Asset [Line Items]    
Digital assets (see NOTE 5) 1,676,351  
Total Assets 1,676,351
Derivative liability 2,853 758
Total Liabilities 2,853 758
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]    
Platform Operator, Crypto Asset [Line Items]    
Digital assets (see NOTE 5) 1,676,351  
Total Assets 1,676,351
Derivative liability
Total Liabilities
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member]    
Platform Operator, Crypto Asset [Line Items]    
Digital assets (see NOTE 5)  
Total Assets
Derivative liability
Total Liabilities
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member]    
Platform Operator, Crypto Asset [Line Items]    
Digital assets (see NOTE 5)  
Total Assets
Derivative liability 2,853 758
Total Liabilities $ 2,853 $ 758
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF REVENUE GENERATED (Details) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Product Information [Line Items]    
Gross billings/receipts $ 10,678,588 $ 16,493,893
Refunds, incentives, credits, and chargebacks (648,536) (821,976)
Net revenue 10,030,052 15,671,917
Membership Revenue [Member]    
Product Information [Line Items]    
Gross billings/receipts 9,439,857 13,851,294
Refunds, incentives, credits, and chargebacks (648,414) (821,976)
Net revenue 8,791,443 13,029,318
Mining Revenue [Member]    
Product Information [Line Items]    
Gross billings/receipts 862,944 2,642,599
Refunds, incentives, credits, and chargebacks
Net revenue 862,944 2,642,599
Health and Wellness Revenue [Member]    
Product Information [Line Items]    
Gross billings/receipts 368,443  
Refunds, incentives, credits, and chargebacks (122)  
Net revenue 368,321
Other [Member]    
Product Information [Line Items]    
Gross billings/receipts 7,344  
Refunds, incentives, credits, and chargebacks  
Net revenue $ 7,344
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF INVENTORY (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Accounting Policies [Abstract]    
Finished goods $ 5,451 $ 27,802
Work in process 191,440 312
Raw materials 659,235 467,751
Inventory $ 856,126 $ 495,865
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DILUTED EARNINGS PER SHARE (Details) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Accounting Policies [Abstract]    
Net income $ (687,853) $ 1,669,940
Less: preferred dividends $ (204,835) (204,835)
Add: interest expense on convertible debt   225,129
Net income available to common shareholders (numerator)   $ 1,690,234
Basic weighted average number of common shares outstanding 1,859,076,249 2,053,046,229
Dilutive impact of convertible notes   471,428,571
Dilutive impact of non-voting membership interest   565,000,000
Diluted weighted average number of common shares outstanding (denominator) 1,859,076,249 3,089,474,800
Diluted income per common share $ (0.00) $ 0.00
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details) - shares
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities 351,416,665 191,666,665
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities 1,178,090 1,178,090
Convertible Debt Securities [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities 471,428,571  
Conversion of Non-voting Membership Interest [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities 565,000,000  
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
3 Months Ended
Mar. 31, 2025
USD ($)
Segment
Mar. 31, 2024
USD ($)
Dec. 31, 2024
USD ($)
Product Information [Line Items]      
Number of reportable segments | Segment 3    
Cash, FDIC insured amount $ 250,000    
Cash balances exceeded FDIC limits 11,306,081   $ 10,837,830
Cash equivalents 0   0
Depreciation expense 224,302 $ 1,178,430  
Impairment of long-lived assets 0 0  
Deferred revenues 2,834,758   3,029,145
Deposits collected from customers for orders to be filled at future date 844,318   1,014,164
Revenues 10,030,052 15,671,917  
Advertising, selling, and marketing expenses 95,103 11,795  
Cost of sales and service 1,544,116 2,142,334  
Membership Revenue [Member]      
Product Information [Line Items]      
Deferred revenues 1,852,839   $ 1,905,734
Revenues 8,791,443 13,029,318  
Foreign Revenue [Member]      
Product Information [Line Items]      
Revenues 7,600,000 11,800,000  
Domestic Revenue [Member]      
Product Information [Line Items]      
Revenues $ 2,400,000 $ 3,900,000  
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.25.1
LIQUIDITY (Details Narrative) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Cash and cash equivalents $ 17,506,288 $ 22,467,710
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DIGITAL ASSETS (Details)
Mar. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Crypto Asset, Holding [Line Items]        
Digital assets held, Cost basis $ 1,896,535   $ 232,834 $ 585,632
Digital assets held, Fair value $ 1,676,351 $ 1,127,891    
Bitcoin [Member]        
Crypto Asset, Holding [Line Items]        
Digital assets held, Quantity 20.30      
Digital assets held, Cost basis $ 1,896,337      
Digital assets held, Fair value $ 1,676,153      
USDC [Member]        
Crypto Asset, Holding [Line Items]        
Digital assets held, Quantity 198.00      
Digital assets held, Cost basis $ 198      
Digital assets held, Fair value $ 198      
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DIGITAL ASSETS ACTIVITY (Details) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]    
Beginning balance, Fair Value $ 1,127,891  
Beginning balance, Cost Basis   $ 585,632
Cumulative effect adjustment upon adoption of ASU 2023-08 148,346  
Revenue recognized from Bitcoin mined 862,944 2,642,599
Digital assets collected from membership revenue 336,614 407,138
Purchase of digital assets 1,695
Operating expenses paid with digital assets (527,058) (3,599,825)
Dividends paid via digital assets (40,645) (40,170)
Debt extinguished in exchange for digital assets (38,767)
Realized (gain) loss on sale of digital assets (13,252) 276,227
Change in fair value of digital assets (220,184)
Ending balance, Fair Value 1,676,351  
Ending balance, Cost Basis $ 1,896,535 $ 232,834
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.25.1
DIGITAL ASSETS (Details Narrative) - USD ($)
3 Months Ended
Jan. 01, 2025
Mar. 31, 2025
Increase in digital assets $ 148,346  
Decrease in accumulated deficit   $ 148,346
Retained Earnings [Member]    
Decrease in accumulated deficit $ 148,346 $ 148,346
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF RELATED PARTY PAYABLES (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Related Party [Member]    
Related Party Transaction [Line Items]    
Total related-party debt $ 2,789,224 $ 2,705,608
Less: Current portion (1,204,897) (1,204,567)
Related-party debt, long term 1,584,327 1,501,041
Convertible Promissory Note One [Member]    
Related Party Transaction [Line Items]    
Total related-party debt [1] 640,033 607,996
Convertible Promissory Note Two [Member]    
Related Party Transaction [Line Items]    
Total related-party debt [2] 341,691 324,304
Convertible Promissory Note Three [Member]    
Related Party Transaction [Line Items]    
Total related-party debt [3] 602,603 568,742
Working Capital Promissory Note [Member]    
Related Party Transaction [Line Items]    
Total related-party debt [4] $ 1,204,897 $ 1,204,567
[1] On April 27, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the three months ended March 31, 2025, we recognized $32,037 of the debt discount into interest expense, as well as expensed an additional $65,004 of interest expense on the note, all of which was repaid during the period.
[2] On May 27, 2020, we received proceeds of $700,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $700,000. During the three months ended March 31, 2025, we recognized $17,387 of the debt discount into interest expense as well as expensed an additional $35,001 of interest expense on the note, all of which was repaid during the period.
[3] On November 9, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 38.5% per annum, made up of a 25% interest rate per annum and a facility fee of 13.5% per annum, payable monthly beginning February 1, 2021, and the principal is due and payable on April 27, 2030. Per the terms of the agreement, the note is convertible into common stock at a conversion price of $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the three months ended March 31, 2025, we recognized $33,861 of the debt discount into interest expense as well as expensed an additional $125,124 of interest expense on the note, all of which was repaid during the period.
[4] On March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. (See NOTE 11). Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA only provided advances of $1,200,000, to date. The note bears interest at the rate of 0.11% per annum. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations, and the other damages we sustained as a result of the actions of Mr. Cammarata. During the three months ended March 31, 2025, we recorded interest expense of $330 on the note. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan.
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF RELATED PARTY PAYABLES (Details) (Parenthetical) - USD ($)
3 Months Ended 9 Months Ended
Mar. 22, 2021
Nov. 09, 2020
May 27, 2020
Apr. 27, 2020
Mar. 31, 2025
Mar. 31, 2024
Sep. 30, 2024
Related Party Transaction [Line Items]              
Debt discount into interest expense         $ 83,286 $ 84,210  
Securities Purchase Agreements [Member] | SSA Technologies LLC [Member]              
Related Party Transaction [Line Items]              
Acquired percentage 100.00%            
Convertible Promissory Note One [Member]              
Related Party Transaction [Line Items]              
Debt discount         659,967    
Convertible Promissory Note One [Member] | DBR Capital LLC [Member]              
Related Party Transaction [Line Items]              
Received proceeds from related party debt       $ 1,300,000      
Debt interest rate       20.00%      
Debt instrument maturity date       Apr. 27, 2030      
Debt conversion price per share   $ 0.007   $ 0.01257      
Beneficial conversion feature and debt discount       $ 1,300,000      
Debt discount into interest expense         32,037    
Interest expense         65,004    
Convertible Promissory Note Two [Member]              
Related Party Transaction [Line Items]              
Debt discount         358,309    
Convertible Promissory Note Two [Member] | DBR Capital LLC [Member]              
Related Party Transaction [Line Items]              
Received proceeds from related party debt     $ 700,000        
Debt interest rate     20.00%        
Debt instrument maturity date     Apr. 27, 2030        
Debt conversion price per share   $ 0.007 $ 0.01257        
Beneficial conversion feature and debt discount     $ 700,000        
Debt discount into interest expense         17,387    
Interest expense         35,001    
Convertible Promissory Note Three [Member]              
Related Party Transaction [Line Items]              
Debt discount         697,397    
Convertible Promissory Note Three [Member] | DBR Capital LLC [Member]              
Related Party Transaction [Line Items]              
Received proceeds from related party debt   $ 1,300,000          
Debt interest rate   38.50%          
Debt instrument maturity date   Apr. 27, 2030          
Beneficial conversion feature and debt discount   $ 1,300,000          
Debt discount into interest expense         33,861    
Interest expense         125,124    
Debt interest rate   25.00%          
Facility fee percentage   13.50%          
Working Capital Promissory Note [Member] | SSA Technologies LLC [Member] | Securities Purchase Agreements [Member]              
Related Party Transaction [Line Items]              
Debt interest rate 0.11%            
Interest expense         330   $ 990
Debt instrument face amount         $ 1,200,000    
Debt secured by common stock 12,000,000            
Working Capital Promissory Note [Member] | SSA Technologies LLC [Member] | Securities Purchase Agreements [Member] | Maximum [Member]              
Related Party Transaction [Line Items]              
Debt instrument face amount $ 1,500,000            
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.25.1
RELATED-PARTY TRANSACTIONS (Details Narrative) - USD ($)
3 Months Ended
Feb. 07, 2024
Sep. 29, 2023
Apr. 27, 2020
Mar. 31, 2025
Mar. 31, 2024
Related Party Transaction [Line Items]          
Consideration paid for purchased shares       $ 842,940 $ 842,940
DBR Capital LLC [Member] | Securities Purchase Agreements [Member]          
Related Party Transaction [Line Items]          
Related party transaction amounts of advance     $ 11,000,000    
Mario Romano and Annette Raynor [Member] | Stock Purchase and Release Agreement [Member]          
Related Party Transaction [Line Items]          
Number of shares repurchased   302,919,223      
Shares purchased value   $ 2,922,380      
Share price   $ 0.00964739      
Amount owed       793,095  
Legal fees   $ 250,000      
Consideration paid for purchased shares   2,922,380      
Consideration paid for purchased shares and expenses   $ 3,172,380      
Mario Romano and Annette Raynor [Member] | Stock Purchase and Release Agreement [Member] | Accounts Payable and Accrued Liabilities [Member]          
Related Party Transaction [Line Items]          
Amount owed       795,095  
Ryan Smith and Chand Miller [Member] | Stock Purchase and Release Agreement [Member]          
Related Party Transaction [Line Items]          
Amount owed       1,339,180  
Ryan Smith and Chand Miller [Member] | Stock Purchase and Release Agreement [Member] | Common Stock [Member]          
Related Party Transaction [Line Items]          
Consideration paid for purchased shares $ 3,571,146        
Shares purchased and cancelled 472,374,710        
Purchase price $ 3,571,146        
Purchase price per share $ 0.007559985        
Ryan Smith and Chand Miller [Member] | Stock Purchase and Release Agreement [Member] | Accounts Payable and Accrued Liabilities [Member]          
Related Party Transaction [Line Items]          
Amount owed       $ 1,339,180  
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DEBT (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Nonrelated Party [Member]    
Short-Term Debt [Line Items]    
Total debt $ 517,176 $ 519,863
Less: Current portion 29,244 29,244
Debt, long term portion 487,932 490,619
US Small Business Administration [Member]    
Short-Term Debt [Line Items]    
Total debt [1] $ 517,176 $ 519,863
[1] In April 2020 we received proceeds of $500,000 from a loan entered into with the U.S. Small Business Administration. Under the terms of the loan interest is to accrue at a rate of 3.75% per annum and installment payments of $2,437 monthly will begin twelve months from the date of the loan, with all interest and principal due and payable thirty years from the date of the loan. During the three months ended March 31, 2025, we recorded $4,623 worth of interest on the loan. During the three months ended March 31, 2025, we made repayments on the loan of $7,310.
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DEBT (Details) (Parenthetical) - US Small Business Administration [Member] - USD ($)
1 Months Ended 3 Months Ended
Apr. 30, 2020
Mar. 31, 2025
Short-Term Debt [Line Items]    
Proceeds from debt $ 500,000  
Debt instrument interest rate 3.75%  
Monthly installment payments $ 2,437  
Interest expense   $ 4,623
Repayments on loan   $ 7,310
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.25.1
DEBT (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2021
Dec. 31, 2023
Nov. 30, 2020
Defined Benefit Plan Disclosure [Line Items]          
Repayments of debt $ 7,310 $ 114,261      
Digital assets issued value $ 1,896,535 232,834   $ 585,632  
APEX Tex LLC [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Note amount         $ 19,089,500
Debt payment terms     The remaining notes were due December 31, 2024, and had a fixed monthly payment that is equal to 75% of the face value of the note, divided by 48 months. The monthly payments began the last day of January 2021 and continued until December 31, 2024, when the last monthly payment was made, along with a balloon payment equal to 25% of the face value of the note, to extinguish the debt    
Repayments of debt   106,950      
Digital assets issued value   $ 38,767      
APEX Tex LLC [Member] | Common Stock [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Shares issued for debt     48,000,000    
APEX Tex LLC [Member] | Preferred Stock [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Shares issued for debt     49,418    
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DERIVATIVE LIABILITY (Details) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Derivative liability $ 758  
Derivative liability recorded on new instruments  
Derivative liability reduced by warrant exercise  
(Gain) loss on fair value 2,095 $ (74)
Derivative liability $ 2,853  
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL (Details) - Warrant [Member]
Mar. 31, 2025
Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]  
Derivative [Line Items]  
Derivative liability measurement input 4.23
Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]  
Derivative [Line Items]  
Derivative liability measurement input 4.32
Measurement Input, Expected Term [Member] | Minimum [Member]  
Derivative [Line Items]  
Derivative liability measurement input 0.33
Measurement Input, Expected Term [Member] | Maximum [Member]  
Derivative [Line Items]  
Derivative liability measurement input 1.25
Measurement Input, Price Volatility [Member] | Minimum [Member]  
Derivative [Line Items]  
Derivative liability measurement input 132
Measurement Input, Price Volatility [Member] | Maximum [Member]  
Derivative [Line Items]  
Derivative liability measurement input 161
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Operating Lease    
Remainder of 2025 $ 126,962  
2026 61,057  
Total 188,019  
Less: Interest (14,526)  
Present value of lease liability 173,493  
Operating lease liability, current (140,112) [1] $ (165,707)
Operating lease liability, long term $ 33,381 $ 46,433
[1] Represents lease payments to be made in the next 12 months.
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.25.1
OPERATING LEASE (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Dec. 31, 2024
Nov. 30, 2024
Jul. 31, 2021
Mar. 31, 2025
Sep. 30, 2021
Lessee, Lease, Description [Line Items]          
Weighted average remaining lease term       1 year 3 months 7 days  
Operating lease right of use asset $ 211,996     $ 173,412  
Operating lease liability       173,493  
Operating lease expense       44,124  
Operating cash flows used for operating leases       $ 44,187  
Weighted average discount rate       12.00%  
Wyckoff Lease [Member]          
Lessee, Lease, Description [Line Items]          
Right-of-use assets obtained in exchange for new operating lease liabilities     $ 22,034 $ 23,520  
Weighted average remaining lease term     24 months 15 days    
Haverford Lease [Member]          
Lessee, Lease, Description [Line Items]          
Right-of-use assets obtained in exchange for new operating lease liabilities       $ 172,042  
Operating lease right of use asset         $ 125,522
Operating lease liability         $ 152,961
Warminster Lease [Member]          
Lessee, Lease, Description [Line Items]          
Right-of-use assets obtained in exchange for new operating lease liabilities   $ 108,327      
Weighted average remaining lease term   14 months      
Ivyland Lease [Member]          
Lessee, Lease, Description [Line Items]          
Right-of-use assets obtained in exchange for new operating lease liabilities $ 115,037        
Weighted average remaining lease term 24 months        
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF OPTIONS ACTIVITY (Details)
3 Months Ended
Mar. 31, 2025
$ / shares
shares
Equity [Abstract]  
Number of Options, Options outstanding, beginning | shares 351,416,665
Weighted Average Exercise Price, Options outstanding, beginning $ 0.05
Weighted Average Grant-Date Per Share Fair Value, Options outstanding beginning $ 0.03
Number of Options, Granted | shares
Weighted Average Exercise Price, Granted
Number of Options, Canceled/Expired | shares
Weighted Average Exercise Price, Canceled/Expired
Number of Options, Exercised | shares
Weighted Average Exercise Price, Exercised
Number of Options, Options outstanding, ending | shares 351,416,665
Weighted Average Exercise Price, Options outstanding, ending $ 0.05
Weighted Average Grant-Date Per Share Fair Value, Options outstanding ending $ 0.03
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF OPTIONS OUTSTANDING (Details)
3 Months Ended
Mar. 31, 2025
$ / shares
shares
Equity [Abstract]  
Options Exercisable | shares 233,116,665
Weighted Average Exercise Price of Options Exercisable | $ / shares $ 0.05
Weighted Average Contractual Life of Options Exercisable (Years) 4 years 2 months 26 days
Weighted Average Contractual Life of Options Outstanding (Years) 4 years 4 months 17 days
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF WARRANTS ISSUED (Details)
3 Months Ended
Mar. 31, 2025
$ / shares
shares
Equity [Abstract]  
Number of Warrants Outstanding, beginning | shares 1,178,090
Weighted Average Exercise Price Outstanding, beginning | $ / shares $ 0.10
Number of Warrants Granted | shares
Weighted Average Exercise Price Granted | $ / shares
Number of Warrants Canceled/Expired | shares
Weighted Average Exercise Price, Canceled/Expired | $ / shares
Number of Warrants Exercised | shares
Weighted Average Exercise Price Exercised | $ / shares
Number of Warrants Outstanding, ending | shares 1,178,090
Weighted Average Exercise Price Outstanding, ending | $ / shares $ 0.10
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF WARRANTS OUTSTANDING (Details)
Mar. 31, 2025
shares
Equity [Abstract]  
Warrants Exercisable 1,178,090
Weighted Average Contractual Life (Years) 10 months 20 days
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY (DEFICIT) (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Sep. 03, 2021
Aug. 17, 2021
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2021
Mar. 06, 2025
Dec. 31, 2024
Class of Stock [Line Items]              
Preferred stock, shares authorized     50,000,000       50,000,000
Preferred stock par value     $ 0.001       $ 0.001
Preferred stock, shares issued     252,192       252,192
Preferred stock, shares outstanding     252,192       252,192
Dividend liability     $ 247,437       $ 245,101
Par value of shares repurchased     $ 0.001       $ 0.001
Consideration payable for purchased shares and expenses     $ 3,571,146      
Common stock, shares issued     1,859,231,786       1,859,231,786
Common stock, shares outstanding     1,858,142,500       1,859,231,786
Common stock reserves for issuance     600,000,000        
Stock compensation expense     $ 387,634 422,250      
Unrecognized compensation cost     $ 2,900,000        
Weighted average period for recognition     1 year 6 months        
Investview Financial Group Holding LLC [Member]              
Class of Stock [Line Items]              
Converted market value $ 58,900,000            
Closing market price per share $ 0.1532            
Transaction cost $ 86,600,000            
Fair value discounted percentage 32.00%            
Business acquisition, transaction costs discount value $ 27,700,000            
Number of exchange shares issuable 565,000,000            
Stock Repurchase Program [Member]              
Class of Stock [Line Items]              
Consideration payable for purchased shares and expenses     $ 3,124,755        
Stock-based compensation       $ 8,510      
Stock Repurchase Program [Member] | Common Stock [Member]              
Class of Stock [Line Items]              
Value of shares authorized for repurchase           $ 1,000,000  
Par value of shares repurchased           $ 0.001  
Number of shares repurchased     1,089,286 472,374,710      
Value of shares repurchased     $ 24,006        
Exchange for cash       $ 446,391      
Unit Offering [Member]              
Class of Stock [Line Items]              
Number of shares issued in transaction   252,192     2,000,000    
Sale of stock, price per share         $ 25    
Description of offering         (i) one share of our newly authorized Series B Preferred Stock and (ii) five warrants each exercisable to purchase one share of common stock at an exercise price of $0.10 per warrant share. Each Warrant offered is immediately exercisable on the date of issuance, will expire 5 years from the date of issuance, and its value has been classified as a fair value liability due to the terms of the instrument (see NOTE 8).    
Series B Preferred Stock [Member]              
Class of Stock [Line Items]              
Preferred stock par value     $ 25        
Preferred stock designated     2,000,000        
Cumulative dividends annual rate percentage     13.00%        
Preferred stock, dividend price per share     $ 3.25        
Dividends, cash     $ 204,835 204,835      
Dividends paid in cash     161,854 174,760      
Digital assets issued for dividend payment     $ 40,645 $ 40,170      
Class B Units [Member] | Investview Financial Group Holding LLC [Member]              
Class of Stock [Line Items]              
Units, issued     565,000,000       565,000,000
Units, outstanding     565,000,000       565,000,000
Conversion description     The Class B Redeemable Units have no voting rights but can be exchanged at any time, within 5 years from the date of issuance, for 565,000,000 shares of our common stock on a one-for-one basis and are subject to significant restrictions upon resale through 2025 under the terms of a lock up agreement entered into as part of the purchase agreement.        
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.25.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Jan. 17, 2025
Dec. 31, 2024
Aug. 31, 2023
Jun. 30, 2020
Jun. 20, 2020
Mar. 31, 2025
Mar. 31, 2024
Sep. 21, 2021
Mar. 30, 2021
Product Liability Contingency [Line Items]                  
Penalty amount paid $ 375,000                
Repayment of debt           $ 7,310 $ 114,261    
Distribution of digital currencies prior to termination     $ 16,600,000            
Receivable balance   $ 2,534,727       2,231,577      
Credit card receivables           $ 1,870,000      
Joseph Cammarata [Member]                  
Product Liability Contingency [Line Items]                  
Debt instrument, principal amount                 $ 1,550,000
Debt conversion price per share               $ 0.008 $ 0.02
Debt conversion description           As of the date of this Report, Mr. Cammarata has not accepted our tender of the cash payment, and through his then counsel, has asserted his entitlement to exercise his right to convert the Cammarata Note into our common shares. Although we believe that our cash tender was appropriate under the terms of the Cammarata Note and our claims for damages by Mr. Cammarata have merit, if Mr. Cammarata elects to challenge our cash tender in a court proceeding, and if we are unable to sustain our legal position on the matter, Mr. Cammarata could receive up to approximately 203 million shares of our common stock upon conversion of the Cammarata Note. As a result of his recent incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata.      
iGenius, LLC [Member] | Credit Card [Member]                  
Product Liability Contingency [Line Items]                  
Receivable balance           $ 2,110,000      
Promissory Note [Member]                  
Product Liability Contingency [Line Items]                  
Notes issued value       $ 19,000,000          
Notes maturity date       Dec. 31, 2024          
Debt premium percentage         25.00%        
Repayment of debt   $ 19,000,000              
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE (Details) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Revenue $ 10,030,052 $ 15,671,917
Commissions 5,076,503 7,275,210
Salary and related 1,701,092 1,628,970
Selling and marketing 95,103 11,795
Depreciation 224,302 1,178,430
General and administrative 1,416,168 2,336,655
Net income (loss) from operations (413,080) 1,870,424
Reportable Subsegments [Member]    
Segment Reporting Information [Line Items]    
Revenue 10,030,052 15,671,917
Commissions 5,076,503 7,275,210
Market experts 174,520 260,250
Credit card processing 407,025 607,234
Salary and related 842,485 885,613
Selling and marketing 94,912 10,922
Energy and hosting 1,037,599 1,882,084
Depreciation 189,872 1,177,796
Cost of sales 331,998  
General and administrative 888,213 [1] 331,936 [2]
Net income (loss) from operations 986,925 3,240,872
Reportable Subsegments [Member] | Financial Education and Technology [Member]    
Segment Reporting Information [Line Items]    
Revenue 8,791,443 13,029,318
Commissions 5,076,503 7,275,210
Market experts 174,520 260,250
Credit card processing 407,025 607,234
Salary and related 410,290 599,111
Selling and marketing 87,819 10,770
Energy and hosting
Depreciation 450
Cost of sales  
General and administrative 489,357 [1] 255,641 [2]
Net income (loss) from operations 2,145,479 4,021,102
Reportable Subsegments [Member] | Blockchain Technology and Crypto Mining Products and Services [Member]    
Segment Reporting Information [Line Items]    
Revenue 862,944 2,642,599
Commissions
Market experts
Credit card processing
Salary and related 134,103 286,502
Selling and marketing 152
Energy and hosting 1,037,599 1,882,084
Depreciation 189,422 1,177,796
Cost of sales  
General and administrative 129,945 [1] 76,295 [2]
Net income (loss) from operations (628,125) $ (780,230)
Reportable Subsegments [Member] | Manufacturing and Development of Health Beauty and Wellness Products [Member]    
Segment Reporting Information [Line Items]    
Revenue [3] 375,665  
Commissions [3]  
Market experts [3]  
Credit card processing [3]  
Salary and related [3] 298,092  
Selling and marketing [3] 7,093  
Energy and hosting [3]  
Depreciation [3]  
Cost of sales [3] 331,998  
General and administrative [1],[3] 268,911  
Net income (loss) from operations [3] $ (530,429)  
[1] General and administrative costs consist mainly of professional fees, insurance, information technology and software and other payment processing fees.
[2] General and administrative costs consist mainly of professional fees, contracting services, equipment, shipping and tariffs, insurance and information technology and software.
[3] The Development of Health, Beauty and Wellness Products business was acquired in October 2024.
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES (Details) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Income (loss) before income taxes $ (677,853) $ 2,170,015
Reportable Subsegments [Member]    
Segment Reporting Information [Line Items]    
Segment income from operations 986,925 3,240,872
Bank interest 44,283 4,338
Event ticket sales 38,553
Leasing income 63,244 167,500
All other, net 5,583 3,531
Income (loss) before income taxes $ 1,138,588 $ 3,416,241
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT REPORTING (Details Narrative)
3 Months Ended
Mar. 31, 2025
Segment
Segment Reporting [Abstract]  
Number of reportable segments 3
Description of Products and Services Financial Education and Technology, Blockchain Technology and Crypto Mining Products and Services, and Manufacturing and Development of Health, Beauty and Wellness Products. The reportable segments are identified based on the types of products that generate revenue.
XML 77 R66.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Oct. 11, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]      
Cash     $ 1,495
Customer deposits – intercompany     7,360
Domain names [1]     40,310
Raw materials     149,260
Manufacturing equipment     717,020
Total assets acquired     915,445
Accounts payable     323
Customer deposits     572,386
Total liabilities assumed     572,709
Net assets acquired     342,736
Consideration [2]     1,207,614
Fair value of noncontrolling interest in ELRT Technologies, LLC     8,823
Total     1,216,437
Goodwill $ 873,701 $ 873,701 $ 873,701
[1] Domain names were deemed to have an indefinite life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy.
[2] This amount is equal to the $1,780,000 purchase price less $572,386 of customer deposits collected by Renu Labs, Inc. prior to acquisition.
XML 78 R67.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) (Parenthetical)
Oct. 11, 2024
USD ($)
Customer deposits $ (572,386)
Renu Laboratories, Inc [Member]  
Purchase price 1,780,000
Customer deposits $ 572,386
XML 79 R68.htm IDEA: XBRL DOCUMENT v3.25.1
ACQUISITION (Details Narrative)
Oct. 11, 2024
USD ($)
Renu Laboratories, Inc [Member]  
Business Acquisition [Line Items]  
Purchase price $ 1,780,000
Goldman's Pharmaceuticals LLC [Member]  
Business Acquisition [Line Items]  
Ownership interest, percentage 100.00%
ELRT Technologies, LLC [Member]  
Business Acquisition [Line Items]  
Ownership interest, percentage 50.00%
XML 80 R69.htm IDEA: XBRL DOCUMENT v3.25.1
INCOME TAXES (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Tax Disclosure [Abstract]    
Income tax provision $ 10,000 $ 500,075
Effective tax rate 1.50% 23.00%
XML 81 R70.htm IDEA: XBRL DOCUMENT v3.25.1
SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - Stock Repurchase Program [Member] - Treasury Stock, Common [Member]
1 Months Ended
May 14, 2025
USD ($)
shares
Subsequent Event [Line Items]  
Number of shares bought back | shares 282,000
Value of shares bought back | $ $ 3,634
EXCEL 82 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 83 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 84 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 86 FilingSummary.xml IDEA: XBRL DOCUMENT 3.25.1 html 204 362 1 true 79 0 false 7 false false R1.htm 00000001 - Document - Cover Sheet http://investview.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://investview.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://investview.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited) Sheet http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) Sheet http://investview.com/role/StatementsOfStockholdersEquityDeficit Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://investview.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 999012 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS Sheet http://investview.com/role/OrganizationAndNatureOfBusiness ORGANIZATION AND NATURE OF BUSINESS Notes 9 false false R10.htm 999013 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://investview.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 999014 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS Sheet http://investview.com/role/RecentAccountingPronouncements RECENT ACCOUNTING PRONOUNCEMENTS Notes 11 false false R12.htm 999015 - Disclosure - LIQUIDITY Sheet http://investview.com/role/Liquidity LIQUIDITY Notes 12 false false R13.htm 999016 - Disclosure - DIGITAL ASSETS Sheet http://investview.com/role/DigitalAssets DIGITAL ASSETS Notes 13 false false R14.htm 999017 - Disclosure - RELATED-PARTY TRANSACTIONS Sheet http://investview.com/role/Related-partyTransactions RELATED-PARTY TRANSACTIONS Notes 14 false false R15.htm 999018 - Disclosure - DEBT Sheet http://investview.com/role/Debt DEBT Notes 15 false false R16.htm 999019 - Disclosure - DERIVATIVE LIABILITY Sheet http://investview.com/role/DerivativeLiability DERIVATIVE LIABILITY Notes 16 false false R17.htm 999020 - Disclosure - OPERATING LEASE Sheet http://investview.com/role/OperatingLease OPERATING LEASE Notes 17 false false R18.htm 999021 - Disclosure - STOCKHOLDERS??? EQUITY (DEFICIT) Sheet http://investview.com/role/StockholdersEquityDeficit STOCKHOLDERS??? EQUITY (DEFICIT) Notes 18 false false R19.htm 999022 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://investview.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 19 false false R20.htm 999023 - Disclosure - SEGMENT REPORTING Sheet http://investview.com/role/SegmentReporting SEGMENT REPORTING Notes 20 false false R21.htm 999024 - Disclosure - ACQUISITION Sheet http://investview.com/role/Acquisition ACQUISITION Notes 21 false false R22.htm 999025 - Disclosure - INCOME TAXES Sheet http://investview.com/role/IncomeTaxes INCOME TAXES Notes 22 false false R23.htm 999026 - Disclosure - SUBSEQUENT EVENTS Sheet http://investview.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 23 false false R24.htm 999027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 24 false false R25.htm 999028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://investview.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://investview.com/role/SummaryOfSignificantAccountingPolicies 25 false false R26.htm 999029 - Disclosure - DIGITAL ASSETS (Tables) Sheet http://investview.com/role/DigitalAssetsTables DIGITAL ASSETS (Tables) Tables http://investview.com/role/DigitalAssets 26 false false R27.htm 999030 - Disclosure - RELATED-PARTY TRANSACTIONS (Tables) Sheet http://investview.com/role/Related-partyTransactionsTables RELATED-PARTY TRANSACTIONS (Tables) Tables http://investview.com/role/Related-partyTransactions 27 false false R28.htm 999031 - Disclosure - DEBT (Tables) Sheet http://investview.com/role/DebtTables DEBT (Tables) Tables http://investview.com/role/Debt 28 false false R29.htm 999032 - Disclosure - DERIVATIVE LIABILITY (Tables) Sheet http://investview.com/role/DerivativeLiabilityTables DERIVATIVE LIABILITY (Tables) Tables http://investview.com/role/DerivativeLiability 29 false false R30.htm 999033 - Disclosure - OPERATING LEASE (Tables) Sheet http://investview.com/role/OperatingLeaseTables OPERATING LEASE (Tables) Tables http://investview.com/role/OperatingLease 30 false false R31.htm 999034 - Disclosure - STOCKHOLDERS??? EQUITY (DEFICIT) (Tables) Sheet http://investview.com/role/StockholdersEquityDeficitTables STOCKHOLDERS??? EQUITY (DEFICIT) (Tables) Tables http://investview.com/role/StockholdersEquityDeficit 31 false false R32.htm 999035 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://investview.com/role/SegmentReportingTables SEGMENT REPORTING (Tables) Tables http://investview.com/role/SegmentReporting 32 false false R33.htm 999036 - Disclosure - ACQUISITION (Tables) Sheet http://investview.com/role/AcquisitionTables ACQUISITION (Tables) Tables http://investview.com/role/Acquisition 33 false false R34.htm 999037 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) Sheet http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) Details http://investview.com/role/OrganizationAndNatureOfBusiness 34 false false R35.htm 999038 - Disclosure - SCHEDULE OF RECEIVABLES (Details) Sheet http://investview.com/role/ScheduleOfReceivablesDetails SCHEDULE OF RECEIVABLES (Details) Details 35 false false R36.htm 999039 - Disclosure - SCHEDULE OF FIXED ASSETS (Details) Sheet http://investview.com/role/ScheduleOfFixedAssetsDetails SCHEDULE OF FIXED ASSETS (Details) Details 36 false false R37.htm 999040 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) Sheet http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) Details 37 false false R38.htm 999041 - Disclosure - SCHEDULE OF REVENUE GENERATED (Details) Sheet http://investview.com/role/ScheduleOfRevenueGeneratedDetails SCHEDULE OF REVENUE GENERATED (Details) Details 38 false false R39.htm 999042 - Disclosure - SCHEDULE OF INVENTORY (Details) Sheet http://investview.com/role/ScheduleOfInventoryDetails SCHEDULE OF INVENTORY (Details) Details 39 false false R40.htm 999043 - Disclosure - SCHEDULE OF DILUTED EARNINGS PER SHARE (Details) Sheet http://investview.com/role/ScheduleOfDilutedEarningsPerShareDetails SCHEDULE OF DILUTED EARNINGS PER SHARE (Details) Details 40 false false R41.htm 999044 - Disclosure - SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details) Sheet http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details) Details 41 false false R42.htm 999045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://investview.com/role/SummaryOfSignificantAccountingPoliciesTables 42 false false R43.htm 999046 - Disclosure - LIQUIDITY (Details Narrative) Sheet http://investview.com/role/LiquidityDetailsNarrative LIQUIDITY (Details Narrative) Details http://investview.com/role/Liquidity 43 false false R44.htm 999047 - Disclosure - SCHEDULE OF DIGITAL ASSETS (Details) Sheet http://investview.com/role/ScheduleOfDigitalAssetsDetails SCHEDULE OF DIGITAL ASSETS (Details) Details 44 false false R45.htm 999048 - Disclosure - SCHEDULE OF DIGITAL ASSETS ACTIVITY (Details) Sheet http://investview.com/role/ScheduleOfDigitalAssetsActivityDetails SCHEDULE OF DIGITAL ASSETS ACTIVITY (Details) Details 45 false false R46.htm 999049 - Disclosure - DIGITAL ASSETS (Details Narrative) Sheet http://investview.com/role/DigitalAssetsDetailsNarrative DIGITAL ASSETS (Details Narrative) Details http://investview.com/role/DigitalAssetsTables 46 false false R47.htm 999050 - Disclosure - SCHEDULE OF RELATED PARTY PAYABLES (Details) Sheet http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails SCHEDULE OF RELATED PARTY PAYABLES (Details) Details 47 false false R48.htm 999051 - Disclosure - SCHEDULE OF RELATED PARTY PAYABLES (Details) (Parenthetical) Sheet http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical SCHEDULE OF RELATED PARTY PAYABLES (Details) (Parenthetical) Details 48 false false R49.htm 999052 - Disclosure - RELATED-PARTY TRANSACTIONS (Details Narrative) Sheet http://investview.com/role/Related-partyTransactionsDetailsNarrative RELATED-PARTY TRANSACTIONS (Details Narrative) Details http://investview.com/role/Related-partyTransactionsTables 49 false false R50.htm 999053 - Disclosure - SCHEDULE OF DEBT (Details) Sheet http://investview.com/role/ScheduleOfDebtDetails SCHEDULE OF DEBT (Details) Details 50 false false R51.htm 999054 - Disclosure - SCHEDULE OF DEBT (Details) (Parenthetical) Sheet http://investview.com/role/ScheduleOfDebtDetailsParenthetical SCHEDULE OF DEBT (Details) (Parenthetical) Details 51 false false R52.htm 999055 - Disclosure - DEBT (Details Narrative) Sheet http://investview.com/role/DebtDetailsNarrative DEBT (Details Narrative) Details http://investview.com/role/DebtTables 52 false false R53.htm 999056 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITY (Details) Sheet http://investview.com/role/ScheduleOfDerivativeLiabilityDetails SCHEDULE OF DERIVATIVE LIABILITY (Details) Details 53 false false R54.htm 999057 - Disclosure - SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL (Details) Sheet http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL (Details) Details 54 false false R55.htm 999058 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details) Sheet http://investview.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details) Details 55 false false R56.htm 999059 - Disclosure - OPERATING LEASE (Details Narrative) Sheet http://investview.com/role/OperatingLeaseDetailsNarrative OPERATING LEASE (Details Narrative) Details http://investview.com/role/OperatingLeaseTables 56 false false R57.htm 999060 - Disclosure - SCHEDULE OF OPTIONS ACTIVITY (Details) Sheet http://investview.com/role/ScheduleOfOptionsActivityDetails SCHEDULE OF OPTIONS ACTIVITY (Details) Details 57 false false R58.htm 999061 - Disclosure - SCHEDULE OF OPTIONS OUTSTANDING (Details) Sheet http://investview.com/role/ScheduleOfOptionsOutstandingDetails SCHEDULE OF OPTIONS OUTSTANDING (Details) Details 58 false false R59.htm 999062 - Disclosure - SCHEDULE OF WARRANTS ISSUED (Details) Sheet http://investview.com/role/ScheduleOfWarrantsIssuedDetails SCHEDULE OF WARRANTS ISSUED (Details) Details 59 false false R60.htm 999063 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details) Sheet http://investview.com/role/ScheduleOfWarrantsOutstandingDetails SCHEDULE OF WARRANTS OUTSTANDING (Details) Details 60 false false R61.htm 999064 - Disclosure - STOCKHOLDERS??? EQUITY (DEFICIT) (Details Narrative) Sheet http://investview.com/role/StockholdersEquityDeficitDetailsNarrative STOCKHOLDERS??? EQUITY (DEFICIT) (Details Narrative) Details http://investview.com/role/StockholdersEquityDeficitTables 61 false false R62.htm 999065 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://investview.com/role/CommitmentsAndContingencies 62 false false R63.htm 999066 - Disclosure - SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE (Details) Sheet http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE (Details) Details 63 false false R64.htm 999067 - Disclosure - SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES (Details) Sheet http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES (Details) Details 64 false false R65.htm 999068 - Disclosure - SEGMENT REPORTING (Details Narrative) Sheet http://investview.com/role/SegmentReportingDetailsNarrative SEGMENT REPORTING (Details Narrative) Details http://investview.com/role/SegmentReportingTables 65 false false R66.htm 999069 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) Sheet http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) Details 66 false false R67.htm 999070 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) (Parenthetical) Sheet http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetailsParenthetical SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) (Parenthetical) Details 67 false false R68.htm 999071 - Disclosure - ACQUISITION (Details Narrative) Sheet http://investview.com/role/AcquisitionDetailsNarrative ACQUISITION (Details Narrative) Details http://investview.com/role/AcquisitionTables 68 false false R69.htm 999072 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://investview.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://investview.com/role/IncomeTaxes 69 false false R70.htm 999073 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://investview.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://investview.com/role/SubsequentEvents 70 false false All Reports Book All Reports form10-q.htm invu-20250331.xsd invu-20250331_cal.xml invu-20250331_def.xml invu-20250331_lab.xml invu-20250331_pre.xml http://fasb.org/srt/2024 http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 88 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-q.htm": { "nsprefix": "INVU", "nsuri": "http://investview.com/20250331", "dts": { "inline": { "local": [ "form10-q.htm" ] }, "schema": { "local": [ "invu-20250331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "invu-20250331_cal.xml" ] }, "definitionLink": { "local": [ "invu-20250331_def.xml" ] }, "labelLink": { "local": [ "invu-20250331_lab.xml" ] }, "presentationLink": { "local": [ "invu-20250331_pre.xml" ] } }, "keyStandard": 320, "keyCustom": 42, "axisStandard": 27, "axisCustom": 0, "memberStandard": 27, "memberCustom": 45, "hidden": { "total": 132, "http://investview.com/20250331": 24, "http://fasb.org/us-gaap/2024": 104, "http://xbrl.sec.gov/dei/2024": 4 }, "contextCount": 204, "entityCount": 1, "segmentCount": 79, "elementCount": 670, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 824, "http://xbrl.sec.gov/dei/2024": 29, "http://xbrl.sec.gov/ecd/2024": 4, "http://fasb.org/srt/2024": 1 }, "report": { "R1": { "role": "http://investview.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R2": { "role": "http://investview.com/role/BalanceSheets", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:PrepaidExpenseCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R3": { "role": "http://investview.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R4": { "role": "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited)", "shortName": "Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ProfessionalFees", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R5": { "role": "http://investview.com/role/StatementsOfStockholdersEquityDeficit", "longName": "00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)", "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_PreferredStockMember", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_PreferredStockMember", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R6": { "role": "http://investview.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R7": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R8": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R9": { "role": "http://investview.com/role/OrganizationAndNatureOfBusiness", "longName": "999012 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS", "shortName": "ORGANIZATION AND NATURE OF BUSINESS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R10": { "role": "http://investview.com/role/SummaryOfSignificantAccountingPolicies", "longName": "999013 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R11": { "role": "http://investview.com/role/RecentAccountingPronouncements", "longName": "999014 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS", "shortName": "RECENT ACCOUNTING PRONOUNCEMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R12": { "role": "http://investview.com/role/Liquidity", "longName": "999015 - Disclosure - LIQUIDITY", "shortName": "LIQUIDITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R13": { "role": "http://investview.com/role/DigitalAssets", "longName": "999016 - Disclosure - DIGITAL ASSETS", "shortName": "DIGITAL ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:CryptoAssetTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:CryptoAssetTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R14": { "role": "http://investview.com/role/Related-partyTransactions", "longName": "999017 - Disclosure - RELATED-PARTY TRANSACTIONS", "shortName": "RELATED-PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R15": { "role": "http://investview.com/role/Debt", "longName": "999018 - Disclosure - DEBT", "shortName": "DEBT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R16": { "role": "http://investview.com/role/DerivativeLiability", "longName": "999019 - Disclosure - DERIVATIVE LIABILITY", "shortName": "DERIVATIVE LIABILITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R17": { "role": "http://investview.com/role/OperatingLease", "longName": "999020 - Disclosure - OPERATING LEASE", "shortName": "OPERATING LEASE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R18": { "role": "http://investview.com/role/StockholdersEquityDeficit", "longName": "999021 - Disclosure - STOCKHOLDERS\u2019 EQUITY (DEFICIT)", "shortName": "STOCKHOLDERS\u2019 EQUITY (DEFICIT)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R19": { "role": "http://investview.com/role/CommitmentsAndContingencies", "longName": "999022 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R20": { "role": "http://investview.com/role/SegmentReporting", "longName": "999023 - Disclosure - SEGMENT REPORTING", "shortName": "SEGMENT REPORTING", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R21": { "role": "http://investview.com/role/Acquisition", "longName": "999024 - Disclosure - ACQUISITION", "shortName": "ACQUISITION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R22": { "role": "http://investview.com/role/IncomeTaxes", "longName": "999025 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R23": { "role": "http://investview.com/role/SubsequentEvents", "longName": "999026 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R24": { "role": "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "999027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "24", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R25": { "role": "http://investview.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "999028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R26": { "role": "http://investview.com/role/DigitalAssetsTables", "longName": "999029 - Disclosure - DIGITAL ASSETS (Tables)", "shortName": "DIGITAL ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:CryptoAssetHoldingTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CryptoAssetTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:CryptoAssetHoldingTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CryptoAssetTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R27": { "role": "http://investview.com/role/Related-partyTransactionsTables", "longName": "999030 - Disclosure - RELATED-PARTY TRANSACTIONS (Tables)", "shortName": "RELATED-PARTY TRANSACTIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R28": { "role": "http://investview.com/role/DebtTables", "longName": "999031 - Disclosure - DEBT (Tables)", "shortName": "DEBT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R29": { "role": "http://investview.com/role/DerivativeLiabilityTables", "longName": "999032 - Disclosure - DERIVATIVE LIABILITY (Tables)", "shortName": "DERIVATIVE LIABILITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R30": { "role": "http://investview.com/role/OperatingLeaseTables", "longName": "999033 - Disclosure - OPERATING LEASE (Tables)", "shortName": "OPERATING LEASE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R31": { "role": "http://investview.com/role/StockholdersEquityDeficitTables", "longName": "999034 - Disclosure - STOCKHOLDERS\u2019 EQUITY (DEFICIT) (Tables)", "shortName": "STOCKHOLDERS\u2019 EQUITY (DEFICIT) (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R32": { "role": "http://investview.com/role/SegmentReportingTables", "longName": "999035 - Disclosure - SEGMENT REPORTING (Tables)", "shortName": "SEGMENT REPORTING (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R33": { "role": "http://investview.com/role/AcquisitionTables", "longName": "999036 - Disclosure - ACQUISITION (Tables)", "shortName": "ACQUISITION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R34": { "role": "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "longName": "999037 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative)", "shortName": "ORGANIZATION AND NATURE OF BUSINESS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "dei:EntityIncorporationDateOfIncorporation", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "dei:EntityIncorporationDateOfIncorporation", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R35": { "role": "http://investview.com/role/ScheduleOfReceivablesDetails", "longName": "999038 - Disclosure - SCHEDULE OF RECEIVABLES (Details)", "shortName": "SCHEDULE OF RECEIVABLES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "INVU:DueFromMerchantProcessors", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock", "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "INVU:DueFromMerchantProcessors", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock", "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R36": { "role": "http://investview.com/role/ScheduleOfFixedAssetsDetails", "longName": "999039 - Disclosure - SCHEDULE OF FIXED ASSETS (Details)", "shortName": "SCHEDULE OF FIXED ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R37": { "role": "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "longName": "999040 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)", "shortName": "SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:CryptoAssetFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:CryptoAssetHoldingTableTextBlock", "us-gaap:CryptoAssetTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31_us-gaap_FairValueMeasurementsRecurringMember", "name": "us-gaap:CryptoAssetFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R38": { "role": "http://investview.com/role/ScheduleOfRevenueGeneratedDetails", "longName": "999041 - Disclosure - SCHEDULE OF REVENUE GENERATED (Details)", "shortName": "SCHEDULE OF REVENUE GENERATED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "INVU:GrossBillingsReceipts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "INVU:GrossBillingsReceipts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R39": { "role": "http://investview.com/role/ScheduleOfInventoryDetails", "longName": "999042 - Disclosure - SCHEDULE OF INVENTORY (Details)", "shortName": "SCHEDULE OF INVENTORY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:InventoryFinishedGoods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:InventoryFinishedGoods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R40": { "role": "http://investview.com/role/ScheduleOfDilutedEarningsPerShareDetails", "longName": "999043 - Disclosure - SCHEDULE OF DILUTED EARNINGS PER SHARE (Details)", "shortName": "SCHEDULE OF DILUTED EARNINGS PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31", "name": "us-gaap:InterestOnConvertibleDebtNetOfTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R41": { "role": "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails", "longName": "999044 - Disclosure - SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details)", "shortName": "SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "From2025-01-012025-03-31_us-gaap_EmployeeStockOptionMember", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-03-31_us-gaap_EmployeeStockOptionMember", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R42": { "role": "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "999045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "Segment", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:CashFDICInsuredAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R43": { "role": "http://investview.com/role/LiquidityDetailsNarrative", "longName": "999046 - Disclosure - LIQUIDITY (Details Narrative)", "shortName": "LIQUIDITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R44": { "role": "http://investview.com/role/ScheduleOfDigitalAssetsDetails", "longName": "999047 - Disclosure - SCHEDULE OF DIGITAL ASSETS (Details)", "shortName": "SCHEDULE OF DIGITAL ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:CryptoAssetCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:CryptoAssetHoldingTableTextBlock", "us-gaap:CryptoAssetTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31_custom_BitcoinMember", "name": "INVU:CryptoAssetsNumberOfUnits", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:CryptoAssetHoldingTableTextBlock", "us-gaap:CryptoAssetTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R45": { "role": "http://investview.com/role/ScheduleOfDigitalAssetsActivityDetails", "longName": "999048 - Disclosure - SCHEDULE OF DIGITAL ASSETS ACTIVITY (Details)", "shortName": "SCHEDULE OF DIGITAL ASSETS ACTIVITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CryptoAssetFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:CryptoAssetActivityTableTextBlock", "us-gaap:CryptoAssetTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R46": { "role": "http://investview.com/role/DigitalAssetsDetailsNarrative", "longName": "999049 - Disclosure - DIGITAL ASSETS (Details Narrative)", "shortName": "DIGITAL ASSETS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "From2025-01-012025-01-01", "name": "us-gaap:CryptoAssetPeriodIncreaseDecrease", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CryptoAssetTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-01-01", "name": "us-gaap:CryptoAssetPeriodIncreaseDecrease", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CryptoAssetTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R47": { "role": "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails", "longName": "999050 - Disclosure - SCHEDULE OF RELATED PARTY PAYABLES (Details)", "shortName": "SCHEDULE OF RELATED PARTY PAYABLES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "AsOf2025-03-31_us-gaap_RelatedPartyMember", "name": "us-gaap:ConvertibleNotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31_us-gaap_RelatedPartyMember", "name": "us-gaap:ConvertibleNotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R48": { "role": "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "longName": "999051 - Disclosure - SCHEDULE OF RELATED PARTY PAYABLES (Details) (Parenthetical)", "shortName": "SCHEDULE OF RELATED PARTY PAYABLES (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:AmortizationOfDebtDiscountPremium", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-03-22_custom_SecuritiesPurchaseAgreementsMember_custom_SSATechnologiesLLCMember", "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "link:footnote", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R49": { "role": "http://investview.com/role/Related-partyTransactionsDetailsNarrative", "longName": "999052 - Disclosure - RELATED-PARTY TRANSACTIONS (Details Narrative)", "shortName": "RELATED-PARTY TRANSACTIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:PaymentsForRepurchaseOfEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2020-04-272020-04-27_custom_DBRCapitalLLCMember_custom_SecuritiesPurchaseAgreementsMember", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R50": { "role": "http://investview.com/role/ScheduleOfDebtDetails", "longName": "999053 - Disclosure - SCHEDULE OF DEBT (Details)", "shortName": "SCHEDULE OF DEBT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "AsOf2025-03-31_us-gaap_NonrelatedPartyMember", "name": "us-gaap:ConvertibleNotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31_us-gaap_NonrelatedPartyMember", "name": "us-gaap:ConvertibleNotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R51": { "role": "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "longName": "999054 - Disclosure - SCHEDULE OF DEBT (Details) (Parenthetical)", "shortName": " SCHEDULE OF DEBT (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "From2020-04-012020-04-30_custom_USSmallBusinessAdministrationMember", "name": "us-gaap:ProceedsFromConvertibleDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "link:footnote", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2020-04-012020-04-30_custom_USSmallBusinessAdministrationMember", "name": "us-gaap:ProceedsFromConvertibleDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "link:footnote", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R52": { "role": "http://investview.com/role/DebtDetailsNarrative", "longName": "999055 - Disclosure - DEBT (Details Narrative)", "shortName": "DEBT (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:RepaymentsOfDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-11-30_custom_APEXTexLLCMember", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R53": { "role": "http://investview.com/role/ScheduleOfDerivativeLiabilityDetails", "longName": "999056 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITY (Details)", "shortName": "SCHEDULE OF DERIVATIVE LIABILITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:DerivativeLiabilitiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R54": { "role": "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails", "longName": "999057 - Disclosure - SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL (Details)", "shortName": "SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "AsOf2025-03-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember_us-gaap_WarrantMember", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember_us-gaap_WarrantMember", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R55": { "role": "http://investview.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails", "longName": "999058 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details)", "shortName": "SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R56": { "role": "http://investview.com/role/OperatingLeaseDetailsNarrative", "longName": "999059 - Disclosure - OPERATING LEASE (Details Narrative)", "shortName": "OPERATING LEASE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R57": { "role": "http://investview.com/role/ScheduleOfOptionsActivityDetails", "longName": "999060 - Disclosure - SCHEDULE OF OPTIONS ACTIVITY (Details)", "shortName": "SCHEDULE OF OPTIONS ACTIVITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R58": { "role": "http://investview.com/role/ScheduleOfOptionsOutstandingDetails", "longName": "999061 - Disclosure - SCHEDULE OF OPTIONS OUTSTANDING (Details)", "shortName": "SCHEDULE OF OPTIONS OUTSTANDING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R59": { "role": "http://investview.com/role/ScheduleOfWarrantsIssuedDetails", "longName": "999062 - Disclosure - SCHEDULE OF WARRANTS ISSUED (Details)", "shortName": "SCHEDULE OF WARRANTS ISSUED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R60": { "role": "http://investview.com/role/ScheduleOfWarrantsOutstandingDetails", "longName": "999063 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details)", "shortName": "SCHEDULE OF WARRANTS OUTSTANDING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "INVU:SummaryOfWarrantsOutstandingTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "INVU:SummaryOfWarrantsOutstandingTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R61": { "role": "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative", "longName": "999064 - Disclosure - STOCKHOLDERS\u2019 EQUITY (DEFICIT) (Details Narrative)", "shortName": "STOCKHOLDERS\u2019 EQUITY (DEFICIT) (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:DividendsPayableCurrentAndNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R62": { "role": "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "longName": "999065 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "From2025-01-172025-01-17", "name": "us-gaap:LitigationSettlementExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-172025-01-17", "name": "us-gaap:LitigationSettlementExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R63": { "role": "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails", "longName": "999066 - Disclosure - SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE (Details)", "shortName": "SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-03-31_us-gaap_ReportableSubsegmentsMember", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R64": { "role": "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails", "longName": "999067 - Disclosure - SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES (Details)", "shortName": "SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-03-31_us-gaap_ReportableSubsegmentsMember", "name": "us-gaap:GrossProfit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R65": { "role": "http://investview.com/role/SegmentReportingDetailsNarrative", "longName": "999068 - Disclosure - SEGMENT REPORTING (Details Narrative)", "shortName": "SEGMENT REPORTING (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "Segment", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:DescriptionOfTypesOfProductsAndServicesFromWhichEachReportableSegmentDerivesItsRevenues", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R66": { "role": "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails", "longName": "999069 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details)", "shortName": "SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "AsOf2024-10-11", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-10-11", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R67": { "role": "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetailsParenthetical", "longName": "999070 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) (Parenthetical)", "shortName": "SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "AsOf2024-10-11", "name": "INVU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCustomerDeposits", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-10-11_custom_RenuLaboratoriesIncMember", "name": "INVU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCustomerDeposits", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "link:footnote", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R68": { "role": "http://investview.com/role/AcquisitionDetailsNarrative", "longName": "999071 - Disclosure - ACQUISITION (Details Narrative)", "shortName": "ACQUISITION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "From2024-10-112024-10-11_custom_RenuLaboratoriesIncMember", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-10-11_custom_GoldmansPharmaceuticalsLLCMember", "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R69": { "role": "http://investview.com/role/IncomeTaxesDetailsNarrative", "longName": "999072 - Disclosure - INCOME TAXES (Details Narrative)", "shortName": "INCOME TAXES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R70": { "role": "http://investview.com/role/SubsequentEventsDetailsNarrative", "longName": "999073 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "From2025-04-012025-05-14_us-gaap_SubsequentEventMember_custom_StockRepurchaseProgramMember_us-gaap_TreasuryStockCommonMember", "name": "us-gaap:StockRepurchasedDuringPeriodShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-012025-05-14_us-gaap_SubsequentEventMember_custom_StockRepurchaseProgramMember_us-gaap_TreasuryStockCommonMember", "name": "us-gaap:StockRepurchasedDuringPeriodShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } } }, "tag": { "INVU_APEXTexLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "APEXTexLLCMember", "presentation": [ "http://investview.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "APEX Tex LLC [Member]", "documentation": "APEX Tex LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingChangesAndErrorCorrectionsAbstract", "lang": { "en-us": { "role": { "label": "Accounting Changes and Error Corrections [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsAndOtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsAndOtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReceivablesDetails": { "parentTag": "us-gaap_AccountsReceivableGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts and other receivables", "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued liabilities", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r87", "r88" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndAccruedLiabilitiesMember", "presentation": [ "http://investview.com/role/Related-partyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities [Member]", "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableGross", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReceivablesDetails": { "parentTag": "us-gaap_AccountsReceivableNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Receivable, gross", "label": "Accounts Receivable, before Allowance for Credit Loss", "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r217", "r336", "r337", "r1053" ] }, "us-gaap_AccountsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNet", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/ScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Receivables", "label": "Accounts Receivable, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r712", "r779", "r842", "r1052", "r1053" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Income tax payable", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r88", "r148" ] }, "INVU_AccruedLiabilitiesLongTerm": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "AccruedLiabilitiesLongTerm", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued liabilities, long term", "documentation": "Accrued liabilities long term." } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfFixedAssetsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r41", "r209", "r635" ] }, "INVU_AccumulatedNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "AccumulatedNoncontrollingInterest", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated noncontrolling interest", "documentation": "Accumulated noncontrolling interest." } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive income (loss)", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r20", "r21", "r106", "r218", "r630", "r657", "r660" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r11", "r21", "r541", "r544", "r591", "r653", "r654", "r956", "r957", "r958", "r969", "r970", "r971", "r972" ] }, "INVU_AcquisitionAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "AcquisitionAgreementMember", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Acquisition Agreement [Member]", "documentation": "Acquisition Agreement [Member]" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r898" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r98", "r833", "r1088" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r675", "r969", "r970", "r971", "r972", "r1025", "r1091" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r904" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r904" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r904" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r904" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "crdr": "credit", "presentation": [ "http://investview.com/role/DigitalAssetsDetailsNarrative", "http://investview.com/role/ScheduleOfDigitalAssetsActivityDetails", "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Cumulative effect adjustment upon adoption of ASU 2023-08", "verboseLabel": "Decrease in accumulated deficit", "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC)." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Advertising, Selling and Marketing Costs", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r164" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r869", "r880", "r890", "r915" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r872", "r883", "r893", "r918" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r904" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r911" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r873", "r884", "r894", "r911", "r919", "r923", "r931" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfReceivablesDetails": { "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Allowance for doubtful accounts", "label": "Accounts Receivable, Allowance for Credit Loss", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r219", "r341", "r348", "r349", "r350", "r1053" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of debt discount", "verboseLabel": "Debt discount into interest expense", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r7", "r113", "r424", "r1035" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r876" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Anti-dilutive securities", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r295" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r30" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r30" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "http://investview.com/role/Related-partyTransactionsDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r531" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r146", "r159", "r212", "r244", "r299", "r307", "r324", "r327", "r343", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r533", "r537", "r563", "r623", "r717", "r800", "r801", "r833", "r850", "r1010", "r1011", "r1041" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r204", "r223", "r244", "r343", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r533", "r537", "r563", "r833", "r1010", "r1011", "r1041" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Total Assets", "documentation": "Fair value portion of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r554", "r555", "r824" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r876" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Exercise Price" } } }, "auth_ref": [ "r926" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r927" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r922" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r922" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method" } } }, "auth_ref": [ "r922" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r922" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r922" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined" } } }, "auth_ref": [ "r922" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Securities" } } }, "auth_ref": [ "r925" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r924" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r923" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r923" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://investview.com/role/Related-partyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement of Financial Position Location, Balance [Axis]", "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported." } } }, "auth_ref": [ "r384", "r1055", "r1056" ] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://investview.com/role/Related-partyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported." } } }, "auth_ref": [ "r75", "r77", "r384", "r1055", "r1056" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Accounting", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "INVU_BitcoinMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "BitcoinMember", "presentation": [ "http://investview.com/role/ScheduleOfDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Bitcoin [Member]", "documentation": "Bitcoin [Member]" } } }, "auth_ref": [] }, "INVU_BlockchainTechnologyAndCryptoMiningProductsAndServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "BlockchainTechnologyAndCryptoMiningProductsAndServicesMember", "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Blockchain Technology and Crypto Mining Products and Services [Member]", "documentation": "Blockchain Technology and Crypto Mining Products and Services [Member]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r360", "r361", "r362", "r363", "r364", "r526", "r818", "r819" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r58", "r60", "r360", "r361", "r362", "r363", "r364", "r526", "r818", "r819" ] }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Transaction cost", "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition." } } }, "auth_ref": [] }, "INVU_BusinessAcquisitionCostOfAcquiredEntityTransactionFairValueDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionFairValueDiscount", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business acquisition, transaction costs discount value", "documentation": "Business Acquisition Cost Of Acquired Entity Transaction Fair Value Discount." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares exchanged for common stock", "verboseLabel": "Number of exchange shares issuable", "documentation": "Number of shares of equity interests issued or issuable to acquire entity." } } }, "auth_ref": [ "r141" ] }, "us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "presentation": [ "http://investview.com/role/Acquisition" ], "lang": { "en-us": { "role": { "label": "ACQUISITION", "documentation": "The entire description for costs incurred to effect a business combination that have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs." } } }, "auth_ref": [ "r140" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r526" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage of shares contributed", "verboseLabel": "Acquired percentage", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r59" ] }, "us-gaap_BusinessAcquisitionSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionSharePrice", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Closing market price per share", "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Fair value of noncontrolling interest in ELRT Technologies, LLC", "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date." } } }, "auth_ref": [ "r63" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "crdr": "credit", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Value pre-merger liabilities", "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination." } } }, "auth_ref": [ "r1", "r2", "r64", "r528" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets acquired", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "documentation": "Amount of assets acquired at the acquisition date." } } }, "auth_ref": [ "r62" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r62" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date." } } }, "auth_ref": [ "r62" ] }, "INVU_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCustomerDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCustomerDeposits", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails", "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetailsParenthetical" ], "lang": { "en-us": { "role": { "negatedLabel": "Customer deposits", "label": "Customer deposits", "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current liabilities customer deposits." } } }, "auth_ref": [] }, "INVU_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerDepositsIntercompany": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerDepositsIntercompany", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Customer deposits \u2013 intercompany", "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed customer deposits inter company." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Manufacturing equipment", "documentation": "Amount of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment, acquired at the acquisition date." } } }, "auth_ref": [ "r62" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Domain names", "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date." } } }, "auth_ref": [ "r62" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Raw materials", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "documentation": "The amount of inventory recognized as of the acquisition date." } } }, "auth_ref": [ "r61", "r62" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities assumed", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "documentation": "Amount of liabilities assumed at the acquisition date." } } }, "auth_ref": [ "r62" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net assets acquired", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r61", "r62" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Consideration", "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree." } } }, "auth_ref": [ "r62" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r62" ] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1", "crdr": "credit", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Converted market value", "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages." } } }, "auth_ref": [ "r17" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/LiquidityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r24", "r207", "r786" ] }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash Equivalents", "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits." } } }, "auth_ref": [ "r25", "r145" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents - beginning of period", "periodEndLabel": "Cash and cash equivalents - end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r24", "r119", "r240" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r119" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash, FDIC insured amount", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Non-cash investing and financing activities:" } } }, "auth_ref": [] }, "INVU_CashPaidDuringThePeriodForAbstract": { "xbrltype": "stringItemType", "nsuri": "http://investview.com/20250331", "localname": "CashPaidDuringThePeriodForAbstract", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid during the period for:", "documentation": "Cash Paid During The Period For [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashUninsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashUninsuredAmount", "crdr": "debit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash balances exceeded FDIC limits", "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r902" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "INVU_ClassBUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "ClassBUnitsMember", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class B Units [Member]", "documentation": "Class B Units [Member]" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r182", "r214", "r215", "r216", "r244", "r273", "r276", "r292", "r294", "r301", "r302", "r343", "r393", "r395", "r396", "r397", "r400", "r401", "r429", "r430", "r433", "r436", "r443", "r563", "r664", "r665", "r666", "r667", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r704", "r726", "r748", "r772", "r773", "r774", "r775", "r776", "r939", "r963", "r973" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockLineItems", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r214", "r215", "r216", "r301", "r429", "r430", "r431", "r433", "r436", "r441", "r443", "r664", "r665", "r666", "r667", "r813", "r939", "r963" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://investview.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Exercisable", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r444" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r903" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r903" ] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r531" ] }, "INVU_Commissions": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "Commissions", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Commissions", "documentation": "Commissions." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r94", "r152", "r626", "r703" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://investview.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r128", "r385", "r386", "r780", "r999", "r1004" ] }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock reserves for issuance", "documentation": "Aggregate number of common shares reserved for future issuance." } } }, "auth_ref": [ "r97" ] }, "us-gaap_CommonStockConversionFeatures": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockConversionFeatures", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion description", "documentation": "Description of common stock conversion feature. Includes, but is not limited to, conversion price; conversion right; timing of right; terms, event or change in circumstance causing contingency to be met or adjustment to conversion price or number of shares; manner of settlement upon conversion; and method of settlement." } } }, "auth_ref": [ "r175", "r176", "r177", "r444" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://investview.com/role/DebtDetailsNarrative", "http://investview.com/role/Related-partyTransactionsDetailsNarrative", "http://investview.com/role/StatementsOfStockholdersEquityDeficit", "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r839", "r840", "r841", "r843", "r844", "r845", "r846", "r969", "r970", "r972", "r1025", "r1085", "r1091" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://investview.com/role/BalanceSheetsParenthetical", "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "verboseLabel": "Par value of shares repurchased", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r97" ] }, "INVU_CommonStockRepurchasedForPayables": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "CommonStockRepurchasedForPayables", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock repurchased for payables", "verboseLabel": "Consideration payable for purchased shares and expenses", "documentation": "Common stock repurchased for payables." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://investview.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r97", "r704" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://investview.com/role/BalanceSheetsParenthetical", "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r97" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://investview.com/role/BalanceSheetsParenthetical", "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r13", "r97", "r704", "r723", "r1091", "r1092" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, par value $0.001; 10,000,000,000 shares authorized; 1,859,231,786 and 1,859,231,786 shares issued and 1,858,142,500 and 1,859,231,786 outstanding as of March 31, 2025 and December 31, 2024, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r97", "r629", "r833" ] }, "us-gaap_CommonUnitIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonUnitIssued", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Units, issued", "documentation": "Number of common units issued of limited liability company (LLC)." } } }, "auth_ref": [ "r135" ] }, "us-gaap_CommonUnitOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonUnitOutstanding", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Units, outstanding", "documentation": "Number of common units of ownership outstanding of a limited liability company (LLC)." } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r908" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r907" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r909" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r906" ] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComputerEquipmentMember", "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentration of Credit Risk", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r85", "r167" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r183", "r195", "r248", "r533", "r534", "r537", "r538", "r602", "r781", "r943", "r944", "r945", "r1009", "r1012", "r1013" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r183", "r195", "r248", "r533", "r534", "r537", "r538", "r602", "r781", "r943", "r944", "r945", "r1009", "r1012", "r1013" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Principles of Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r67", "r790" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred revenue", "verboseLabel": "Deferred revenues", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r446", "r447", "r458" ] }, "INVU_ContributionAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "ContributionAgreementMember", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Contribution Agreement [Member]", "documentation": "Contribution Agreement [Member]" } } }, "auth_ref": [] }, "INVU_ConversionOfNonVotingMembershipInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "ConversionOfNonVotingMembershipInterestMember", "presentation": [ "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Conversion of Non-voting Membership Interest [Member]", "documentation": "Conversion of Non-voting Membership Interest [Member]" } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockSharesConverted1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConversionOfStockSharesConverted1", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt secured by common stock", "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r27", "r28", "r29" ] }, "us-gaap_ConvertibleDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleDebtSecuritiesMember", "presentation": [ "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Convertible Debt Securities [Member]", "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder." } } }, "auth_ref": [ "r1020" ] }, "us-gaap_ConvertibleLongTermNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleLongTermNotesPayable", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Debt, net of discounts, long term", "verboseLabel": "Related-party debt, long term", "terseLabel": "Debt, long term portion", "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r18" ] }, "us-gaap_ConvertibleNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleNotesPayable", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Total related-party debt", "verboseLabel": "Total debt", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder." } } }, "auth_ref": [ "r18", "r151", "r1050" ] }, "us-gaap_ConvertibleNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleNotesPayableCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Debt, net of discounts, current", "negatedLabel": "Less: Current portion", "verboseLabel": "Less: Current portion", "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r88" ] }, "INVU_ConvertiblePromissoryNoteOneMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "ConvertiblePromissoryNoteOneMember", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Convertible Promissory Note One [Member]", "documentation": "Convertible Promissory Note One [Member]" } } }, "auth_ref": [] }, "INVU_ConvertiblePromissoryNoteThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "ConvertiblePromissoryNoteThreeMember", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Convertible Promissory Note Three [Member]", "documentation": "Convertible Promissory Note Three [Member]" } } }, "auth_ref": [] }, "INVU_ConvertiblePromissoryNoteTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "ConvertiblePromissoryNoteTwoMember", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Convertible Promissory Note Two [Member]", "documentation": "Convertible Promissory Note Two [Member]" } } }, "auth_ref": [] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfRevenue", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Cost of sales", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r109", "r244", "r343", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r563", "r800", "r1010" ] }, "us-gaap_CostOfSalesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfSalesPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cost of Sales and Service", "documentation": "Disclosure of accounting policy for cost of product sold and service rendered." } } }, "auth_ref": [ "r942" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditCardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditCardMember", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Credit Card [Member]", "documentation": "Card issued to user to facilitate payment for purchase of product and service, paid directly to merchant by card issuer, and later paid by cardholder to card issuer." } } }, "auth_ref": [ "r1019" ] }, "INVU_CreditCardProcessing": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "CreditCardProcessing", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Credit card processing", "documentation": "Credit card processing." } } }, "auth_ref": [] }, "us-gaap_CreditCardReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditCardReceivables", "crdr": "debit", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Credit card receivables", "documentation": "Amounts receivable from issuing a card to individuals or businesses that allows someone to make a purchase on borrowed money." } } }, "auth_ref": [ "r951" ] }, "us-gaap_CryptoAssetActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CryptoAssetActivityTableTextBlock", "presentation": [ "http://investview.com/role/DigitalAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DIGITAL ASSETS ACTIVITY", "documentation": "Tabular disclosure of information about activity for crypto asset. Excludes information about crypto asset held for platform user." } } }, "auth_ref": [ "r991" ] }, "srt_CryptoAssetAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CryptoAssetAxis", "presentation": [ "http://investview.com/role/ScheduleOfDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Crypto Asset [Axis]", "documentation": "Information by crypto-asset." } } }, "auth_ref": [ "r197", "r368", "r369", "r370", "r371", "r372", "r378", "r988", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998" ] }, "us-gaap_CryptoAssetCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CryptoAssetCost", "crdr": "debit", "presentation": [ "http://investview.com/role/DebtDetailsNarrative", "http://investview.com/role/ScheduleOfDigitalAssetsActivityDetails", "http://investview.com/role/ScheduleOfDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Digital assets held, Cost basis", "periodStartLabel": "Beginning balance, Cost Basis", "periodEndLabel": "Ending balance, Cost Basis", "verboseLabel": "Digital assets issued value", "documentation": "Cost of crypto asset. Excludes crypto asset held for platform user." } } }, "auth_ref": [ "r368", "r370" ] }, "srt_CryptoAssetDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CryptoAssetDomain", "presentation": [ "http://investview.com/role/ScheduleOfDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "Crypto-asset." } } }, "auth_ref": [ "r197", "r368", "r369", "r370", "r371", "r372", "r378", "r988", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998" ] }, "us-gaap_CryptoAssetFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CryptoAssetFairValue", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://investview.com/role/ScheduleOfDigitalAssetsActivityDetails", "http://investview.com/role/ScheduleOfDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Digital assets (see NOTE 5)", "verboseLabel": "Digital assets held, Fair value", "periodStartLabel": "Beginning balance, Fair Value", "periodEndLabel": "Ending balance, Fair Value", "documentation": "Fair value of crypto asset. Excludes crypto asset held for platform user." } } }, "auth_ref": [ "r367", "r368", "r371", "r373" ] }, "us-gaap_CryptoAssetFairValueNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CryptoAssetFairValueNoncurrent", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Digital assets", "documentation": "Fair value of crypto asset classified as noncurrent. Excludes crypto asset held for platform user." } } }, "auth_ref": [ "r367", "r368", "r371", "r373" ] }, "us-gaap_CryptoAssetHoldingLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CryptoAssetHoldingLineItems", "presentation": [ "http://investview.com/role/ScheduleOfDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Crypto Asset, Holding [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r368", "r369", "r370", "r371", "r372" ] }, "us-gaap_CryptoAssetHoldingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CryptoAssetHoldingTable", "presentation": [ "http://investview.com/role/ScheduleOfDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Crypto Asset, Holding [Table]", "documentation": "Disclosure of information about crypto asset. Includes, but is not limited to, name, cost basis, fair value, and number of units held. Excludes information about crypto asset held for platform user." } } }, "auth_ref": [ "r368", "r369", "r370", "r371", "r372" ] }, "us-gaap_CryptoAssetHoldingTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CryptoAssetHoldingTableTextBlock", "presentation": [ "http://investview.com/role/DigitalAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DIGITAL ASSETS", "documentation": "Tabular disclosure of information about crypto asset. Includes, but is not limited to, name, cost basis, fair value, and number of units held. Excludes information about crypto asset held for platform user." } } }, "auth_ref": [ "r990" ] }, "us-gaap_CryptoAssetPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CryptoAssetPeriodIncreaseDecrease", "presentation": [ "http://investview.com/role/DigitalAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Increase in digital assets", "documentation": "Amount of increase (decrease) in crypto asset. Excludes crypto asset held for platform user." } } }, "auth_ref": [ "r991" ] }, "us-gaap_CryptoAssetRealizedGainLossNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CryptoAssetRealizedGainLossNonoperating", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 }, "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfDigitalAssetsActivityDetails", "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Realized gain (loss) on digital assets", "negatedLabel": "Realized (gain) loss on digital assets", "verboseLabel": "Realized (gain) loss on sale of digital assets", "documentation": "Amount of realized gain (loss) from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user." } } }, "auth_ref": [ "r989" ] }, "us-gaap_CryptoAssetSale": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CryptoAssetSale", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfDigitalAssetsActivityDetails", "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Revenue recognized from bitcoin mined", "label": "Revenue recognized from Bitcoin mined", "documentation": "Amount of decrease in crypto asset from sale. Excludes crypto asset held for platform user." } } }, "auth_ref": [ "r993" ] }, "us-gaap_CryptoAssetTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CryptoAssetTextBlock", "presentation": [ "http://investview.com/role/DigitalAssets" ], "lang": { "en-us": { "role": { "label": "DIGITAL ASSETS", "documentation": "The entire disclosure for crypto asset. Excludes crypto asset held for platform user." } } }, "auth_ref": [ "r374", "r375", "r376" ] }, "us-gaap_CryptoAssetUnrealizedGainLossNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CryptoAssetUnrealizedGainLossNonoperating", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 }, "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfDigitalAssetsActivityDetails", "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Unrealized gain (loss) on digital assets", "negatedLabel": "Change in fair value of digital assets", "verboseLabel": "Change in fair value of digital assets", "documentation": "Amount of unrealized gain (loss) from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user." } } }, "auth_ref": [ "r989" ] }, "INVU_CryptoAssetsNumberOfUnits": { "xbrltype": "pureItemType", "nsuri": "http://investview.com/20250331", "localname": "CryptoAssetsNumberOfUnits", "presentation": [ "http://investview.com/role/ScheduleOfDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Digital assets held, Quantity", "documentation": "Crypto assets number of units." } } }, "auth_ref": [] }, "INVU_CumulativeEffectAdjustmentUponAdoptionOfASU202308": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "CumulativeEffectAdjustmentUponAdoptionOfASU202308", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Cumulative effect adjustment upon adoption of ASU 2023-08", "documentation": "Cumulative effect adjustment uponadoption of asu 202308.", "label": "CumulativeEffectAdjustmentUponAdoptionOfASU202308" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "INVU_DBRCapitalLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "DBRCapitalLLCMember", "presentation": [ "http://investview.com/role/Related-partyTransactionsDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "DBR Capital LLC [Member]", "documentation": "DBR Capital LLC [Member]" } } }, "auth_ref": [] }, "INVU_DataProcessingEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "DataProcessingEquipmentMember", "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Data Processing Equipment [Member]", "documentation": "Data Processing Equipment [Member]" } } }, "auth_ref": [] }, "INVU_DebtAndRelatedPartyDebtExtinguishedInExchangeForCryptocurrency": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "DebtAndRelatedPartyDebtExtinguishedInExchangeForCryptocurrency", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDigitalAssetsActivityDetails", "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Debt extinguished in exchange for digital assets", "negatedLabel": "Debt extinguished in exchange for digital assets", "documentation": "Debt and related party debt extinguished in exchange for cryptocurrency." } } }, "auth_ref": [] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://investview.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares issued for debt", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r27", "r29" ] }, "us-gaap_DebtConversionDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionDescription", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt conversion description", "documentation": "Description of conversion of original debt instrument in noncash or part noncash transaction." } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://investview.com/role/Debt" ], "lang": { "en-us": { "role": { "label": "DEBT", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r129", "r242", "r379", "r380", "r381", "r382", "r383", "r391", "r392", "r402", "r408", "r409", "r410", "r411", "r412", "r413", "r418", "r425", "r426", "r427", "r572" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r18", "r87", "r88", "r147", "r151", "r248", "r403", "r404", "r405", "r406", "r407", "r409", "r414", "r415", "r416", "r417", "r419", "r420", "r421", "r422", "r423", "r424", "r808", "r809", "r810", "r811", "r812", "r831", "r964", "r1000", "r1001", "r1002", "r1034", "r1036" ] }, "us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentConvertibleBeneficialConversionFeature", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Beneficial conversion feature and debt discount", "documentation": "Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date." } } }, "auth_ref": [ "r48" ] }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentConvertibleConversionPrice1", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt conversion price per share", "documentation": "The price per share of the conversion feature embedded in the debt instrument." } } }, "auth_ref": [ "r130", "r405" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/DebtDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt instrument face amount", "verboseLabel": "Note amount", "terseLabel": "Debt instrument, principal amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r403", "r572", "r573", "r809", "r810", "r831" ] }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateDuringPeriod", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "verboseLabel": "Debt interest rate", "label": "Debt Instrument, Interest Rate During Period", "documentation": "The average effective interest rate during the reporting period." } } }, "auth_ref": [ "r90", "r421", "r1034" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt interest rate", "verboseLabel": "Debt instrument interest rate", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r90", "r404" ] }, "us-gaap_DebtInstrumentIssuedPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentIssuedPrincipal", "crdr": "credit", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Notes issued value", "documentation": "Amount of principal of debt issued." } } }, "auth_ref": [ "r664" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt instrument maturity date", "verboseLabel": "Notes maturity date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r213", "r808", "r1029", "r1030" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r18", "r248", "r403", "r404", "r405", "r406", "r407", "r409", "r414", "r415", "r416", "r417", "r419", "r420", "r421", "r422", "r423", "r424", "r808", "r809", "r810", "r811", "r812", "r831", "r964", "r1000", "r1001", "r1002", "r1034", "r1036" ] }, "us-gaap_DebtInstrumentPaymentTerms": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentPaymentTerms", "presentation": [ "http://investview.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt payment terms", "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment." } } }, "auth_ref": [ "r84", "r91" ] }, "us-gaap_DebtInstrumentPeriodicPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentPeriodicPayment", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Monthly installment payments", "documentation": "Amount of the required periodic payments including both interest and principal payments." } } }, "auth_ref": [ "r18", "r84" ] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r1015", "r1033", "r1034", "r1036" ] }, "INVU_DebtPremiumPercentage": { "xbrltype": "percentItemType", "nsuri": "http://investview.com/20250331", "localname": "DebtPremiumPercentage", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt premium percentage", "documentation": "Debt premium percentage." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DepositsAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepositsAssetsCurrent", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deposits, current", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter." } } }, "auth_ref": [ "r955" ] }, "us-gaap_DepositsAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepositsAssetsNoncurrent", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deposits", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r948" ] }, "INVU_DepositsCollectedFromCustomersForOrdersToBeFilledAtFutureDate": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "DepositsCollectedFromCustomersForOrdersToBeFilledAtFutureDate", "crdr": "credit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deposits collected from customers for orders to be filled at future date", "documentation": "Deposits collected from customers for orders to be filled at future date." } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails", "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation", "verboseLabel": "Depreciation expense", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r7", "r40" ] }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeGainLossOnDerivativeNet", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 }, "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfDerivativeLiabilityDetails", "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Gain (loss) on fair value of derivative liability", "negatedLabel": "(Gain) loss on fair value of derivative liability", "negatedTerseLabel": "(Gain) loss on fair value", "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r1024" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://investview.com/role/DerivativeLiability" ], "lang": { "en-us": { "role": { "label": "DERIVATIVE LIABILITY", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r144", "r539", "r547" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilities", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivative liability", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r224", "r225", "r554", "r555", "r560", "r562", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r718", "r720", "r721", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r789", "r1028", "r1029", "r1030", "r1086" ] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Derivative liability", "periodStartLabel": "Derivative liability", "periodEndLabel": "Derivative liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r224" ] }, "us-gaap_DerivativeLiabilityMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilityMeasurementInput", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "label": "Derivative liability measurement input", "documentation": "Value of input used to measure derivative liability." } } }, "auth_ref": [ "r556", "r557", "r558" ] }, "INVU_DerivativeLiabilityRecordedOnNewInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "DerivativeLiabilityRecordedOnNewInstruments", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Derivative liability recorded on new instruments", "documentation": "Derivative liability recorded on new instruments." } } }, "auth_ref": [] }, "INVU_DerivativeLiabilityReducedByWarrantExercise": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "DerivativeLiabilityReducedByWarrantExercise", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Derivative liability reduced by warrant exercise", "documentation": "Warrant exercise." } } }, "auth_ref": [] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLineItems", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r547" ] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeTable", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "label": "Derivative [Table]", "documentation": "Disclosure of information about derivative instrument or group of derivative instruments, including, but not limited to, type of derivative instrument, risk being hedged, notional amount, hedge designation, related hedged item, inception date, and maturity date." } } }, "auth_ref": [ "r14", "r71", "r72", "r73", "r74", "r76", "r78", "r79", "r80", "r81", "r547" ] }, "us-gaap_DescriptionOfTypesOfProductsAndServicesFromWhichEachReportableSegmentDerivesItsRevenues": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DescriptionOfTypesOfProductsAndServicesFromWhichEachReportableSegmentDerivesItsRevenues", "presentation": [ "http://investview.com/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of Products and Services", "documentation": "Description of the types of products and services from which the reportable segment derives its revenue." } } }, "auth_ref": [ "r123", "r795", "r802" ] }, "INVU_DigitalAssetsCollectedForMembershipRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "DigitalAssetsCollectedForMembershipRevenue", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfDigitalAssetsActivityDetails", "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Digital assets collected for membership revenue", "label": "Digital assets collected from membership revenue", "documentation": "Digital assets collected for membership revenue." } } }, "auth_ref": [] }, "INVU_DigitalAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://investview.com/20250331", "localname": "DigitalAssetsPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Digital Assets", "documentation": "Digital Assets [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF REVENUE GENERATED", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r1018" ] }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPTIONS ACTIVITY", "documentation": "Tabular disclosure of share-based payment arrangement." } } }, "auth_ref": [ "r9", "r56" ] }, "INVU_DisclosureOperatingLeaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://investview.com/20250331", "localname": "DisclosureOperatingLeaseAbstract", "lang": { "en-us": { "role": { "label": "Operating Lease", "verboseLabel": "Schedule Of Future Minimum Lease Payments Under Non-cancellable Leases" } } }, "auth_ref": [] }, "INVU_DistributionOfDigitalCurrenciesPriorToTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "DistributionOfDigitalCurrenciesPriorToTermination", "crdr": "debit", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Distribution of digital currencies prior to termination", "documentation": "Distribution of digital currencies prior to termination." } } }, "auth_ref": [] }, "us-gaap_Dividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Dividends", "crdr": "debit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends", "label": "Dividends declared", "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock." } } }, "auth_ref": [ "r5", "r135" ] }, "us-gaap_DividendsCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsCash", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Dividends, cash", "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred." } } }, "auth_ref": [ "r5", "r135" ] }, "INVU_DividendsPaidWithDigitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "DividendsPaidWithDigitalAssets", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDigitalAssetsActivityDetails", "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Dividends paid with digital assets", "negatedLabel": "Dividends paid via digital assets", "documentation": "Dividends paid with digital assets." } } }, "auth_ref": [] }, "us-gaap_DividendsPayableAmountPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsPayableAmountPerShare", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, dividend price per share", "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date." } } }, "auth_ref": [ "r27" ] }, "us-gaap_DividendsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsPayableCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Dividend liability", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r88" ] }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Dividend liability", "label": "Dividends Payable", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding." } } }, "auth_ref": [ "r88", "r93", "r149", "r847", "r1049" ] }, "us-gaap_DividendsPreferredStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsPreferredStockCash", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Dividends paid in cash", "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r5", "r135" ] }, "us-gaap_DividendsPreferredStockPaidinkind": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsPreferredStockPaidinkind", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Digital assets issued for dividend payment", "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in payment-in-kind (PIK)." } } }, "auth_ref": [ "r5", "r135" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r864" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r862", "r864", "r876" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r863" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r851" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r864" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r864" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r897" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r854" ] }, "INVU_DomesticRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "DomesticRevenueMember", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Domestic Revenue [Member]", "documentation": "Domestic Revenue [Member]" } } }, "auth_ref": [] }, "INVU_DueFromMerchantProcessors": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "DueFromMerchantProcessors", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReceivablesDetails": { "parentTag": "us-gaap_AccountsReceivableGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Due from merchant processors", "documentation": "Due from merchant processors." } } }, "auth_ref": [] }, "INVU_DueFromPayoutServiceProviders": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "DueFromPayoutServiceProviders", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReceivablesDetails": { "parentTag": "us-gaap_AccountsReceivableGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Due from payout service providers", "documentation": "Due from payout service providers." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Basic income (loss) per common share", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r232", "r258", "r259", "r260", "r261", "r262", "r263", "r270", "r273", "r292", "r293", "r294", "r298", "r524", "r530", "r551", "r552", "r620", "r642", "r792" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://investview.com/role/ScheduleOfDilutedEarningsPerShareDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Diluted income (loss) per common share", "verboseLabel": "Diluted income per common share", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r232", "r258", "r259", "r260", "r261", "r262", "r263", "r273", "r292", "r293", "r294", "r298", "r524", "r530", "r551", "r552", "r620", "r642", "r792" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) per Share", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r269", "r295", "r296", "r297" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "presentation": [ "http://investview.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Effective tax rate", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r501", "r821", "r966", "r1023" ] }, "INVU_ElRTTechnologiesLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "ElRTTechnologiesLLCMember", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "ELRT Technologies, LLC [Member]", "documentation": "ELRT Technologies, LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Payroll liabilities", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r88" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average period for recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r494" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized compensation cost", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r1022" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOptionMember", "presentation": [ "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "INVU_EnergyAndHosting": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "EnergyAndHosting", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Energy and hosting", "documentation": "Energy and Hosting." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r857" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r853" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityDomain", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative", "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetailsParenthetical" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r853" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r938" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r853" ] }, "dei_EntityIncorporationDateOfIncorporation": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationDateOfIncorporation", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Entity incorporation, date of incorporation", "documentation": "Date when an entity was incorporated" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r935" ] }, "dei_EntityListingParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingParValuePerShare", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Par Value Per Share", "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r876" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r853" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r853" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r853" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r853" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r936" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://investview.com/role/DebtDetailsNarrative", "http://investview.com/role/DigitalAssetsDetailsNarrative", "http://investview.com/role/Related-partyTransactionsDetailsNarrative", "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails", "http://investview.com/role/StatementsOfStockholdersEquityDeficit", "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r13", "r200", "r229", "r230", "r231", "r249", "r250", "r251", "r255", "r262", "r264", "r266", "r300", "r344", "r347", "r377", "r445", "r512", "r513", "r519", "r520", "r521", "r525", "r529", "r530", "r540", "r541", "r542", "r543", "r544", "r546", "r550", "r564", "r565", "r566", "r567", "r568", "r569", "r574", "r577", "r591", "r641", "r653", "r654", "r655", "r675", "r748" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r905" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r869", "r880", "r890", "r915" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r866", "r877", "r887", "r912" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r911" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://investview.com/role/DerivativeLiabilityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r556", "r557", "r827" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r416", "r460", "r461", "r462", "r463", "r464", "r465", "r553", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r606", "r607", "r608", "r809", "r810", "r815", "r816", "r817", "r824", "r827" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r554", "r555", "r556", "r558", "r824", "r1029", "r1031" ] }, "INVU_FairValueDiscountedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://investview.com/20250331", "localname": "FairValueDiscountedPercentage", "presentation": [ "http://investview.com/role/StockholdersEquityDeficitDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value discounted percentage", "documentation": "Fair value discounted percentage." } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r416", "r460", "r465", "r555", "r560", "r606", "r815", "r816", "r817", "r824" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r416", "r460", "r465", "r555", "r556", "r560", "r607", "r809", "r810", "r815", "r816", "r817", "r824" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r416", "r460", "r461", "r462", "r463", "r464", "r465", "r555", "r556", "r557", "r558", "r560", "r608", "r809", "r810", "r815", "r816", "r817", "r824", "r827" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement frequency." } } }, "auth_ref": [ "r554", "r555", "r556", "r558", "r824", "r1029", "r1031" ] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r416", "r460", "r461", "r462", "r463", "r464", "r465", "r553", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r606", "r607", "r608", "r809", "r810", "r815", "r816", "r817", "r824", "r827" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r824", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031" ] }, "INVU_FinancialEducationAndTechnologyMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "FinancialEducationAndTechnologyMember", "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Financial Education and Technology [Member]", "documentation": "Financial Education and Technology [Member]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r615", "r987" ] }, "INVU_ForeignRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "ForeignRevenueMember", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Foreign Revenue [Member]", "documentation": "Foreign Revenue [Member]" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r873", "r884", "r894", "r919" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r873", "r884", "r894", "r919" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r873", "r884", "r894", "r919" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r873", "r884", "r894", "r919" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r873", "r884", "r894", "r919" ] }, "INVU_FurnitureFixturesAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "FurnitureFixturesAndEquipmentMember", "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Furniture, Fixtures and Equipment [Member]", "documentation": "Furniture, Fixtures and Equipment [Member]" } } }, "auth_ref": [] }, "INVU_GainLossonLeaseCostNetofRepayment": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "GainLossonLeaseCostNetofRepayment", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Lease cost, net of repayment", "documentation": "Gain loss on lease cost net of repayment.", "label": "GainLossonLeaseCostNetofRepayment" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "General and administrative", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r111", "r728" ] }, "INVU_GoldmansPharmaceuticalsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "GoldmansPharmaceuticalsLLCMember", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Goldman's Pharmaceuticals LLC [Member]", "documentation": "Goldman's Pharmaceuticals LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r210", "r357", "r619", "r801", "r807", "r825", "r833", "r985", "r986" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined." } } }, "auth_ref": [ "r356", "r358", "r807" ] }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible Assets", "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined." } } }, "auth_ref": [ "r359", "r365", "r366" ] }, "INVU_GrossBillingsReceipts": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "GrossBillingsReceipts", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfRevenueGeneratedDetails": { "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails" ], "lang": { "en-us": { "role": { "label": "Gross billings/receipts", "documentation": "Gross billings/receipts." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Segment income from operations", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r107", "r109", "r158", "r244", "r343", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r563", "r794", "r800", "r975", "r977", "r978", "r979", "r980", "r1010" ] }, "INVU_HaverfordLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "HaverfordLeaseMember", "presentation": [ "http://investview.com/role/OperatingLeaseDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Haverford Lease [Member]", "documentation": "Haverford Lease [Member]" } } }, "auth_ref": [] }, "INVU_HealthAndWellnessRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "HealthAndWellnessRevenueMember", "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Health and Wellness Revenue [Member]", "documentation": "Health and Wellness Revenue [Member]" } } }, "auth_ref": [] }, "INVU_HeldInReserveByMerchantProcessorsForFutureReturnsAndChargebacks": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20250331", "localname": "HeldInReserveByMerchantProcessorsForFutureReturnsAndChargebacks", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReceivablesDetails": { "parentTag": "us-gaap_AccountsReceivableGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Held in reserve by merchant processors for future returns and chargebacks", "documentation": "Held in reserve by merchant processors for future returns and charge backs." } } }, "auth_ref": [] }, "INVU_IGeniusLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20250331", "localname": "IGeniusLLCMember", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "iGenius, LLC [Member]", "documentation": "iGenius, LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "crdr": "debit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairment of long-lived assets", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale." } } }, "auth_ref": [ "r7", "r125", "r826" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of Long-Lived Assets", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r127" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 }, "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Income (loss) before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r108", "r154", "r158", "r621", "r637", "r794", "r800", "r975", "r977", "r978", "r979", "r980" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://investview.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "INCOME TAXES", "docum